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Changes in the size and shape of the head are common across many different 
animals and are perhaps most noticeable in the dog. Popular dog breeds such as the 
Greyhound have long, narrow heads whilst breeds such as the Pug have very flat 
faces. Dog breeders have slowly introduced the flat-faced look into many of these 
breeds by carefully controlling which dogs have litters. An unintentional side effect 
of these breeding programmes has been the introduction of many diseases into the 
flat-faced dogs. One of the most common diseases are a group of breathing problems 
called Brachycephalic Obstructive Airway Syndrome (BOAS). Dogs that suffer from 
BOAS have difficulty breathing and often need to have surgery to improve their 
symptoms. This is a major welfare concern. 
The objective of this project was to improve the welfare of dogs by finding the 
DNA changes that cause differences in face length and that increase the risk of 
suffering from BOAS. To do this, computer tomography (CT) scans of 84 different dog 
breeds were analysed to measure the changes in the shape of their skulls. Comparing 
the changes in these measurements to changes in the dogs’ DNA revealed that the 
flat-faced dogs have an error in the SMOC2 gene. It is thought that this error reduces 
the amount of the SMOC2 protein in flat-faced breeds. This protein is normally found 
in the parts of the embryo that will later become the face and when it is removed 
from mice, it causes the mice to have abnormal head shapes similar to the flat-faced 
dogs. These studies strongly suggest that SMOC2 has an important role in 
determining head shapes across different animals.  
The Norwich Terrier is not a flat-faced dog breed, however it is known to suffer 
from breathing problems very similar to dogs diagnosed with BOAS. The symptoms 
of affected Norwich Terriers were assessed using an endoscopic camera which can 
examine the airways of the dogs. Changes in the airways visualised by the camera 
were compared to changes in the dogs’ DNA, which identified a mutation in a gene 
called ADAMTS3. Exactly how this mutation causes breathing problems in the 




breathing difficult. Eighty-nine different dog breeds were checked to determine if 
they also have the same error in the ADAMTS3 gene. The error was only observed in 
the Norwich Terrier and flat-faced breeds such as the Bulldog and French bulldog. 
This suggests that ADAMTS3 might be contributing to breathing problems across 
several breeds.  
This study has found errors in DNA believed to cause the flat-faced look and 
breathing problems in the dog. This provides an opportunity to offer DNA tests to 
reduce the likelihood of these breeds suffering from BOAS and to increase the 






The brachycephalic head conformation is a morphological trait under human 
selection across many popular breeds such as the Pug. The conformation is 
characterised by the concurrent rostrocaudal shortening and mediolateral widening 
of the skull. Overwhelming evidence suggests this skull conformation predisposes 
breeds to a respiratory morbidity, Brachycephalic Obstructive Airway Syndrome 
(BOAS) which restricts airflow. This is a major welfare concern.  
To date, very little is known regarding the genetic factors underpinning canine 
craniofacial variation or how such factors may influence BOAS aetiology. This project 
utilised computer tomography scans of 560 dogs to generate high resolution three-
dimensional reconstructions of the skull. Geometric morphometric analysis 
permitted the separation of the confounding influence of size on shape (allometry) 
at an individual-level – a study design never previously utilised in dogs. Genome-wide 
association studies (GWAS) using viscerocranial shape changes identified a QTL on 
chromosome 1 associated with canine brachycephaly. Haplotype mapping refined 
the critical interval to encompass the SPARC-related modular calcium-binding protein 
2 (SMOC2) gene. Leveraging haplotype mapping and whole-genome sequencing, a 
long interspersed nuclear element (LINE-1) was discovered within intron eight of 
SMOC2. Transcriptomic analysis revealed the presence of alternative SMOC2 
transcripts containing premature stop codons and a downregulation of the gene 
among brachycephalic carriers of the LINE-1. Models of phenotypic effect predicted 
that this structural variant explains up to 36% of the total craniofacial variation in the 
dog.  
Despite many brachycephalic dogs being fixed for the SMOC2 LINE-1 mutation, 
heterogeneity in BOAS presentation suggests additional genetic factors contribute to 
disease risk and presentation. To address this, a respiratory distress syndrome with 
remarkable similarities to BOAS was assessed in the Norwich Terrier. Endoscopic 
examinations of 233 Norwich Terriers graded and characterised the respiratory 




with changes in the structure of the laryngeal saccules and cartilage of affected dogs. 
The underlying disease-associated haplotype encompassed the disintegrin and 
metalloproteinase with thrombospondin motifs 3 (ADAMTS3) gene which was 
observed to harbour a missense mutation in severely affected dogs. Screening for the 
variant across 89 diverse dog breeds revealed it was enriched in brachycephalic 
breeds, suggesting that the brachycephalic conformation alone does not completely 
explain the presentation of BOAS in these breeds. Together, these results provide the 
opportunity to improve animal welfare by offering genetic screening tests and further 
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manuscript. All figures in the manuscript were generated exclusively by Thomas 
Marchant and have been modified for the inclusion in the thesis. A full copy of the 
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A second manuscript describing the causes of upper airway syndrome in the 
Norwich Terrier was submitted to the journal, PLoS Genetics (submitted: 23rd July 
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Chapter 1: Introduction 
1.1 The Brachycephalic Skull 
The mammalian skull is a profoundly complex unit which houses the visual, 
auditory, olfactory and gustatory sensory systems and serves to protect the brain. It 
also facilitates ingestion and respiration and plays a prominent role in 
communication and recognition. The skulls of the human, dog and mouse 
demonstrate that whilst the gross morphologies between species vary due to their 
specific evolutionary needs e.g. larger braincase in humans and more sophisticated 
foreface/teeth in dogs, many of their constituent bones are conserved (Figure 1.1). 
Each of these constituent bones (excluding the mandible) fuse together at fibrous 
sites called cranial sutures to form the mature cranium (Beederman et al. 2014). This 
is subdivided into the neurocranium which includes bones encompassing the brain, 
and the viscerocranium which includes bones of the fore-face. The comparative skull 
morphology across species is reflective of the shared evolutionary history of the 
human, dog and mouse and the high sequence synteny between them (Murphy et al. 
2001; Arnason et al. 2002; Kirkness et al. 2003; Lindblad-Toh et al. 2005).  
Figure 1.1 - Structure of the Mammalian Skull. Lateral view of the human, dog and mouse skulls. 
Bone labels: temporal (T), occipital (O), interparietal (IP), parietal (P), frontal (F), sphenoid (S), 
ethmoid (E), nasal (N), lacrimal (L), zygomatic (Z), incisive (I), maxilla (Max), mandible (Man) and 
palatine (P). The right lambdoid suture (LS) and coronal suture is (CS) is labelled with the metopic 
and sagittal sutures positioned along the dorsal midline of the skull between the paired parietal and 




Morphological deviation of the skull away from the ‘normal’ structure for each 
species have been shown to induce a wide range of detrimental health problems 
(Wang et al. 2005; Bannink et al. 2010; Fasanella et al. 2010). A common collection 
of disorders in humans characterised by abnormal skull development are 
craniosynostoses. 
1.1.1 Craniosynostosis 
Craniosynostoses are one of the most frequent forms of craniofacial 
abnormalities in new-born children, predicted to affect between 2,100 and 2,500 
births (Lajeunie et al. 1995; Persing 2008). The condition is caused by the premature 
fusion of one or more of the cranial sutures during the maturation of the skull which 
prevents further growth at that site. The remaining unfused sutures allow continued 
bone growth which distorts the overall shape of the skull. The sagittal suture is most 
commonly affected (40-58% cases), followed by the coronal suture (20-29%), 
metopic suture (4-10%) and lambdoid suture (2-4%) (Figure 1.1) (Kimonis et al. 2007). 
The majority (85%) of craniosynostoses occur in isolation and present clinically in a 
Figure 1.2 – Brachycephaly across Mammalian Species. For each of the mammalian species, a 
brachycephalic skull is pictured beneath that of a ‘normal’ skull. Brachycephalic mouse 
representative of the Fgfr2+/S252W mutant mouse (Wang et al. 2005). Mesocephalic and 




highly heterogenous state (Johnson and Wilkie, 2011). However, due to the finite 
number of possible cranial suture fusion sites, craniosynostoses can form distinct and 
characteristic head shapes. For example, the bilateral fusion of the coronal sutures in 
humans causes midface retrusion – the shortening, widening and heightening of the 
skull known as “brachycephaly” (Figure 1.2) (Persing et al. 1989). This nomenclature 
was used to originally describe the characteristic human head shapes but has since 
been adopted across species to describe similar morphological changes, whether it is 
the result of a disease inducing mutation, a desirable trait under selection or an 
intentional genetic modification (Figure 1.2) (Wang et al. 2005; Schlueter et al. 2009; 
Koch et al. 2012; Veitschegger et al. 2018).  
A smaller proportion (15%) of craniosynostoses present as part of broader 
clinical syndromes which commonly have additional skeletal anomalies and most 
notably include abnormalities of the hands and feet (Kimonis et al. 2007). Crouzon, 
Apert and Pfeiffer syndromes are some of the most frequent forms and all have 
similar craniofacial characteristics including midface retrusion (brachycephaly), wide 
set bulging eyes, broad beaked nose, an underdeveloped jaw and are often only 
clinically distinguished by the extra-cranial features. Apert syndrome commonly 
presents with webbed or fused digits (syndactyly) whilst Pfeiffer syndrome has 
characteristic short digits (brachydactyly) and often has large, medially deviating 
thumbs and great toes (Apert 1906). The digits of Crouzon patients are largely 
unaffected (Anderson et al. 1997). Beyond these examples are over 100 further 
syndromic craniosynostoses but only a small subset of which have had their causal 
genetic variants mapped resulting in only 21% of craniosynostosis patients receiving 
a genetic diagnosis (Johnson and Wilkie 2011; Cox et al. 2014).  
The structural skeletal alterations in craniosynostosis can seriously impede 
normal function and the quality of life of patients from an early age. Care must be 
taken to acutely assess restrictions to feeding, increased risk of choking and eye 
protection during sleep. Intracranial pressure must also be monitored to reduce the 




Approximately 40% of patients can have intellectual developmental difficulties 
(Speltz et al. 2015) including forms of attention deficits and autism (Sarimski 1998; 
2001). The brachycephalic midface retrusion in craniosynostosis also severely 
predisposes patients to obstructive respiratory problems such as obstructive sleep 
apnoea throughout life (Bannink et al. 2011).  
1.1.2 Obstructive Sleep Apnoea 
Obstructive sleep apnoea (OSA) is a chronic respiratory condition caused by the 
repetitive partial or complete collapse of the upper airway during sleep (Lattimore et 
al. 2003). Sufferers commonly experience fragmented sleep and oxygen desaturation 
and are linked with the failure to thrive, delayed development, recurrent infections, 
increased risk of morbidities such as cardiovascular disease and sudden death (Sin et 
al. 1999; Lattimore et al. 2003; Nixon and Brouillette 2005).  
The midface retrusion of patients with craniosynostosis is considered to be the 
primary predisposing factor in OSA which stimulates the collapse of the pharynx and 
tonsillar hypertrophy (Bannink et al. 2011). The proportion of craniosynostosis 
patients which suffer from OSA can be as high as 70% and largely presents before 6 
years of age and continues throughout life (Bannink et al. 2010; 2011; Driessen et al. 
2013). Crouzon and Pfeiffer syndromes appear to have a slightly higher incidence of 
OSA due to their specific skull conformation compared to other forms of 
craniosynostosis (Moore 1993). 
OSA is not just restricted to patients with craniosynostosis. Up to 5% of the 
general population are also diagnosed with the condition (Ward and Marcus 1996; 
Bixler et al. 1998; Sin et al. 1999; Bixler et al. 2001). Men have a slightly greater 
susceptibility compared to women with obesity being the greatest predisposing 
factor and accounts for 24% of variation in the apnoea-hypopnea index, a method for 
scoring the severity of OSA (Bixler et al. 1998; 2001; Dempsey et al. 2002). 
Interestingly, like cases of craniosynostoses, structural variation in craniofacial 
morphology also predisposes the general population to OSA. However, unlike 




predisposed to OSA represent natural variation and are often very subtle. This natural 
variation has a major genetic component as shown in studies of common facial traits 
between twins and across families (Hunter et al. 1970; Nakata et al. 1973; King et al. 
1993; Savoye et al. 1998; Johannsdottir et al. 2005). The heritability of these 
craniofacial traits is predicted to be as high as 0.8 with some traits such as cranial 
height being more heritable than others (King et al. 1993; Johannsdottir et al. 2005; 
Carson 2006).  
In the general population, a single craniometric measurement, facial depth at 
the height of the palate can account for up to 15% of the apnoea-hypopnea index, 
making it the second greatest explanatory variable after obesity (Dempsey et al. 
2002). In a separate study, face width, eye width and mandibular length can predict 
OSA with a sensitivity of 86% (Lee et al. 2009) and correlations between maxilla 
length are also seen in severe OSA cases (Ferguson et al. 1995). More specifically, 
Capistrano et al., (2015) showed that members of the general population with subtle 
brachycephaly-like craniofacial variation had a significantly increased risk of OSA 
compared to the mesocephalic (“normal face”) and dolichocephalic (“long faced”) 
individuals (Capistrano et al. 2015). Some craniofacial assessments of OSA have been 
less clear with regards to specific facial shapes associated with the condition. In fact, 
it has been suggested that the dolichocephalic head shape is also associated with 
cases of OSA and may in fact present an equal risk to the brachycephalic 
conformation (Kikuchi et al. 2001; Di Francesco et al. 2012). 
Overall, variation in craniofacial morphology significantly increases the risk OSA 
regardless of whether it is part of a clinically diagnosed syndrome or subtle sub-
clinical natural variation in the general population (Ferguson et al. 1995; Dempsey et 
al. 2002; Bannink et al. 2011). In order to understand how obstructive respiratory 
conditions manifest, a better understanding of the developmental origins of the skull, 




1.2 Developmental Origins of Skull Development 
Craniofacial development is a complex three dimensional (3D) process and 
although the duration of gestation varies between mammalian species, for example 
280 days in humans and just 65 days in dogs, many of the processes are comparable 
(Evans and de Lahunta 2013). Integral to the development of the craniofacial skeleton 
is the production and migration of mesenchymal stem cells (MSC). MSCs are derived 
from two tissue origins; the neural crest cell (NCC) and paraxial mesoderm which are 
both generated during the formation and closure of the neural tube along the dorsal 
axis of the embryo at approximately stage 10 (early week 4) in humans (O'Rahilly and 
Müller 2007) (Figure 1.3A). The NCC and paraxial mesoderm populations stream into 
the developing frontonasal prominence and pharyngeal arches (swellings) on the 
ventral surface of the embryo (Figure 1.3B). In humans, there are four pharyngeal 
arches which begin to emerge during week four of development and contribute to 
different aspects of the face. Pharyngeal arch (PA) 1 has two nodules – the maxillary 
and mandibular prominences which give rise to the upper and lower jaw, respectively 
(Figure 1.3C). PA2 and PA3 most notably form the hyoid bone which acts as an anchor 
site for muscles of the neck, tongue and larynx. PA4 forms the larynx and the cricoid 
cartilage (Moore and Persuad 2003; Carlson 2009; Schoenwolf et al. 2015). 
Comparatively, in its shorter gestation, the maxillary and mandibular processes are 
first distinguishable at Day 23 in the dog (Pretzer 2008).  
In humans, at approximately Day 35 of development the frontonasal 
prominence folds to form a pair of nasal pits which creates the lateral and medial 
nasal processes (Figure 1.3C). The medial nasal processes will merge at the midline 
to generate the nose, philtrum (groove of the upper lip) and primary palate whilst 
the lateral nasal processes form the sides of the nose. The paired maxillary processes 
fold and fuse to make the cheeks and maxilla whilst the mandibular processes fuse 
caudally to create the lower jaw and to establish the oral cavity. The final facial plan 




The bone of the skull is derived from MSCs which are distributed amongst the 
mesenchyme of the frontonasal prominences and pharyngeal arches. These MSCs 
have two distinct origins along the dorsal axis of the embryo – the NCC and paraxial 
mesoderm and generally contribute to the formation of the viscerocranium and 
neurocranium, respectively. 
Figure 1.3 – Embryology of the Face. (A) The neuroectoderm is positioned along the dorsal midline 
of the embryo which invaginates to form the neural tube. Cells along the ridge of this fold form the 
neural crest along the length of the anterior-posterior axis. Paraxial mesoderm forms on either side 
of the neural tube. Both the NCC and paraxial mesoderm are sources of MSC. (B) Dorsal and lateral 
views of the embryo highlighting the subdivisions of the cranial neural crest by colour into the 
rhombomeres (r), diencephalon (Di.) and anterior/posterior mesencephalon (A./P. Mes.). NCC 
migrate in streams (black arrows) to populate the facial prominences and pharyngeal arches (PA). 
Coloured dots indicate the approximate origin of MSC at that location as predicted by fate map 
experiments in the chick and mouse. (C) Growth of the facial prominences between weeks 4 and 5 




1.2.1 Bones of Neural Crest Origin 
The NCC is a transient population of multipotent migratory cells found 
exclusively in vertebrates. It is localised to the border between the neuroectoderm 
and ectoderm during the formation and closure of the neural tube along the length 
of the anterior-posterior axis (Figure 1.3A). NCC migrate around the time of neural 
tube closure and maintain their multipotent capacity whilst migrating (Nichols 1981; 
Erickson and Weston 1983; Calloni et al. 2009). NCCs were first identified as far back 
as 1868 by Wilhelm His and have since been shown to be the progenitors to many 
starkly diverse cell types. Cranial NCC, found at the most anterior aspect of the 
developing embryo have the potential to differentiate into neurons, their supporting 
glia, melanocytes, adrenomedullary cells, osteocytes and chondrocytes (Bronner-
Fraser and Fraser 1988, Calloni et al 2009). Owing to its versatility and wide cellular 
potential, the neural crest has often been likened to being the fourth embryonic germ 
cell layer (Hall 2001).  
The ectoderm-derived NCC was suggested to be involved in the formation of 
craniofacial mesenchyme as early as 1888 which went against the then dogma that 
the mesoderm was the only source of bone (Katschenko 1888). Since then, extensive 
work across species has demonstrated that the viscerocranium is in fact almost 
exclusively derived from cranial NCCs. Early cell labelling techniques used tritiated 
thymidine, a radioactively tagged nucleoside to track the dividing NCC as they 
migrated to medial and lateral nasal processes, in addition to the maxillary process 
of the chick (Johnston 1966; Noden 1975). Fluorescent markers such as Dil similarly 
tracked NCC into facial tissues and identified three well characterised streams of NCC 
migrating from the dorsal surface into the developing head (Lumsden 1991, Le 
Douarin 2004). The trigeminal stream originating from the most cranial aspect of the 
NCC migrates to populate the frontonasal prominence and first pharyngeal arch 
(Figure 1.3B). The hyoid stream emerges at the level of the fourth rhombomere and 
populates the second pharyngeal arch whilst the postotic stream emerges from the 
sixth rhombomere to populate the remaining pharyngeal arches (Figure 1.3B) 




were limited by the dilution of tagging markers over progressive cell divisions but 
gave sufficient time to grossly track NCC contributions.  
During the early 1970’s quail-chicken transplantation experiments became 
popular as a means to track cell populations throughout the course of embryonic 
early development using a quail-specific nuclear marker (Le Douarin 1973). Grafts of 
different cranial NCC regions were transplanted from the quail into the chicken host 
to determine the contribution of each level to the final facial bones (Figure 1.3B) (Le 
Lièvre 1978; Couly et al. 1993).  
Equivalent studies in mammals were more challenging, largely due to the 
inaccessibility of embryos for grafting. Instead, conditional transgenic mouse lines 
were used to elucidate the origins of facial bones. One example system was created 
by crossing a mouse line expressing Cre-recombinase under the Wnt1 promoter with 
a second line carrying the ROSA26 conditional reporter (R26R) (Chai et al. 2000; Jiang 
et al. 2002). The conditional marker is only activated on the presence of Cre-
recombinase which is restricted to the NCC lineage by the NCC-specific Wnt1 
Figure 1.4 – Cellular Origins of the Bones of the Murine Skull. (A) Dorsoventral and (B) lateral views 
of the Wnt1-cre/R26R reporter line with the (C) Mesp1-cre/R26R reporter line showing the 
viscerocranium and neurocranium are derived from neural crest cell and paraxial mesoderm 
populations, respectively. Schematics of the (D) dorsoventral and (E) ventrodorsal views of the skull 
summarising the origins of cranial bones. A&C modified from (Yoshida et al. 2008). B&D modified 




promoter. All derivatives of the NCC line expressed ß-galactosidase which is identified 
with X-gal staining. This system confirmed that like the chicken experiments over 25 
years earlier, the dorsally positioned NCC stream into populate the frontonasal 
prominence, the first pharyngeal arch (consisting of the maxillary and mandibular 
processes) and second pharyngeal arch (Chai et al. 2000; Jiang et al. 2002). These 
papers only studied the superficial bones of the foreface and determined that bones 
of the viscerocranium (nasal and maxilla), the paired frontal bones and sphenoid 
bones were derived from NCC cells (bones in blue) (Figure 1.4A and B) (Noden and 
Trainor 2005). Interestingly, the medial aspect of the interparietal bone at the 
posterior of the skull is also NCC-derived. It is unclear whether similar observations 
would be seen in the dog or human since the intraparietal bone is only distinguishable 
in rodents – it becomes fully fused with the occipital bone in humans and dogs 
(Koyabu et al. 2012). Of note, the Wnt1-Cre mouse line has been shown to cause 
ectopic expression of Wnt1 which alters the development of the mid-brain (Lewis et 
al. 2013). It is unclear whether this would have any role on the effectiveness in 
tracking NCC for bone development, however a corrected Wnt1-Cre line has been 
made available for future studies (Lewis et al. 2013). 
1.2.2 Bones of Mesoderm Origin 
A similar reporter line was used to identify mesoderm-derived bones of the 
skull, this time using the mesoderm-expressed Mesp1 promoter (Jiang et al. 2002; 
Yoshida et al. 2008). These studies elegantly used both the Wnt1 and Mesp1 reporter 
lines in a complementary manner to trace the origins of the cranial vault and its 
underlying cranial base (chondrocranium). These experiments concluded that the 
paired parietal bones and the lateral aspect of the interparietal bones were derived 
from mesoderm (Figure 1.4C). With the exception of the medial intraparietal bone, 
the coronal suture acts as a border between the NCC-sourced anterior of the skull 
and mesoderm-sourced posterior of the skull (Figure 1.4D).  
The Wnt1 and Msp1 reporter lines also identified a similar, broad anterior-




2008). Anterior bones of the chondrocranium including the ethmoid, presphenoid 
and basisphenoid are derived from the NCC whilst the bones positioned posteriorly 
to the basisphenoid are mesoderm-derived and include the auditory capsule, 
basioccipital, exoccipital and supraoccipital bones (Figure 1.4E). Interestingly, the 
basisphenoid bone appears to largely be derived from NCC however there are also 
mesodermal contributions (Figure 1.4E). Bones of the chondrocranium are formed 
by the fusion of multiple smaller cartilages prior to ossification. The constituent 
cartilages of the basisphenoid bone have duel origins. 
1.2.3 Bone Mineralisation  
In the dog, ossification of bone occurs sequentially starting rostrally in the 
mandible, maxilla, palatine and frontal bones at Day 35 followed by the basioccipital 
and basisphenoid bones and finally the caudally positioned optic capsule (Evans 
1958; Watson et al. 1986). Regardless of the time of ossification, the skull is formed 
of two types of bone with distinct matrix and cellular compositions (Scott and 
Hightower 1991; Hayashi et al. 2014). The first is endochondral bone which is the 
major bone type throughout the body. It requires an intermediate cartilage 
framework to become ossified through a process called endochondral ossification. 
This occurs in many of the bones of the cranial base, collectively known as the 
chondrocranium (McBratney-Owen et al. 2008). The second bone type is 
intramembranous bone which is found almost exclusively in the skull (with the 
exception of the clavicle in humans). Intramembranous ossification does not need a 
cartilage intermediate, instead, it is directly derived from mesenchymal condensates 
in a process called intramembranous ossification. This produces the bones of the 
viscerocranium and remaining bones of the neurocranium.   
Common to both types of ossification is the progression of MSCs to terminally 
differentiated bone-forming osteoblasts. These MSCs are derived from either the 
migratory NCC or paraxial mesoderm which feed into the frontonasal process and 
pharyngeal arches. The cellular intermediates and pathways taken between MSC and 




have the capability to give rise to chondrocytes, osteoblasts, myoblasts and 
adipocytes which are under the control of master transcription factors (Rutkovskiy et 
al. 2016). SRY (Sex-Determining Region Y)-Box 9 Protein (Sox9) and runt-related 
transcription factor 2 (Runx2) determine the fate of MSCs by initiating endochondral 
or intramembranous ossification, respectively (Figure 1.5) (de Crombrugghe et al. 
2000; Chen et al. 2014).  
1.2.3.1 Endochondral Ossification  
During endochondral ossification, the cartilaginous fate of mesenchymal cells 
is induced by the Sox9 transcription factor, under bone morphogenetic protein (BMP) 
control (Bi et al. 1999; Healy et al. 1999; de Crombrugghe et al. 2000; Nishimura et 
al. 2012). This stimulates their differentiation into chondrocytes and expression of 
classic chondrocyte genes such collagen II and aggrecan (Chambers et al. 2002) 
(Figure 1.5). Chondrocytes cease to grow and undergo a condensation step via an N-
cadherin dependent mechanism on their cell surface (Janners and Searls 1970; 
Oberlender and Tuan 1994). Indian hedgehog homologue (IHH) and parathyroid 
hormone-related protein (PTHrP) signalling stimulate chondrocytes to proliferate 
rapidly and secrete a variety of matrix proteins to generate the intermediate cartilage 
Figure 1.5 – Bone Formation of the Skull. Two methods of bone formation exist in the skull. 
Generally, posterior bones of the skull are produced through endochondral ossification which 
requires chondrocytes to build a cartilage template prior to mineralisation by osteoblasts. 
Meanwhile, anterior bones of the skull are produced through intramembranous ossification which 




structure (St-Jacques et al. 1999; DeLise et al. 2000; Zhao et al. 2002). Following the 
formation of the cartilage, the chondrocytes swell over 20-fold in size to form 
hypertrophic chondrocytes (Cooper et al. 2013). This terminally differentiated 
chondrocyte marks the onset of bone formation as the cells secrete collagen X and 
fibronectin which permits the calcification of the matrix (Zheng et al. 2003). The fate 
of hypertrophic chondrocytes is unclear with some reports claiming they undergo 
apoptosis whilst others suggest they may go on to transdifferentiate into bone-
forming osteoblasts (Gibson 1998; Yang et al. 2014). Regardless of their fate, 
vascularisation of the cartilage framework accompanied by the invasion of 
osteoblasts and osteoclasts permits the deposition of a mineralised bone matrix and 
establishment of bone marrow (Erlebacher et al. 1995). Eventually the cartilage 
framework is completely replaced by bone.  
1.2.3.2 Intramembranous Ossification 
The intramembranous ossification process is initiated by the master 
transcription factor Runx2 (Figure 1.5) (Abzhanov et al. 2007; Takarada et al. 2015). 
Bmp2/4 then act in a threshold-dependent manner to confirm the fate of the MSCs. 
Low levels permit intramembranous ossification via condensation and differentiation 
into pre-osteoblast cells however high Bmp levels stimulate the formation of 
chondrocytes (see previous) (Liu et al. 2005; Abzhanov et al. 2007; Bonilla-Claudio et 
al. 2012). For intramembranous ossification, the Bmp signalling regulates the self-
renewal and proliferation of pre-osteoblast cells (Bonilla-Claudio et al. 2012). 
Signalling peptides PTHrP and IHH then regulate the differentiation of pre-osteoblast 
cells into chondrocyte-like osteoblasts (Lenton et al. 2011) – so named because they 
express both chondroblastic (collagen II/IX) and osteoplastic (osteopontin) markers 
simultaneously (Abzhanov et al. 2007).  Finally, the chondrocyte-like osteoblasts 
differentiate into the mature osteoblast. The osteoblasts secrete an osteoid matrix 
containing osteopontin, alkaline phosphatase and collagen I which mineralises and 
encases the osteoblasts within (Stein et al. 1989; Jabalee et al. 2013).  These trapped 
osteoblasts have the capability to become osteoclasts which together regulate bone 




1.3 The Genetic Determinants of Craniofacial Variation  
Given that craniofacial development consists of a complex interplay of 
migrating, proliferating and differentiating cells from multiple origins under the tight 
coordination of numerous major signalling pathways, it is perhaps unsurprising that 
subtle perturbations in any of these steps give rise to craniofacial variation. This 
variation can vary from subtle changes in the position/depth of facial features to 
substantial alterations that present significant clinical challenges whether in human 
or veterinary medicine.  
1.3.1 Causes of Craniosynostoses 
The discoveries to date of causal variants of craniosynostoses were 
predominantly identified in rare or family-based studies. This included the first 
craniosynostoses (Boston-type) to be mapped to a pair of missense mutations in the 
Msh homeobox 2 (MSX2) gene which are predicted to disrupt neural crest cell 
migration and survival (Jabs et al. 1993; Liu et al. 1995; Ma et al. 1996; Winograd et 
al. 1997; Finnerty et al. 2009). Meanwhile, mutations within the twist-related protein 
1 (TWIST1) were shown to cause Saethre-Chotzen syndrome by stimulating the 
premature maturation of bone-forming osteoblasts in cranial bones (Howard et al. 
1997; Yousfi et al. 2002; Bialek et al. 2004; Guenou et al. 2005). A number of further 
rare craniosynostoses were shown to be caused by missense mutations in genes such 
as Gli family zinc finger 3 (GLI3, Greig syndrome), establishment of cohesion 1 
homolog 2 (ESCO2, Robert syndrome) and Jagged 1 (JAG1, Alagille syndrome) (Table 
1.1) (Wild et al. 1997; Colliton et al. 2001; Vega et al. 2005).  
Beyond these, some of the more common syndromic craniosynostoses such as 
Crouzon, Apert and Saethre-Chotzen syndrome have a remarkably narrow aetiology. 
Many of the mutations identified in these conditions are restricted to the fibroblast 
growth factor receptor (FGFR) family and its related pathways. Of the diagnosed 
cases, mutations have been found in FGFR2 (32%), FGFR3 (25%), TWIST1 (19%) and 
Ephrin B1 (EFNB1) (7%) (Johnson and Wilkie 2011). Interestingly, variants within the 




craniosynostoses and in some instances the exact same mutation is responsible 
(Reardon et al. 1994; Jabs et al. 1994; Rutland et al. 1995; Wilkie et al. 1995; Oldridge 
et al. 1999; Bochukova et al. 2008; Chokdeemboon et al. 2013) (Table 1.1). The 
restriction of a collection of craniosynostoses with similar craniofacial abnormalities 
to a narrow network of affected genes is perhaps unsurprising. However, given the 
variable extra-cranial phenotypes in the hands and feet of many of these syndromes, 
it likely suggests a more complex relationship between these variants and other 
genetic loci.  
In order to further elucidate the underlying genetics of complex traits such as 
craniofacial morphology, genome-wide association studies have been a popular 
study design across fields in recent years (Thorleifsson et al. 2008; Marouli et al. 
2017). To date, only one study has sought to use GWAS for craniosynostoses. 
Specifically, the study focussed on a non-syndromic form of craniosynostosis 
affecting just the sagittal suture and found significant associations in regions adjacent 
to the BMP2 and Bardet-Biedl syndrome protein 9 (BBS9) genes (Justice et al. 2012). 
Table 1.1 – Mutations Causing Craniosynostoses. Summary of the genes harbouring mutations 
known to cause some of the most common forms of craniosynostosis. 
Gene Condition Reference 






(Reardon et al. 1994; Jabs et al. 1994; 
Rutland et al. 1995; Wilkie et al. 1995; 
Oldridge et al. 1999; Bochukova et al. 2008; 
Chokdeemboon et al. 2013) 
FGFR3 Crouzon syndrome (Meyers et al. 1995; Muenke et al. 1997) 
ALX3 Frontonasal syndrome (Twigg et al. 2009) 
EFNB1 Frontonasal syndrome (Wieland et al. 2004; Twigg et al. 2004) 
ESCO2 Roberts syndrome (Vega et al. 2005) 
GLI3 Greig syndrome (Wild et al. 1997) 
JAG1 Alagille syndrome (Warthen et al. 2006) 
MSX2 Boston-type (Jabs et al. 1993; Ma et al. 1996; Florisson 
et al. 2013) 




Later, a variant in a regulatory element of BMP2 was shown to be the cause of the 
preceding association study (Justice et al. 2017).  
These studies begin to broaden the pool of known candidate genes and causal 
variants for craniosynostoses however it remains that just 21% of patients with 
craniosynostoses receive a genetic diagnosis (Johnson and Wilkie 2011). Due to the 
rarity of clinical cases, the recruitment of adequate populations to power such GWAS 
is extremely challenging as reflected by only the one GWAS-based craniosynostosis 
study to date. Therefore, an alternative approach to determining the genetic 
determinants of craniofacial variation has been to focus on the natural, sub-clinical 
variation that exists in the human general population.  
1.3.2 Associations with Normal Variation 
The stark craniofacial alterations in craniosynostoses permits for the use of a 
case vs control phenotype for GWAS. However, the subtle morphological variation 
amongst the general population requires a more accurate means to capture and 
decipher the craniofacial form as a phenotype. Recent developments and increased 
availability of several precision phenotyping techniques coupled with cheaper SNP 
microarray data have permitted large-scale assessments with as many as 5,300 
participants. Analyses adopting GWAS have focused on methods to capture the 3-
dimensional (3D) shape of the face, using superficial tissues as landmarks e.g. edges 
of the nose, mouth, eyes etc. A commonly adopted approach has been to overlay 
multiple 2D images taken at multiple angles to generate a dense 3D surface 
reconstruction of the face (known as stereophotogrammetry) (Hammond et al. 
2004). Subsequently, facial features are landmarked using geometric morphometrics 
to give 3D coordinate-based phenotypes. This technology has advanced significantly 
from it first use and now permits fully automated landmarking of large reconstruction 
datasets, which negates the previous need of manual landmarking samples which 
was time consuming and prone to user error (Guo et al. 2013).  
To date, five large-scale GWAS exploring normal craniofacial variation in 




Paternoster et al., 2012 first adopted this stereophotogrammetric approach to study 
a UK population of adolescents (Paternoster et al. 2012). Their association studies 
using distances between 3D landmarks identified a genome-wide significant marker 
within the Paired Box Protein 3 (PAX3) gene to be associated with variation in the 
nasion position (Table 1.2). PAX3 makes for an excellent candidate for modifying 
craniofacial features. It is a transcription factor expressed and enriched in cranial 
neural crest cells and neural crest-derived craniofacial mesenchyme (Goulding et al. 
1991; Hagiwara et al. 2014). PAX3 regulates the balance between proliferation and 
differentiation of the neural crest lineage (Monsoro-Burq 2015). Over 80 mutations 
within this gene have been linked with Waardenburg syndrome, which amongst 
other defects, commonly presents with the widening of the nasal bridge (location of 
the nasion) (Pingault et al. 2010). Interestingly, a persistent overexpression of PAX3 
causes cleft palates in mice (Wu et al. 2008).  
Table 1.2 – Positional Gene Candidates of Normal Human Variation. Summary of positional gene 
candidates identified across genome-wide association analyses of normal human craniofacial 
variation. Gene candidates are only listed if significant markers are located within a gene. 
Author Gene Phenotype 
Paternoster et al. 2012 PAX3 Nasion position 
Liu et al. 2012 
PAX3 Nasion-eye distance 
PRDM16 Nose width & height 
TP63 Distance between eyes 
COL17A1 Nasion-eye distance 
Adhikari et al. 2016 
DCHS2 Nose inclination 
RUNX2 Nose width (bridge) 
GLI3 Nose width (wing) 
PAX3 Nasion position 
EDAR Chin protrusion 
Cole et al. 2016 
SCHIP1 Face size 
PDE8A Face size 
Lee et al. 2017 
FREM1 Lip height 




PAX3 was then subsequently identified in a further two independent studies 
which also used stereophotogrammetry or an magnetic resonance image (MRI) 
scanner to capture the surface structure of participants (Liu et al. 2012; Adhikari et 
al. 2016). Together, these studies also found associations with variations in 
craniofacial features with RUNX2, GLI3, PR domain containing 16 (PRDM16), 
transformation-related protein 63 (TP63), collagen type XVII alpha 1 chain (COL17A1), 
dachsous cadherin-related 2 (DCHS2) and ectodysplasin A receptor (EDAR) (Table 
1.2). Two further stereophotogrammetry-based studies found associations with the 
schwannomin interacting protein 1 (SCHIP1), phosphodiesterase 8A (PDE8A), FRAS1-
related extracellular matrix 1 (FREM1) and parkin 2 (PARK2) genes (Cole et al. 2016; 
Lee et al. 2017) (Table 1.2). Notably, many of these variants are predicted to have 
low effect sizes with limited heritability. In an attempt to find large effect variants, a 
recent study by Crouch et al. first identified highly heritable regions of the face using 
a cohort of twins prior to using extreme variations of these regions in the People of 
the British Isles study to execute a GWAS (Crouch et al. 2018). This study identified 
variants in the protocadherin-15 (PCDH15), transmembrane protein 163 (TMEM163), 
and membrane-bound transcription factor site-1 protease (MBTPS1) genes. 
Collectively, many of these aforementioned positional genes are compelling 
candidates for regulating craniofacial variation. RUNX2 and GLI3 are the most striking 
due to their known known roles in regulating bone mineralisation (see Section 1.2.3) 
and causing a form of craniosynostosis (Greig Syndrome), respectively (Wild et al. 
1997; Abzhanov et al. 2007; Takarada et al. 2015) whilst knockout mice for Frem1 
and Schip1 both have abnormal foreface shapes (Schmahl et al. 2006; Alazami et al. 
2009; Slavotinek et al. 2011). From this, it is clear that GWAS is a powerful method 
for detecting genetic signatures of facial features albeit it, often finding variants of 
low effect size. Due to the high number of tests and potential underlying population 
structure, spurious associations can mistakenly be found although this can be 
accounted for by careful cohort selection as demonstrated by the reproducible 
discovery of candidate genes such as PAX3. Importantly, causal genetic variants at 




associations are representative of changes in the superficial soft tissue of the face or 
its underlying skeleton.  
1.3.3 Associations with Obstructive Sleep Apnoea 
In contrast to the exploration of craniofacial variation using GWAS, 
investigations into the underlying genetics of OSA have predominantly used 
association studies with candidate genes. A major advance of using this study design 
is to significantly increase the power of detecting associations with small size effects 
(Risch and Merikangas 1996). To this end, measurements of OSA such as the apnoea-
hypopnoea index have been associated with gene markers within c-reactive protein 
(CRP), glial cell-derived neurotrophic factor (GDNF) and 5-hydroxytryptamine 
receptor 2A (HTR2A) amongst others (Larkin et al. 2010; Patel et al. 2012; Grilo et al. 
2013; Xu et al. 2014; Kripke et al. 2014; Baik et al. 2015; Cade et al. 2016). However, 
in line with the common criticisms of candidate gene studies, these analyses have 
failed to give reproducible findings across studies (Tabor et al. 2002). Also, such 
studies fundamentally rely on prior knowledge and an understanding of pathways 
and genes that are potentially involved in disease phenotypes (Tabor et al. 2002). 
These studies have relied on databases of gene candidates associated with the 
circadian rhythm, obesity, inflammation, ventilation control, heart defects and blood 
disorders which are potential target networks but ultimately introduce an element 
of bias and negate the discovery of novel genes and networks (Larkin et al. 2010; 
Patel et al. 2012; Grilo et al. 2013; Xu et al. 2014; Kripke et al. 2014; Baik et al. 2015). 
From the collective studies on craniosynostosis, normal craniofacial variation 
and OSA, it remains that just 21% of craniosynostoses receive a genetic diagnosis and 
no known variants cause OSA. The recent adoption of GWAS-focussed study designs 
in the aforementioned analyses have demonstrated the effectiveness of association 
studies in detecting genetic signatures of facial variation in humans. Despite this, 
studies in humans are limited by the rarity of extreme craniofacial phenotypes, such 
as those in craniosynostoses and the subtly of ‘normal’ non-clinical variation which 




this reason, the domestic dog was chosen to investigate the underlying genetics of 
craniofacial diversity and presentation of severe obstructive respiratory conditions to 
overcome the challenges in the human field. The dog has highly diverse craniofacial 
features with comparable morphologies to the brachycephalic and dolichocephalic 
skull conformations seen in humans. Once more, these extreme morphologies are 
highly prevalent in the UK dog population and many of which are susceptible to 
obstructive respiratory conditions with parallels to OSA. Beyond this, the dog has a 
simplified genetic architecture which makes it a highly advantageous system to work 
with.  
1.4 The Dog as a Genetic Research Model 
Several characteristics unique to the dog make the genetic endeavours of 
morphological and disease trait mapping in the species much more appealing than 
others. A notable advantage of the domestic dog is its popularity. In 2018, over 1 in 
4 (26%) UK households have a pet dog and over £4.2 billion was spent on veterinary 
healthcare in 2017, which was an 18.7% increase on the previous year (Office for 
National Statistics 2018; PFMA 2018). As a result, there is an unprecedented level of 
access to demographic information, diagnostic test results and biological samples 
over the course of a dog’s life (Patterson 2000). Also, throughout the course of their 
lifetime, dogs age comparatively to humans, albeit over an approximately 7-8 times 
shorter period whilst being exposed to the same environmental factors. This enables 
us to draw much better parallels between human and canine disease presentation, 
progression and response to treatments unlike many of the artificially introduced 
disease states in classic model organisms such as the mouse (Khanna et al. 2006; 
Breen and Modiano 2008). Over 360 of the approximately 450 recognised diseases in 
the dog have equivalents in humans which include complex traits such as diabetes 
and cancers (Shearin and Ostrander 2010). Many of these diseases were shown to be 
caused by gene homologues across the two species making the dog a powerful 




Although genetic investigations into the domestic dog would appear less 
common-place compared to other species such as humans, mice and zebrafish, there 
is a growing availability of genomic tools for the dog. This started with the availability 
of the first 1.5X assembled Poodle reference sequence in 2003 followed by a 7.5X 
Boxer sequence in 2005 which are available for public use on the UCSC genome 
browser (Kirkness et al 2003; Lindblad-Toh et al 2005). The most up to date 
CanFam3.1 assembly of the dog genome has also been annotated (Pruitt et al. 2007; 
Pruitt et al. 2014). More breed-specific assemblies are currently being generated 
including that of a Great Dane and a Labrador which will allow for better short-read 
sequence alignment and study-specific analyses (personal communications). To aid 
in the discovery of variants, commercially available 170,000 SNP microarray chips 
have been made produced. Free to access repositories containing both SNP 
microarray data and whole genome sequences such as the Dog Biomedical Variant 
Database Consortium (DBVDC) and Dog Genome SNP Database (DoGSD) have been 
established to support variant analysis in the community (Bai et al. 2015). Many of 
the genomic software packages designed to analyse such databases were first set up 
for human studies but can easily be transferred to canine experiments. For example, 
association studies can be carried out in the PLINK toolset using dog-specific 
modifiers and arguments whilst packages such as GEMMA can be used to invoke 
kinship matrices to account for relatedness and population structure in dogs (Purcell 
et al. 2007; Zhou and Stephens 2012). 
For traits such as morphology, the dog represents the most morphologically 
diverse land mammal with extremes of phenotypes e.g. there can be over a 40-fold 
difference in body weight between the toy Chihuahua and giant Great Dane (Stockard 
1941). Such broad phenotypic scales coupled with their advantageous genomic 
structure ideally positions the dog to tease apart phenotype-genotype relationships. 





1.4.1 Domestication’s Impact on the Canine Genome 
The modern dog, Canis familiaris was domesticated from the grey wolf, Canis 
lupus estimated to be within the last 11,000 to 32,000 years (Benecke 1987; Tchernov 
and Valla 1997; Boyko et al. 2009; Frischknecht et al. 2013; Freedman et al. 2014; 
Frantz et al. 2016).  The domestication of the dog is thought to be a multi-event 
process in which small populations of wolves at various sites (most likely in South-
East Asia and European areas such as the Levant) were translocated and bred 
together over time. The limited pool of founder wolves and subsequent bottlenecks 
during the establishment of the modern dog breeds ~200 years ago caused significant 
founder effects within the species (Wayne and Ostrander 2007; Freedman et al. 
2014; Frantz et al. 2016). Later, the repeated use of popular sires and events such as 
the World Wars saw the breeding populations further reduced. For example, the 
breeding populations of the English Mastiff was reduced to just 14 and Manchester 
Terriers to as few as 11 (Larson et al. 2012). Now, 80% of chromosomes across breeds 
carry between just two and four haplotypes and linkage disequilibrium (LD) can 
extend up to 3 Mb in breeds such as the Bernese Mountain Dog (Sutter et al. 2004). 
As a result, studies found that LD within the domestic dog is approximately 100 times 
greater than that in humans (Ostrander and Kruglyak 2000; Sutter et al. 2004). 
Genomic alterations such as this are advantageous in that fewer genetic markers are 
required to tag haplotypes which is a major advantage for genotyping arrays, 
however the expanse of LD makes the subsequent fine mapping more challenging. 
At a variant-level, there has been a marked increase in the number of 
nonsynonymous deleterious variants in the dog which are attributed to the relaxation 
of natural selection pressures (Björnerfeldt et al. 2006; Cruz et al. 2008). Further 
modifications include the accumulation and increased heterogeneity of structural 
variants within the canine genome compared to the wolf and human. Elements such 
as long- and short-interspersed nuclear elements (LINE/SINE) are heterozygous at 
over 10,000 sites in the Boxer compared to the Poodle (Kirkness et al. 2003; Lindblad-
Toh et al. 2005; Wang and Kirkness 2005). Such genetic variation coupled with the 




coding regions of the genome are significantly enriched in the dog (Fondon and 
Garner 2004; Koch et al. 2016). The absence of these genomic signatures in the wolf 
and their rapid accumulation and heterogeneity in the dog suggest they could disrupt 
gene transcription and drive the extreme phenotypic diversity in dogs. Using this 
phenotypic diversity as a selection trait, successive and repetitive breeding within the 
confines of the breed barriers have enriched alleles harbouring these variations 
almost to the extent of fixation in some breeds whilst being completely absent from 
others. The breed-specific enrichment of desirable traits and their alleles can also 
inadvertently allow the co-segregation of disease states within breeds in what is 
known as a so-called “hitch-hiker effect”. As a result, in many cases, shared 
morphological traits and disease states across individuals are thought to be caused 
by identity by descent (IBD) genetics in which the same causal variant is shared 
between individuals by a common ancestor. Helpfully, when resolving derived 
haplotypes shared by IBD genetics, recombination events can occur around the 
associated variant to refine the haplotype. Providing the study design is permitting, 
further improvements to fine mapping might be achieved through the inclusion of 
mixed-breed dogs 
Collectively, these effects have resulted in stark phenotypic differences 
between breeds whilst preserving the same basic genomic background – an ideal 
combination to elucidate the underpinnings of morphological variation and disease.   
1.4.2 Canine Craniofacial Variation  
Craniofacial variation in humans is particularly modest with most variation 
going unnoticed without accurate methods of phenotyping. Furthermore, the 
instance of severe craniofacial variation is relatively rare such as the craniosynostoses 
which occur approximately once in 2,500 new-born children (Persing 2008). This 
presents a considerable challenge to investigating the underlying genetic causes of 





In contrast, the domestic dog represents the most morphologically diverse land 
mammal with some of the greatest variation observed in the face (Stockard 1941). 
Many of the dogs’ facial traits mimic the changes seen in humans, albeit on a much 
more extreme scale. Breeds such as the Boxer and Greyhound are representatives of 
the extreme brachycephalic and dolichocephalic head conformation, respectively 
(Figure 1.6B and D). Unlike humans, the brachycephalic trait is very common due to 
the popularity of breeds such as the Bulldog, French bulldog, Boxer, Pug, French 
Mastiff, Shih Tzu and Pekingese. The “flat-faced” trait in dogs was thought to be 
popularised either for its functionality by increasing bite forces needed by breeds 
such as the Bulldog for their original role in bull-baiting (Ellis et al. 2009); or 
aesthetically due to the pronounced eyes and enlarged forehead, characteristic of 
juveniles (Drake 2011; Geiger et al. 2017). The canine skull is also rich in other head 
shape traits including mandible position (e.g. mandibular prognathism in the Boxer), 
angle of the palate (e.g. klinorynchy in Bull Terrier) and neurocranium shape (e.g. 
apple vs deer head shape in the Chihuahua).  
Figure 1.6 – Skull Variation. Lateral skull images of a purebred (A) Rottweiler, (B) Greyhound, (C) 
Miniature Dachshund and (D) Boxer representing some of the diversity across the Canis familiaris 




Noticeably, there is also a significant variation in the overall size of the skull 
between breeds such as that between the Rottweiler and Miniature Dachshund 
(Figure 1.6 A and C) or in more extreme cases, the Chihuahua and the Great Dane 
(not shown here). Such extreme morphological variation also permits the concurrent 
exploration of the genetic determinants of head size (and related body size). 
However, this extreme variation in the size of the dog can have a confounding effect 
on the assessment of shape changes in the skull – a phenomenon known as allometry.  
1.4.2.1 The Confounding Effects of Allometry  
As the size of an organism varies, many of its traits will vary proportionally on 
a 1:1 scale with its size – this is an isometric relationship and can be seen in the 
proportional increase in wing size with the increase in body size of the Drosophila 
melanogaster (Figure 1.7A) (Shingleton et al. 2009). Conversely, some traits do not 
scale proportionally relative to body size in a relationship known as allometry. An 
allometric relationship can describe either an increase or decrease in trait size 
relative to body size – positive and negative allometry, respectively (Shingleton and 
Frankino 2012). For example, negative allometry is observed in the brain size of 
humans which has a reduced sensitivity to the changes in their overall body sizes 
Figure 1.7 – Morphological Scaling. (A) The size of the Drosophila wing has a 1:1 (isometric) scale 
with variation in its body size. (B) The size of the human brain is less sensitive to changes in overall 
body size and scales disproportionately (negative allometry). (C) The antlers of the male Irish elk 
are hypersensitive to changes in body size and become proportionally greater in size with 





(Figure 1.7B) (Koh et al. 2005). Meanwhile the antlers of a male Irish elk are 
hypersensitive whereby a small increase in body size will result in a proportionally 
greater increase in antler size (Figure 1.7C) (Gould 1973).  
 To date, few studies have assessed allometric relationships of traits in the dog. 
One study tracked ontogenetic allometry (allometry over an individual’s lifetime) in 
the Beagle (Helmsmüller et al. 2013). It found that amongst body circumference, 
pelvis size and foot size, the head length had a negative allometric relationship with 
the Beagle’s body weight. Meanwhile, traits such as pelvic height, height at the 
withers and femur length had strong positive allometry. The observation of leg bone 
allometry was confirmed across 63 dog breeds in a separate study (Casinos et al. 
1986). Although less appropriate here, two subsequent studies have explicitly 
focussed on the effects of allometry on sexual dimorphism across breeds albeit with 
conflicting conclusions. One study concluded that males of larger breeds were 
proportionally greater in size relative to a breed-matched female compared males of 
smaller breeds – a biological observation recorded across the animal kingdom known 
as Rensch’s rule (Frynta et al. 2012). The second study observed no such proportional 
changes however it analysed far fewer breeds with smaller population numbers 
compared to the former (Sutter et al. 2008).  
Nonetheless, the presence of allometry within the skull of the dog has been 
made evident by previous studies analysing the changes in the St Bernard overtime 
and modularity of the canine skull (Drake and Klingenberg 2007; 2010). Due to the 
extreme variation in body size of the domestic dog, the confounding influences and 
modifying effects an individual’s body size on its variation in face shape cannot be 
overlooked.  
1.4.3 Brachycephalic Obstructive Airway Syndrome 
In conjunction with providing the opportunity to explore the genetics of the 
diverse craniofacial variation, the dog is also susceptible to a number of 
conformation-related morbidities (Hodgman 1963; Hillbertz et al. 2007; Asher et al. 




brachycephalic skull conformation and include gastrointestinal tract lesions (Poncet 
et al. 2005a; Harvey and Haar 2016), ear and eye-related morbidities (Sanchez et al. 
2007; Packer et al. 2015; Harvey and Haar 2016; O'Neill et al. 2017), neurological 
conditions (Collmann et al. 2005), spinal/vertebral defects (Ryan et al. 2017; 
Mayousse et al. 2017; de Souza et al. 2018) and dystocia (obstructed labour) (O'Neill 
et al. 2017). Furthermore, the brachycephalic dogs have a significantly shorter 
lifespan and quality of life compared to their dolichocephalic counterparts (O'Neill et 
al. 2015).  
In line with OSA in humans, changes in canine craniofacial morphology also 
predisposes the dog to a severe obstructive respiratory problem called 
brachycephalic obstructive airway syndrome (BOAS). BOAS is one of the most 
frequently reported morbidities in brachycephalic dogs such as the Pug, Bulldog, 
French Bulldog, Boston Terrier, Pekingese and Shih Tzu (Poncet et al. 2005b; Torrez 
and Hunt 2006; Riecks et al. 2007; Ginn et al. 2008; De Lorenzi et al. 2009; Fasanella 
et al. 2010). 
1.4.3.1 BOAS Prevalence 
As its name suggests, BOAS is a chronic respiratory condition which is almost 
exclusively seen in brachycephalic dog breeds. It encompasses a range of primary and 
secondary pathological alterations to the upper respiratory tract which increase 
respiratory effort, resulting in laboured breathing, intolerance to heat/exercise, 
cyanosis and collapse (Ginn et al. 2008; Bernaerts et al. 2008). The reported 
prevalence of the condition varies widely which is likely the result of the methods 
used in the assessment. Owner-directed questionnaire-based assessments of BOAS 
have predicted the condition to affect less than 5% of each brachycephalic breed 
(Wiles et al. 2017) however these investigations are markedly biased in that select 
UK Kennel Club registered dog owners were asked to report conditions in their dogs. 
Such surveys are undermined by either the unwillingness to report ill-health, or the 
inability of non-professionals to identify clinical symptoms. Indeed, 58% of owners 




breathing problems (Packer et al. 2012). Meanwhile, in veterinary practices the 
prevalence of BOAS is reported to be much higher and varies by breed - Bulldog (18.0 
– 61.0%), French bulldog (2.7 – 67.0%), Pug (6.8 – 50.0%) and Boston terrier (1.4 – 
12.9%) (Poncet et al. 2005b; Torrez and Hunt 2006; Riecks et al. 2007; Ginn et al. 
2008; De Lorenzi et al. 2009; Fasanella et al. 2010). Again, these estimates are subject 
to the innate biases of using veterinary healthcare records; the majority of dogs 
visiting a veterinary practice are doing so because of their pet’s ill-health and so the 
data may not truly reflect the disease prevalence across the entire population (of 
which healthy dogs aren’t represented).  
Objective assessment using whole body barometric plethysmography has 
found signatures of respiratory distress in up to 89% of French bulldogs, 54% of which 
presented with a clinically-recognised level of disease (Liu et al. 2015). The disparity 
between the perceived rates of BOAS and the underlying levels of respiratory 
dysfunction in this breed is profound, both from a lay and a clinical professional 
perspective, and likely to be transferable to other breeds. One possible explanation 
for this disparity in perception is the desensitisation towards the condition. Loaded 
terminology and phrases used when describing respiratory symptoms such as 
‘laboured breathing is normal for the breed’ indicate a level of acceptability. The 
‘normalisation’ of these symptoms considerably undermines the efforts sought to 
address the problem which is a major welfare concern for brachycephalic dogs. 
1.4.3.2 Clinical Presentation 
The pathogenesis of BOAS has long been considered a two-stage process and a 
downstream effect of the brachycephalic head conformation. Soft tissues within the 
upper airway such as the nostrils, nasal turbinates and soft palette are not thought 
to reduce proportionately in size with the reduced facial skeleton that houses them 
(Figure 1.8) (Harvey 1989). As a result of this discordance, the nostrils become 
stenotic (pinched together), nasal turbinates protrude caudally into the nasopharynx 
and the soft palate is relatively elongated and extends caudally where it can interact 




et al. 2008; Fasanella et al. 2010; Cantatore et al. 2012; Heidenreich et al. 2016). 
These are the primary observations of BOAS which restrict and cause aberrant airflow 
and increase negative pressure within the airway (Harvey 1989; Torrez and Hunt 
2006). Airway resistance and altered pressures are thought to then stimulate 
secondary pathological modification of the upper airway soft tissues. This includes 
the further elongation and thickening of the soft palate, eversion of the laryngeal 
saccules and tonsils, oedema of the nasopharynx, laryngeal collapse and tracheal 
hypoplasia (Koch et al. 2003; Torrez and Hunt 2006; White 2011). Collectively, these 
modifications to the airway severely hamper effective breathing and frequently 
cause respiratory noises (stertor/stridor), sleep apnoea and can accumulate to an 
intolerance to heat/exercise, cyanosis and collapse (Ginn et al. 2008; Bernaerts et al. 
2008). Treatment options for BOAS are largely restricted to surgical interventions in 
which the soft tissues that are protruding into and blocking the airway are excised or 
ablated. Common procedures include the removal of the laryngeal saccules and 
tonsils, wedge resections of the nostrils, laser turbinectomy and excision of the causal 
aspect of the soft palate which have a mixed prognoses (Poncet et al. 2006; Torrez 
Figure 1.8 – Structures of the Upper Airway. (A) Lateral midline schematic of the dog upper airway. 
Diagram sourced and modified from VetHQ Online available at: http://vethq.com.au/mable/. (B) 
Laryngoscopic examination of Norwich Terrier unaffected (left) and affected (right) by upper airway 
syndrome. From top to bottom in affected dogs, the soft palate extends caudally to the epiglottis, 




and Hunt 2006; Riecks et al. 2007; Bernaerts et al. 2008; Fasanella et al. 2010; 
Oechtering et al. 2016). The extent of brachycephalic dogs requiring major upper 
airway surgery is set to rise further with the rapid increase in popularity of breeds 
such as the French bulldog in the UK, which again, highlights the major concerns for 
animal welfare (Kennel Club, 2018b).  
1.4.3.3 Causes of BOAS 
The segregation of BOAS with brachycephalic breeds is a clear indicator that 
there is a hereditary component to the disease (e.g. determinants of skull shape) 
however the genetic factor(s) are extremely limited. To date, only one variant in the 
BMP3 gene has been shown to contribute to brachycephaly in a subset of small 
brachycephalic breeds (Schoenebeck et al. 2012). Beyond this, other factors such as 
age and weight have been inconsistently linked with the disease. Several studies have 
concluded that age has no bearing on the disease presentation with many dogs 
having clinically significant symptoms from 1 year of age and above (Poncet et al. 
2006; Torrez and Hunt 2006; Fasanella et al. 2010). However, the most extreme BOAS 
cases with excessive secondary pathological modification of the airways are observed 
in dogs aged 3 years and above (Fasanella et al. 2010). Body condition scores were 
observed to be significantly higher in BOAS-diagnosed dogs and one analysis showed 
extreme obesity put brachycephalic breeds at high risk (Liu et al. 2015; 2016) 
Conversely, other studies concluded weight had no correlation with the disease 
(Torrez and Hunt 2006). The inconsistency of these findings is likely due to the 
relatively small (<100 dog) study cohorts, variation in diagnostic techniques and 
diverse study demographics across the veterinary practices conducting analyses. 
Long term prospective observational studies are required to answer these. 
Despite this inconsistency, a frequent observation is the variability in BOAS 
susceptibility and heterogeneity in disease presentation across the different 
brachycephalic breeds (Poncet et al. 2005a; Torrez and Hunt 2006; Riecks et al. 2007; 
Ginn et al. 2008; De Lorenzi et al. 2009; Fasanella et al. 2010; Liu et al. 2016). Although 




six studies examining the prevalence of BOAS reported the highest incidences were 
in the Bulldog followed then by the French bulldog and Pug (Poncet et al. 2005b; 
Torrez and Hunt 2006; Riecks et al. 2007; Ginn et al. 2008; De Lorenzi et al. 2009; 
Fasanella et al. 2010). Furthermore, whole-body plethysmography revealed that 
even in unaffected brachycephalic breeds, the Bulldog had distinct breathing 
characteristics compared to the remaining brachycephalic and non-brachycephalic 
breeds (Liu et al. 2016). It is unclear whether factors such as age and weight may truly 
contribute to this variability – again, only larger scale prospective cohort studies 
could start to unravel the roles of these factors and their interactions. However, the 
apparent variable predisposition of BOAS across brachycephalic breeds may suggest 
that additional, possibly genetic and yet unknown factors also contribute to BOAS 
presentation.  
1.4.3.4 BOAS in a Non-Brachycephalic Breed 
In recent years there has been an increase in reported cases of a non-
brachycephalic breed, the Norwich Terrier, suffering from symptoms remarkably 
similar to BOAS (Dietschi et al. 2010; Johnson et al. 2013). Within the breed the 
condition is called Upper Airway Syndrome (UAS) and shares many of the upper 
airway pathological alterations as seen in BOAS including an elongated and thickened 
soft palate, oedema of the pharynx and eversion of the laryngeal saccules (Dietschi 
et al. 2010; Johnson et al. 2013). Intriguingly, a closely related breed to the Norwich 
Terrier, the Norfolk Terrier is not affected by UAS suggesting there is a genetic 
component to the condition irrespective of the non-brachycephalic conformation of 
the breed.  
Currently, the prevailing dogma held by many is that the extreme 
brachycephalic head conformation is the major predisposing factor to disease 
presentation. As such, one of the main research objectives of this thesis was to 





1.5 Thesis Aims 
To date, no study has explicitly addressed the genetic causes of Brachycephalic 
Obstructive Airway Syndrome in the dog. As highlighted previously, studies have 
catalogued the pathological changes in the airway, the prevalence of the condition 
and novel approaches to grading its severity however its cause remains elusive. The 
current consensus within the field is that the brachycephalic head conformation is 
the major predisposing factor to the condition which itself, also has a restricted 
genetic understanding. 
Geometric morphometric analyses of human craniofacial variation were 
successful in isolating multiple positional candidate genes linked with craniofacial 
diversity. This thesis will exploit a similar method of identifying positional gene 
candidates albeit with high-resolution computer tomography scans of the skull rather 
than stereophotogrammetric images of superficial soft tissues of the face. 
Importantly, the biological relevance of variants associated with canine 
brachycephaly will be explored before directly addressing the presentation of 
respiratory distress in dogs.  
The major research objectives of this thesis can be summarised as follows: 
1. Develop a method to quantify canine craniofacial shapes and best account for 
the confounding influences of allometry.  
2. Identify genomic loci driving craniofacial morphology in the dog and find 
causal variants within them. 
3. Characterise the molecular and phenotypic effects of variants within the 
SMOC2 gene associated with canine brachycephaly.  
4. Use a non-brachycephalic dog breed to find genes that cause respiratory 







Chapter 2: Materials and Methods 
2.1 gDNA Extraction from Whole Blood 
Following written consent from owners, residual diagnostic whole blood in 
EDTA-containing 2 mL vials was stored at 4 °C by clinicians at the HfSA. Samples were 
transferred to the Roslin Institute for extraction. 
2.1.1 Preparation of Stock Extraction Buffers 
Stocks of Extraction Buffer A and Extraction Buffer B were prepared in advance. 
Buffer A (red blood cell lysis buffer) stock was made by adding 109.54 g 0.32 M 
sucrose and 1.02 g 5 mM hydrated magnesium chloride to 10 mL 1 mM Tri-HCl in a 1 
L glass bottle. The mixture was made up to 950 mL with Milli-QÒ (ZRXQ003WW, 
Merck) water. The pH was adjusted to 7.6 with 0.2 M hydrochloric acid (12920934, 
Fisher Scientific) (see Section 2.1.2). The pH adjusted solution was vacuum filtered by 
pouring into the top chamber of a Nalgene™ Rapid-Flow™ filter unit (127-0020, 
Thermo Scientific™) and applying a steady flow to the tap. Once complete, the 
solution was kept in the 1 L plastic flow-through bottle supplied as part of the filter 
kit and 7.5 mL 0.75% Triton™ X-100 (10102913, Fisher Scientific) was added. The final 
buffer volume was made to 1 L with Milli-QÒ water.  
Buffer B stock was made by mixing 20 mL 1 M Tris-HCl, 8 mL 0.5 M disodium 
EDTA and 20 mL 5 M sodium chloride in a 1 L glass bottle which was made up to 950 
mL with Milli-QÒ water. The pH was adjusted to 7.4 with 0.2 M hydrochloric acid and 
filter sterilised as described above. The filtered solution was kept in the 1 L plastic 
flow-through bottle and made up to 1 L with Milli-QÒ water. 
2.1.2 Adjusting the pH of a Solution 
A magnetic stirrer bar (11507812, Fisher Scientific) was cleaned in 70% ethanol 
– 7 parts 100% ethanol (10342652, Fisher Scientific): 3 parts Milli-QÒ water. The bar 




stirrer plate (CB161, Bibby Scientific) and stirred at room temperature at a rate to 
induce a small vortex. The S20 SevenEasy™ pH meter (1231165663, Mettler Toledo) 
was turned on and the probe was removed from the storage bottle. A wash bottle 
containing deionised water was used to rinse the probe above a waste jar. To 
calibrate, the probe was placed in the pH 10 solution until the monitor stopped 
flashing. The probe was rinsed with deionised water and placed in the pH 7 solution. 
The probe was subsequently rinsed, placed in the pH 4 solution and rinsed once more 
to complete the calibration. Excess water was removed from the probe with a lint-
free medical wipe (7432, Kimberly-Clark Professional) before using the mounting 
bracket to hold the probe in the solution on the magnetic stirrer. To decrease the pH, 
~1 mL 0.2 M hydrochloric acid (12920934, Fisher Scientific) was added at a time and 
the ‘Read’ button was pressed on the monitor to ensure measurements are up to 
date. The hydrochloric acid was not added directly to the pH probe. Once the pH was 
reduced to the correct level, the probe was rinsed in deionised water and returned 
to the storage buffer. The pH meter was turned off. 
2.1.3 Extraction Protocol 
Stock Buffer A solution was mixed in a 1:2 ratio with deionised water to create 
a Buffer A working solution. Whole blood residual samples were transferred to a 15 
mL Falcon™ tube (188271, Greiner Bio-One) with a 1 mL graduated Pastette (LW4040, 
Alpha Laboratories Ltd.). Buffer A working solution was used to clean and transfer 
samples to the Falcon™ tube. Buffer A working solution was added to a final volume 
of ~5 mL. Samples were gently inverted 10 times and centrifuged (5810 R, Eppendorf) 
at 4,000 rpm for 5 minutes before decanting the supernatant in a waste bottle 
containing 2 effervescent haz-tabs (H8811, Guest Medical).  
Stock Buffer A was mixed in a 1:3 ratio with deionised water and 5ml used to 
re-suspend the cell pellet before centrifuging at 4,000 rpm for 5 minutes and 
decanting the supernatant. Stock Buffer B was mixed in a 10:1 ratio with 10% SDS 
(151-21-3, Sigma-Aldrich) and 2.5 mL used to re-suspend the pellet before 25 µL 




shaken overnight in an air incubator (Innova™ 4000, New Brunswick Scientific) at 55 
°C before 2.5 mL 5 M sodium chloride solution was added. Samples were inverted 10 
times before centrifuging at 4,000 rpm for 20 minutes. The supernatant was 
transferred to a new 15 mL Falcon™ tube containing 5 mL 100% isopropanol 
(BP26181, Fisher Scientific). A plastic Pastette was used to ensure the complete 
transfer of the supernatant without disturbing the pellet. The supernatant and 
isopropanol were mixed by inversion and air incubated at room temperature 
overnight on the benchtop. Samples were centrifuged at 4,000 rpm for 45 minutes 
at 4 °C before the supernatant was decanted and the pellet was gently washed with 
1 mL 70% ethanol for 2 minutes. Samples were centrifuged at 4,000 rpm for 10 
minutes before the supernatant was decanted and the pellet was air dried overnight. 
gDNA was hydrated by adding 200 µL 1X TE and allowed to re-suspend at room 
temperature overnight. Samples were transferred to labelled 1.5 mL screw-cap 
microfuge tubes and stored at 4 °C. 
2.2 gDNA Extraction from Tissue Biopsy 
Following written consent from owners, excised tissue removed in the course 
of planned surgical treatments was stored in 7 mL bijou tubes at -20 °C by clinicians 
at the HfSA. Samples were transferred to the Roslin Institute for extraction. All 
samples were extracted using the same protocol regardless of tissue type. 
An extraction buffer was prepared by mixing 5 mL 1 M Tris (pH 8.0), 10 mL 0.5 
M EDTA (pH 8.0), 25 mL 20% SDS, 10 mL 5 M sodium chloride solution and 450 mL 
deionised water. Frozen tissue samples were cut into~0.5 cm3 pieces on lint-free 
paper (DR670, Berkshire) using a scalpel (P105/5, ParagonÒ) and forceps (F6521, 
Sigma-Aldrich). The tissue was allowed to thaw. For each extraction, one ~0.5 cm3 
sample was used and gently cut into smaller pieces before adding to 750 µL 
extraction buffer, 40 µL 1 M DTT (3483-12-3, Sigma-Aldrich) and 15 µL 20mg/mL 
proteinase K solution (Thermo Fisher Scientific, 25530049) in a 1.5 mL screw-top 
microfuge tube. Samples were incubated 60 °C overnight in a Dri-BlockÒ heat block 




270 µL saturated sodium chloride solution was added to the digested samples and 
vortexed using a Vortex-Genie™ 2 (15547335, Fisher Scientific) for 20 seconds. 
Samples were centrifuged at 15,000 G (5415D, Eppendorf) for 15 minutes before the 
supernatant was transferred to a new 1.5 mL screw-cap microfuge tube. gDNA was 
precipitated using 100% ethanol and pelleted in a centrifuge at 15,000 G for 15 
minutes. The supernatant was decanted and the pellet was gently washed with 200 
µL 70% ethanol for 2 minutes before being centrifuged for a further 15 minutes at 
15,000 G. The supernatant was decanted and the pellet was allowed to air-dry 
overnight inverted on lint-free paper. gDNA was hydrated by adding 200 µL TE and 
allowed to re-suspend at room temperature overnight. Samples were transferred to 
labelled 1.5 mL screw-cap microfuge tubes and stored at 4 °C. 
2.3 gDNA Extraction from Buccal Swab 
The PERFORMAgene™ buccal swab (DNA Genotek, PG-100) is a single-use kit 
designed to collect, stabilise and transport sources of animal gDNA. The kit is 
comprised of an exposed sponge mounted on a screw cap attached to a tube. The 
sponge is placed in the cheek pouch of the dog and gently moved for up to 30 seconds 
to collect the pooling saliva. Once collected, the kit is held upright, the cap-mounted 
sponge is unscrewed and inverted into the tube and resealed tightly. The tube 
contains a stabilising storage buffer. Sealed kits should be shaken vigorously 10 times 
to ensure the sample and storage buffer are mixed. The kit is stored at room 
temperature until extraction. 
With written consent from the owners, the PERFORMAgene™ buccal swabs 
were used by clinicians at the HfSA for patients which did not have available residual 
diagnostic whole blood or excised tissues following surgery. The buccal swabs were 
also used as part of the patient outreach initiative.  
Prior to gDNA extraction, samples were vigorously mixed by inversion for 5 
seconds and placed in an air incubator at 50 °C overnight. The collection sponge was 




recovery. Samples were not poured to avoid the transfer of any debris in the 
collection tube. The sample, totalling ~500 µL was transferred from the Falcon™ tube 
to a 1.5 mL screw-top microfuge tube which contained 20 µL purifier solution (DNA 
Genotek, PG-L2P). Samples were vortexed for 2 seconds and incubated on ice for 10 
minutes. After samples were centrifuged at 15,000 G for 5 minutes, the supernatant 
was carefully transferred to a fresh 1.5 mL screw-top microfuge tube without 
disturbing the pellet. To assist gDNA precipitation, 25 µL 5 M sodium chloride solution 
was added and mixed by inversion. gDNA was precipitated by adding 600 µL 100% 
ethanol and mixing by inverting 10 times. To ensure complete precipitation, samples 
were incubated at room temperature overnight on the benchtop. gDNA was pelleted 
by centrifuging at 15,000 G for 2 minutes prior to carefully decanting the supernatant. 
The gDNA pellet was washed gently in 250 µL of 70% ethanol for 2 minutes at room 
temperature. Samples were centrifuged again at 15,000 G for 2 minutes and allowed 
to air dry overnight by leaving the microfuge tubes open on the benchtop. gDNA was 
hydrated by adding 200 µL TE and allowed to re-suspend at room temperature 
overnight. Samples were transferred to labelled 1.5 mL screw-cap microfuge tubes 
and stored at 4 °C. 
2.4 gDNA Quantification and Quality Assessment 
2.4.1 NanoDrop Device 
Rough indications of gDNA concentration and quality were quantified using a 
NanoDrop 1000 spectrophotometer (Thermo Scientific). The ‘Nucleic Acid’ tab in the 
NanoDrop software was used to quantify gDNA. The software requests that the 
NanoDrop device is prepared by lifting the spectrophotometer arm, pipetting 1 µL 
deionised water onto the measurement pedestal, gently lowering the arm and 
clicking ‘OK’. Before and between loading samples, the arm and pedestal are wiped 
clean with a lint-free tissue. Subsequently, 1 µL TE was added to the pedestal and 
measured by clicking ‘Calibrate’. To measure gDNA samples, the name of the sample 




‘Run’. All measurements were exported and saved as a plain text file. Samples were 
considered to be pure with a 260:280 nm absorbance ratio of ~1.8.  
2.4.2 Qubit™ dsDNA Broad Range Assay Kit 
The concentrations of gDNA samples destined for whole genome sequencing 
were accurately quantified using the Qubit™ instrument (small sample sizes). For 
gDNA quantification within the range of 100 pg/µL – 1,000 ng/µL the Qubit 
fluorometric device (v4) was used with the Qubit™ dsDNA BR assay kit (ThermoFisher 
Scientific, Q32850). One 0.5 mL flip-cap microfuge tube (Q32856, Life Technologies) 
was labelled for Standard 1, Standard 2 and for each sample to be assayed. A working 
solution was prepared in a 7 mL plastic bijou tube (129A, Thermo Scientific) by 
diluting the QubitÒ dsDNA BR Reagent 1:200 in QubitÒ dsDNA BR buffer. The final 
volume of working solution accommodated for 200 µL per microfuge tube prepared 
previously. To prepare the standards, 10 µL of the QubitÒ dsDNA BR Standard #1 was 
added to 190 µL working solution in the labelled microfuge tube. The second 
standard was similarly prepared using the QubitÒ dsDNA BR Standard #2. Both 
standards were mixed by vortex for 2 seconds. To prepare the samples, 1 µL of each 
sample was added to 199 µL working solution in the appropriately labelled microfuge 
tubes and mixed by vortex for 2 seconds. Samples were incubated for 2 minutes at 
room temperature. All steps were carried out with minimal exposure to light. The 
Qubit device was turned on and the ‘dsDNA Broad Range’ tab was selected. The input 
sample volume was selected as ‘1 µL’. Standard 1 was placed in the device beneath 
the arm and measured by pressing ‘Run Standard 1’. This step was repeated for 
standard 2. Once calibrated, the samples were measured in turn by placing in the 
device and clicking ‘Measure Sample’. gDNA concentrations were recorded.  
2.4.3 PicoGreen™ Assay 
The concentrations of large batches of gDNA samples destined for SNP 
microarray genotyping were accurately quantified using the Quant-iT™ PicoGreenÒ 




2.4.3.1 Standard Curve Preparation 
A serial dilution of the 100 µg/mL bacteriophage lambda (l) DNA was used to 
create a DNA standard curve. To do this, eight 0.5 mL microfuge tubes were labelled 
1-8. To tube 1, 490 µL TE and 10 µL 100 µg/mL bacteriophage lambda (l) DNA were 
added before mixing by vortex for 5 seconds. Tubes 2-8 all contained 250 µL TE. After 
vortexing, 250 µL Tube 1 was diluted into Tube 2. Tube 2 was then vortexed before 
transferring 250 µL to Tube 3. The serial dilution was completed for all tubes 
following the instructions in Table 2.1. All samples were vortexed between dilution 
steps.  
2.4.3.2 DNA Sample Preparation 
To a 96-well PCR plate, 199 µL TE and 1 µL gDNA sample were added. Plates 
were sealed with an adhesive plastic cover (AB-0558, Thermo Scientific) before being 
mixed by inversion and collected at the bottom of the plate by briefly centrifuging.  
2.4.3.3 Working Solution and Plate Preparation 
The total volume of required PicoGreenÒ Working Solution is determined by 
adding 21 (for standards) to the number of gDNA samples and then multiplying by 25 
µL. The total volume of PicoGreenÒ Working Solution is made up with a 1:200 dilution 
of Quant-iT™ PicoGreenÒ dsDNA reagent to TE before mixing by vortex. The 
PicoGreenÒ Working Solution is prepared in a 7 mL bijou tube wrapped in tin foil to 
protect from photo-bleaching. To a flat bottomed 96-well plate (167008, Thermo 
Scientific), 25 µL of bacteriophage l DNA standards were loaded into the wells listed 
in Table 2.1. The remaining wells were loaded with 25 µL of each diluted gDNA 
sample. The PicoGreenÒ Working Solution was poured into a multichannel trough 
(12369175, Fisher Scientific) and 25 µL was transferred to every well of the flat-
bottomed plate using a multichannel pipette. The trough was covered with tin foil to 





2.4.3.4 Plate Reading and Analysis 
The Perkin Elmer Wallac 1420 VICTOR2™ plate reader was turned on and the 
flat-bottomed 96-well plate was loaded into the plate compartment with well A1 
being orientated to the top-left corner. The Wallac software was loaded and the 
‘Fluorescein High Count (1s)’ option was selected from the Choose Program’ tab. The 
‘START’ button was clicked to allow the scanner to run for a duration of ~5 minutes. 
The ‘Results of the Latest Assay Run’ option was selected from the ‘TOOLS’ menu and 
a text file containing the results was exported by selecting ‘Export’ from the ‘FILE’ 
menu. The Wallac software and device was exited and turned off after use.  
The results from the Wallac were opened in Microsoft Excel. The Fluorescein 
(1s) counts of the bacteriophage l DNA serial dilutions were plotted against their 
concentration in pg/µL as listed in Table 2.1 to create a standard curve. The 
concentration of the gDNA samples were predicted from their Fluorescein counts 
using the standard curve and the “=TREND” function in Microsoft Excel. When using 
the “=TREND” function, the concentrations of the standard dilutions were selected 
as “known_y’s”, the Fluorescein (1s) counts of the standard dilutions were selected 
as “kown_x’s” and the individual gDNA sample Fluorescein count was selected for 
the “new_x’s”. The “const” factor was set as ‘TRUE’. This was applied to all gDNA 
sample Fluorescein counts. The final gDNA concentration in ng/µL was calculated by 
multiplying the results by 0.4 to account for the dilution during preparation. 
Table 2.1 - PicoGreen Assay Preparation. Volumes of DNA standards required to produce the 
appropriate concentrations for the assay. 
Tube Concentration 
(pg/µL) 
Volumes Add to 
Wells 
1 1,000 10 µL l DNA Standard, 490 µL TE - 
2 500 250 µL Tube 1, 250 µL TE A1 - A3 
3 250 250 µL Tube 2, 250 µL TE B1 - B3 
4 125 250 µL Tube 3, 250 µL TE C1 - C3 
5 62.5 250 µL Tube 4, 250 µL TE D1 - D3 
6 31.25 250 µL Tube 5, 250 µL TE E1 - E3 
7 16.625 250 µL Tube 6, 250 µL TE F1 - F3 




2.4.4 TapeStation Device 
The quality of gDNA samples destined for whole genome sequencing were 
calculated using TapeStation 2200 (Agilent Technologies), Gnomic DNA ScreenTape 
(Agilent Technologies, 5067-5365) and Genomic DNA Reagents (Agilent 
Technologies, 5067-5366). 
Genomic DNA Reagents were allowed to equilibrate to room temperature for 
30 minutes before vortexing for use. A genomic ladder solution was prepared by 
mixing 10 µL Genomic DNA Sample Buffer with 1 µL Genomic DNA ladder in the first 
well of an Optical Tube 8-well strip (Agilent Technologies, 5067- 5150). The gDNA 
samples were prepared by mixing 1 µL gDNA sample with 10 µL Genomic DNA Sample 
Buffer. All samples were collected at the bottom of the tube by briefly spinning in a 
strip tube centrifuge (PMC-860, Stratagene) before being vortexed for 1 minute at 
2000 rpm. Tubes were spun down before being inserted into the TapeStation 
instrument. To prepare the TapeStation, fresh loading tips (Agilent Technologies, 
5067- 5152) were inserted into the left-hand side of the tip cassette and the Genomic 
DNA ScreenTape was slotted into its holder such that the QR code could be read by 
the scanner on the right of the device. The TapeStation software was opened and the 
wells containing the ladder and samples were selected. The ‘START’ button was 
clicked and the results were exported as a PDF file once finished. Once complete, 
used loading tips were discarded and fresh tips were loaded. A DNA integrity number 
(DIN) of ~8.0 and above is considered to represent good quality gDNA. 
2.5 Polymerase Chain Reaction (PCR) 
2.5.1 Standard KOD Xtreme™ Hot Start DNA Polymerase Reaction Mix 
The TProfessional Gradient thermocycler (BiometraÒ) was used for all PCR 
experiments with the KOD Xtreme™ Hot Start DNA Polymerase kit (Merck, 71975-3). 
The kit included KOD Xtreme™ DNA polymerase, 2X Xtreme™ buffer and 2 mM 
dNTPs.  Thermocycler conditions and primers vary between PCRs however a 








Table 2.2 – KOD Xtreme™ Reaction Mixture. The components and volumes of a standard KOD 
Xtreme™ reaction mixture. 
2.5.2 Standard Thermocycler Programme 
A commonly used template for thermocycler settings for PCRs is outlined in 
Table 2.3. The temperature for the primer annealing step is dependent on the specific 
primers used. Primer annealing temperatures were predicted using the Primer3 
online software (see Section 2.5.4). The extension time was also variable and was 
dependent on the size of product being amplified. A guideline extension time of 1 
min/kb is given for the KOD Xtreme™ Hot Start DNA Polymerase. For example, for a 






Table 2.3 – Standard Thermocycler Programme. The temperatures and duration of steps in a 
standard thermocycler programme. The temperature of the annealing step and duration of the 
extension phase are reaction-dependent. 
 
2.5.3 Touchdown Thermocycler Programme 
Some amplicons require the use of a touchdown thermocycler programme 
which is split into two sections. The first section starts with an annealing temperature 
Component Volume for 1x Reaction (µL) 
2X Xtreme™ Buffer 5.0 
dNTPs (2mM) 2.0 
Deionized Water 0.5 
Forward & Reverse Primers (10 µM) 0.3 
DNA (5 µg/µL) 2.0 
KOD Xtreme™ Hot Start DNA Polymerase 0.2 
Cycles Temperature (°C) Time 
1x 95 2 minutes 
40x 
98 15 seconds 
variable 30 seconds 
68 variable 




approximately 10 °C above the optimal temperature (as predicated by Primer3) and 
is successively reduced by 1 °C for every cycle. This is repeated up to 15 times and is 
intended to exclusively select the target amplicon and reduce off-target 
amplification. The second phase then runs 25 cycles at the optimal annealing 
temperature to preferentially use the template generated in the previous cycles. 
Extension times are calculated by 1 min/Kb. 
Cycles Temperature (°C) Time 
1x 95 2 min 
15x 
98 10 s 
Annealing temp - 1 °C/cycle 30 s 
72 variable 
25x 
98 10 s 
variable 30 s 
72 variable 
1x 72 7 min 
 
Table 2.4 – Touchdown Thermocycler Programme. The temperatures and duration of steps in a 
touchdown thermocycler programme. The temperature of the annealing step and duration of the 
extension phase are reaction-dependent. 
2.5.4 Primer Design 
gDNA sequence surrounding the target amplicon was inserted into the Primer3 
(v4.1.0) web input page (http://primer3.ut.ee) (Untergasser et al. 2012). Forward and 
reverse primers were selected using the following parameters: primer size 18-23 bp, 
primer temperature 50-70 °C, GC content 30-70 % with Breslauer et al. 1986 
thermocycler parameters. Optimal annealing temperatures for primers were 
recorded and primer sequences were pasted into the custom oligo ordering system 
from Integrated DNA Technologies (https://www.idtdna.com/site/order/oligoentry). 
The ‘25 nM DNA oligo’ scale and a ‘standard desalting’ purification process was 
selected from the dropdown menus. Dried oligos were resuspended in 1x TE to 
achieve a stock concentration of 100 µM which were stored at -20 °C. Working primer 




2.5.5 Primer Sequences 
Primer sequences designed previously to amplify and genotype variants 
associated with canine morphological variation were acquired from the relevant 
published literature (Table 2.5) (Parker et al. 2009; Schoenebeck et al. 2012; Rimbault 
et al. 2013; Marchant et al. 2017). Primer sequences were also designed here to 
amplify specific variants in this thesis (Table 2.5). 
2.5.6 Genotyping 
2.5.6.1 Preparation of Master Plates 
In order to genotype up to nine morphology-associated QTL for all study 
participants, master working plates of gDNA dilutions were prepared. A final 
concentration of 5 ng/µL was prepared for each sample in a total volume of 60 µL. To 
achieve this, varying volumes of gDNA were added to 96-well plates to ensure each 
well had a total of 300 ng gDNA. The plates were dried using a speed vac (SC250EXP, 
Thermo Scientific) for 15 minutes. gDNA samples were re-hydrated in 60 µL deionised 
water and allowed to resuspend over night at room temperate.  
2.5.6.2 Structural Variants 
Structural variants (SMOC2, IGF1, SMAD2 and the FGF4 retrogene) were 
genotyped based on the amplicon size visualised by 2% agarose gels. To prepare a 
gel, 1 L 1X TAE buffer was created by mixing 20 mL 50X TAE buffer with 980 mL Milli-
QÒ water. To create a 100 mL gel, 2 g Ultrapure™ Agarose (16500500, Thermo 
Scientific) was mixed with 100 mL 1X TAE in a 250 mL glass bottle and heated in a 
microwave (NN-E442W, Panasonic) for ~2-3 until completely dissolved. Once the 
bottle has cooled for 2 minutes, 15 µL 10,000X SYBR Safe DNA gel stain (Invitrogen, 
S33102) was added and mixed by swirling. The gel was cast in a gel dock (Bio-Rad) 
with combs and allowed to set for 2 hours under tin foil. Once set, the gel was place 
in a Sub-CellÒ electrophoresis tank (170-4401, Bio-Rad) and submerged in 1X TAE. 
Following the PCR, 2 µL PCR products were added to wells of an 8-well strip-tube 




(G190A, Promega). The samples were mixed briefly by vortex and collected at the 
bottom of the tube by centrifuging for 10 seconds. Mixes were loaded into the 
prepared agarose gel and ran at 100 V for 30 minutes using the Bio-Rad PowerPak™ 
Basic system. A 1 kb Plus DNA ladder (10787018, Fisher Scientific) was added into the 
first and last lanes. Gels were visualised using a Gel Logic 200 Imaging System (Kodak). 
Gels were placed on the bed of the imager. The Kodak 1D software (v3.6.5 K2) was 
loaded and a ‘New Image Capture’ session was selected. The image of the gel was 
magnified and focussed using the white light live settings before switching to the 
fluorescent transmission setting to capture the banding patterns of the gel. Images 
were saved and printed to allow for banding interpretation and genotyping. 
2.5.6.3 SNPs and small INDELs 
Amplicons targeted at SNP and small INDEL variants (BMP3, ITGA11, IGF1R, 
GHR(1), GHR(2) and ADAMTS3) were sanger sequenced by either Edinburgh 
Genomics, UK or The Institute of Genetics & Molecular Medicine, Edinburgh, UK. 
Samples in 96-well plates or 8-well strip-tubes were delivered in person with an 
excess (2 µL required per sample) of 10 µM forward and reverse primers. Samples 
were given as ‘dirty PCR products’ and required no prior cleaning steps. Upon the 
receipt of raw sequence and sequence traces, reads were entered and aligned using 
the ‘Pro’ setting in SeqMan Pro™ (v10.1.0). Genotype calls were made by a single 
analyst.  
2.6 Generating Plots and Figures 
Throughout this thesis, R (v3.3.0) and RStudio (v1.0.153) have been used to 
generate graphics and to analyse data. Specific R packages are stated when used but 
common packages include: ggplot2, stringr, reshape2, plyr, etc. Figures and data 
analysis out with this programme are explicitly cited throughout but may include 
programmes such as Microsoft Excel 2013,  ImageJ (Schneider et al. 2012) and 


















61 °C, 1 min Rim 
AGTCCTGCCATCCCACAAAG (R) 
GHR   
(1) 4:67,040,898 
(2) 4:67,040,939  
GCTCTCCGTTAAATCAAGCTG (F) 


































GGCAGGGGATGGGGAAGGCT (F) 72-52 °C, 55 
°C,  
45 s * 





62.4 °C, 1 min Mar 
GGCCTGGGAGCACTGCAC (R) 
 
Table 2.5 - PCR Primers. The positional gene candidate and its reported variant(s) positions. Primers 
are denoted as forward (F), reverse (R) ancestral (RA) and reverse derived (RD). All PCR reactions 
use standard thermocycler conditions with primer annealing temperatures and extension times 
given respectively in the conditions column. *denotes the use of a touchdown thermocycler 
programme. Primer sequences are taken from (Rimbault et al. 2013) (Rim), (Schoenebeck et al. 
2012) (Sch) and (Marchant et al. 2017) (Mar).  
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Chapter 3: Capturing Morphological Variation in the 
Domestic Dog Skull 
3.1 Introduction 
Many morphological traits of the domestic dog have changed significantly since 
its derivation from its ancestor, the grey wolf. The dog now occupies a morphospace 
which is distinct and far exceeds that of the wolf (Drake et al. 2015; 2017). This 
morphological distinction is hypothesised to have at least partly been a direct 
response to the domestication process. Fossilised remains of wolf-like dog 
progenitors have been found across Europe from similar time points to the predicted 
onset of domestication based on molecular DNA-based clocks (Tchernov and Valla 
1997; Savolainen et al. 2002; Germonpré et al. 2009; Ovodov et al. 2011; Pionnier-
Capitan et al. 2011; Germonpré et al. 2012; Thalmann et al. 2013; Freedman et al. 
2014; Frantz et al. 2016), indicating that morphological changes were observed early 
in domestication. These observations were supported by a controlled domestication 
experiment of a taxonomically close relative of the dog, the silver fox (Trut et al. 
2009). Over a period of 40 years, wild silver foxes were selectively bred for 
‘tamability’ alone and as a result the foxes underwent some profound morphological 
changes. Tame foxes lost pigmentation across their coats, their ears drooped, legs 
and tails became shorter and they developed under- or overbites. These changes 
were only observed after 15-20 generations in a small number of foxes however 
similar morphological changes have been seen across domestic animals suggesting 
that genetic and morphological changes occur in response to selection for tameness 
during domestication (Zeder 2012). 
The eighteenth and nineteenth centuries were the next major landmark in the 
morphological variability of the dog. During this time, breeding became popular and 
coincided with the establishment of the breed clubs (Wayne and Ostrander 2007). 
Breeders quickly recognised and exploited the ease of propagating desirable 




instances, the accentuated morphological features were restricted to specific breeds 
and groups of breeds which then became breed-defining and a requirement in breed 
standards (Kennel Club 2018a). The hypervariability amongst some breeds of dog are 
in fact comparable to the morphological variation across some genera of wild canids 
(Wayne 1986). Some morphological traits continue to vary and become more 
accentuated over time reflecting the whimsical desires of breeders (Drake and 
Klingenberg 2007). 
Common variable traits across the dog include body size, leg length, various 
coat characteristics and arguably one of the most morphologically diverse features, 
the canine skull (Stockard 1941). Variation in the anatomy of the dog skull has 
fascinated biologists for many years with the most striking craniofacial variability 
within the width and length of the skull. Canine brachycephaly represents an extreme 
skull conformation with morphological parallels to the human trait from which it 
takes its name (Persing et al. 1989). Bones of the viscerocranium including the nasal, 
incisive and maxillary bones have a reduced rostrocaudal length and a premature 
fusion of the cranial base/chondrocranium give the characteristic short and broad 
skulls (Huber 1974; Nussbaumer 1978). The popularity of the brachycephalic 
conformation was thought to be due to their apparent child-like (paedomorphic) 
appearance with relatively enlarged cranium, broad face and wideset eyes (Wayne 
1986; Coppinger and Coppinger 2001; Drake and Klingenberg 2010; Drake 2011). The 
retention of the juvenile features in the adult dog was thought to simply be due to 
an arrestment of the normal wolf skull development at an infant stage 
(heterochrony) however, recent work suggests it is in fact neomorphic (Drake 2011).  
In addition to the brachycephalic versus dolichocephalic (“long-faced”) 
craniofacial variation, notable changes in the prebasial angle are observed across the 
domestic dog. The prebasial angle is the angle between the plane of the hard palate 
and the plane of the cranial base with the extreme klinorhynchy and airorhynchy 
describing the ventral and dorsal rotation of the palate relative to the cranial base, 




2016; Knowler et al. 2017). The extremes of klinorhynchy is most notably observed 
in the Bull Terrier with its characteristic “downward-tilted” foreface whilst many of 
the brachycephalic dog breeds have an “upward-tilted” palate (airorhynchy). 
Similarly to the detrimental effects of brachycephaly on health, variability in the 
prebasial angle is also associated with morbidities in the dog. To date, assessments 
have focussed on the correlation of airorhynchy with neurological defects such as 
syringomyelia and Chiari-like malformations however, it is unclear to what extent the 
prebasial angle may have on disease presentation due to the co-segregation of the 
brachycephalic skull conformation with airorhynchy (Mitchell et al. 2014; Knowler et 
al. 2017). 
Finally, distinct craniofacial variation is also observed in the gross size of the 
dog skull. This characteristic is reflected in the more widely studied body size 
variation which can vary over 40-fold from <2.5 kg in the Chihuahua to >100 kg in the 
Mastiff (Kennel Club 2018a). Similarly, the Chihuahua is also one of the shortest 
breeds which measures at <20 cm at the height of the withers compared to >80 cm 
in the Great Dane (Kennel Club 2018a). This wide variation in the dog has been 
exploited to model and infer genetic contributions to adult weight and height in 
humans (Boyko et al. 2010; Hayward et al. 2016; Plassais et al. 2017). In the context 
of this research, the extreme variability in cranial size introduces the potentially 
confounding effects of allometry (see Section 1.4.2.1). The non-linear scaling of 
canine craniofacial features with the diverse variation in the size of the skull must be 
accounted for when studying purely craniofacial shape alone.  
To date, four studies have directly assessed the morphological variation of the 
canine skull with the intention of determining the underlying genetic contributors to 
canine brachycephaly – the genetic results of which will be discussed in Chapter 4 
(Jones et al. 2008; Bannasch et al. 2010; Boyko et al. 2010; Schoenebeck et al. 2012). 
Each of these studies adopted different techniques to evaluating anatomical changes 
in the canine skull. Jones et al., 2008 took linear measurements of the skull and snout 




2010 compared ‘classic’ brachycephalic against non-brachycephalic breeds (Jones et 
al. 2008; Bannasch et al. 2010). Later, Boyko et al., 2010 used breed average linear 
skull measurements from skeletal remains whilst Schoenebeck et al., 2012 adopted 
the use of a MicroScribe Digitiser to capture 3D geometric coordinates of the skull 
(Boyko et al. 2010; Schoenebeck et al. 2012). The MicroScribe Digitiser is a 
mechanical arm which records the geometric position of landmarks across the ventral 
and dorsal surfaces of the skull before combining them in silico. The use of 3D 
coordinates to asses anatomical variation across individuals is known as geometric 
morphometrics and has proven to be a powerful approach to comparing the 
morphologies of the canine skull (Schoenebeck et al. 2012).  
Geometric morphometrics is a relatively recent approach (within the past two 
decades) of assessing the overall shape of an object based on a coordinate-based 
system. This powerful technique can distinguish subtle changes in shape between 
individuals (Drake et al. 2015; 2017) and has largely superseded the traditional 
morphometric approach which used length, width and angle measurements alone 
(Rohlf and Marcus 1993). An appealing characteristic of geometric morphometrics is 
the ability to recreate objects from their coordinates and to give an intuitive and a 
more easily interpretable representation of the precise changes both within regions 
of an individual sample and across subjects (Webster and Sheets 2010). Furthermore, 
confounding influences on shape change are more easily isolated and removed from 
an object by using one of several methods of superimposition. A Procrustes 
superimposition is one of the most common and it allows for the removal of potential 
errors derived from the location, orientation and scale of the original object 
(Mitteroecker and Gunz 2009; Webster and Sheets 2010). Next, the centroid size of 
an object correlates strongly with its overall size and so has been used previously to 
regress the influence of allometry on the shape of an object (Webster and Sheets 
2010; Drake 2011; Schoenebeck et al. 2012). The centroid of a 3D object is the mean, 
central position of all the landmarks and the centroid size is a summed measure of 
the distance from the centroid to each of its constituent landmarks (Bookstein 1992). 




of variability across an object, particularly if a linear scoring system for morphological 
variation is needed e.g. for a downstream GWAS input. A commonly used method is 
a principal component analysis (PCA) which was originally described by Pearson in 
1901 (Pearson 1901). PCA is a means to extract patterns and trends from high 
dimensionality data by aiming to explain the greatest possible proportion of 
correlated variation within a dataset.  
The aforementioned studies assessing the morphological characteristics of the 
canine skull have exclusively focussed on pedigree breeds (Jones et al. 2008; 
Bannasch et al. 2010; Boyko et al. 2010; Schoenebeck et al. 2012). In doing so, the 
studies have been able to draw from the assumption that all dogs of the same breed 
are morphological homogeneous which permitted for the inclusion of more study 
participants that may not necessarily have both a phenotype and genotype. A 
drawback of this approach has been the oversight of potential variation within the 
confines of the breed boundaries and the neglecting of mixed-breed dogs. The mixed-
breed population is predicted to represent as many as one third of UK dogs (3 million 
dogs) which means the inclusion of this population in a study would not only be a 
significant increment in potential study participants, but also represent a highly 
variable population, possibly with unique combinations of morphological traits 
(PFMA 2018). Furthermore, downstream genomic assessment of genetic 
contributions to morphological variation can be assisted by possible recombination 
events which refine derived haplotypes in the mixed-breed dogs (see Chapter 4). 
In this chapter, high-resolution 3D reconstructions of the canine skull have 
been generated from computer tomography (CT) scans. Computational landmarking 
of the skull reconstructions has negated possible errors in the two-stage landmarking 
and merging of ventral and dorsal datasets which was required when using a 
MicroScribe (Schoenebeck et al. 2012). Furthermore, this chapter has included the 
use of mixed-breed dogs to exploit their diverse morphological variation. Finally, new 
methods to counteract the detrimental confounding effects of allometry have been 




3.2 Materials and Methods 
3.2.1 Participants  
The R(D)SVS Veterinary Ethical Review Committee (20 16, University of 
Edinburgh) approved the study which recruited participants from 2008 to the present 
from the Hospital for Small Animals, The University of Edinburgh. Archived records of 
patient computer tomography (CT) scans were searched using the ClearCanvas 
Workstation (v2.0.12729.37986) and matched with biomaterial archived and stored 
at -20 °C. If frozen biological samples were not available, a priority list of patients to 
contact was created. Potential study participants were targeted if they represented 
a morphological diverse breed, or were a breed at risk of developing brachycephalic 
obstructive airway syndrome (BOAS). A candidate list of dogs was provided to 
Professor Richard Mellanby and Susan Campbell who made contact with owners 
directly. If owners were willing to participate in the study, a PERFORMAgene™ saliva 
swab with instruction for its use, a consent form, a prepaid return envelope and a 
short summary of the project aims were sent to owners. Genomic DNA (gDNA) was 
extracted from the returned saliva swabs as previously described (see Section 2.3) 
and stored at 4 °C for later use in Chapter 4. From 2010 onwards, the owners of new 
patients receiving a diagnostic CT scan were asked during their consultation whether 
they would be willing to be included in the study. Additionally, participants were 
recruited from veterinary practices across the UK and Switzerland and included: 
Davies Veterinary Specialists, Hertfordshire, UK; Small Animal Medicine and Surgery 
Group, The Royal Veterinary College, Hertfordshire, UK; and The Division of Clinical 
Radiology, The Vetsuisse Faculty of Bern, Switzerland.  
All canine participants were admitted to their respective veterinary practices 
and received computer tomography (CT) scans as part of their clinical diagnosis. 
Common diagnoses included foreign bodies, ear infections, BOAS and physical 
trauma to the skeleton. A Siemens Somatom four-slice CT scanner was used to 
acquire spiral or sequential scans of either one- or two-millimetre slice thickness. All 




diagnosis. Case notes were subsequently reviewed to confirm the suitability for the 
inclusion of cases in this study – dogs representing breeds with diverse craniofacial 
morphologies, patients diagnosed with BOAS and breeds with an increased 
susceptibility of BOAS were prioritised. The only exclusion criteria were cases with 
pathologies or injuries compromising the structure of the skull. Later, during 
isosurface reconstruction, several study candidates were excluded as a result of 
corrupt archived files which failed to generate an isosurface.  
Due to the ongoing recruitment of patients and the continued archiving of 
biological samples, participants have been grouped into two study cohorts. The first 
study cohort was analysed and provided the resolution of the major locus controlling 
canine brachycephaly (discussed throughout this thesis) which was published in 2017 
(Marchant et al. 2017). Subsequently, the first study cohort was extended to form 
the second study cohort which has provided more statistical power and allowed for 
the modification of study procedures. Throughout this thesis, the use of study 
cohorts one and two are stated clearly for each analysis.  
3.2.1.1 Cohort 1 Demographics 
In total, the first cohort consisted of 374 (212 male, 162 female) referral 
patients each with computer tomography (CT) scans. All individuals were 24 months 
old and above to ensure the complete maturation of the bones of the skull. Of the 
374 dogs, 291 represented 84 breeds recognised by the UK Kennel Club with a 
median of 2 dogs per breed and a minimum of 1 (various breeds) and a maximum of 
16 (Labrador Retrievers & Golden Retrievers). In addition to this, a further eighty-
three mixed-breed dogs were included. The neurocranium and viscerocranium was 
examined for all participants however a subset of 355 dogs were used for the analysis 
of the mandible. Nineteen dogs could not be used for the mandible assessment due 
to physical trauma to the mandible or absence of the mandible from the CT scan 




3.2.1.2 Cohort 2 Demographics 
All participants of the first study cohort were included in the second cohort. 
Additionally, a further 186 dogs were added to give a total of 560 dogs (315 males, 
245 females). Breed diversity was increased to include a total of 92 UK Kennel Club 
recognised breeds with a median of 2 dogs per breed and a minimum and maximum 
of 1 (various breeds) and 38 (Labrador retriever), respectively. A total of 114 mixed-
breed dogs were also included in the cohort. All dogs were aged 24 months and 
above. The neurocranium and viscerocranium was analysed for all participants 
however the mandible was no longer assessed. Throughout this thesis, the breed 
designations of participants were owner defined but were later verified by genotypic 
profiling (see Chapter 4). 
3.2.2 Skull Reconstruction and Landmarking 
High-resolution three-dimensional (3D) skull reconstructions of each patient 
were reconstructed using the CT scan-derived DICOM files in the Stratovan 
Checkpoint software (v2016.06.28.0428). Once an individual’s DICOM stack had been 
loaded into the Checkpoint software, the “Surface” tab was selected. To display bone, 
a Hounsfield unit of approximately 500 was used. Anatomical substructures (cranium 
and mandible) of the resulting skull isosurfaces were landmarked by a single analyst. 
Patient demographics information was hidden from the analyst. Fifty-six landmarks 
were selected to capture the overall variation in the cranium whilst a further thirty 
landmarks were used for the mandible (Figure 3.1 and 3.2). Landmark positions were 
selected based upon their reproducibility (Schoenebeck et al. 2012). Once 
landmarking was complete, the Stratovan software generated a .ckpt save file which 
contained raw 3D coordinates for each landmark. A custom-made R script extracted 
the raw coordinates for all study participants and created a reformatted plain text 
(.txt) file containing x, y and z coordinates for every landmark across all participants. 
The Hounsfield units used to reconstruct skull isosurfaces were also extracted as 





Figure 3.1 - Landmarks of the Cranium. Position of landmarks placed on the reconstructed isosurfaces of the 
skull divided into landmarks of the viscerocranium (*) and neurocranium (†). Images clockwise from top-left: 




3.2.3 Morphometric Analysis 
The reformatted 3D coordinate file was imported into MorphoJ (v1.06c, 
Klingenberg Lab) (Klingenberg 2010). A generalised Procrustes fit was performed to 
appropriately superimpose the shape data by scaling, transposing and rotating 
Figure 3.2 – Landmarks of the Mandible. Position of landmarks placed on the reconstructed isosurfaces of the 
skull. Images clockwise from top-left: Caudal, Lateral (right side), Dorsal and Rostral. Modified from (Marchant 




(Klingenberg 2016). Landmark pairs were checked for errors using the “Find Outliers” 
function. The landmarks of the cranium were subdivided into those representing the 
neurocranium (n = 18) and viscerocranium (n = 25) (Figure 3.1 and 3.2). The 
viscerocranium was defined by structures rostral to, and not inclusive of the frontal 
bones. The neurocranium was defined by all structures caudal to this. In order to 
remove the effects of allometry from the whole head, viscerocranium and mandible 
symmetric coordinate data, a regression of 10,000 permutations using the 
neurocranium centroid size was used. The neurocranium centroid is a bi-product of 
the Procrustes fit which indicates the scaling required to superimpose the 
neurocranium shape data and has been used as a proxy to body size previously 
(Schoenebeck et al. 2012).  
Subsequently, in an attempt to best counteract the effects of allometry, two 
additional methods were trialled in the second study cohort. The first method used 
a pooled within-group regression for breed. Here, the study population was split into 
its constituent breeds and within these groups, shape (whole head and 
viscerocranium PC1) was regressed on neurocranium centroid size. The rationale for 
doing this is that size is expected to be structured by breed and so a single linear 
regression for the entire dataset may be less representative than a within breed 
regression (Klingenberg 2016).  
A second method similarly used a within-group regression, however this time 
the groups were defined by the combination of size-associated QTL carried by the 
study participant. To identify these size-related QTL, the neurocranium centroid size 
from the second study cohort was used as a phenotypic input for a GWAS in Chapter 
4. Nine QTL were associated and at positions of previously associated variants, 
individuals were genotyped for the variant (see Section 2.5.6), whilst in the absence 
of a variant, the index marker (most significant marker) for each QTL was used. The 
rationale behind this was to predict the size of an individual and negate possible 
errors in phenotype capture, environmental influences and assumptions of 




Following each of the regression methods to remove allometry, a covariance 
matrix was generated from the regression residuals and a principal component 
analysis (PCA) was used to reduce dimensionality. The prebasial angle between the 
plane of the cranial base (hirnstambasis) and the plane of the hard palate was 
calculated using a custom R script. Briefly, the symmetric coordinates from the 
Procrustes fit in MorphoJ were used as an input. An assumption was made that there 
was negligible variation in the z-axis of coordinates since all landmarks are situated 
along the midline of the x/y-axis, therefore 2D vectors were used to calculate the 
prebasial angle. Angles are given in degrees.  
3.3 Results 
3.3.1 Skull Reconstructions 
CT scans for each study participant were reconstructed to produce a high-
resolution three-dimensional (3D) isosurface of the skull completely absent of soft 
Figure 3.3 – Isosurfaces of the Canine Skull. Lateral images of a Smooth Collie (A; dolichocephalic), 
Bernese Mountain dog (B; mesocephalic), Border Terrier (C; mesocephalic) and a Pug (D; 
brachycephalic) with corresponding isosurfaces of the skull. Images and reconstructions are not to 
scale. (E) The cranium and mandible are separated to reveal the position of landmarks across the two 




tissue or trimmings which may hamper other phenotyping approaches (Figure 3.3). 
Extremes of craniofacial phenotypes can be seen in the reconstructions such as the 
brachycephalic skull shape of the Pug and dolichocephaly in the Smooth Collie. The 
Bernese mountain dog and Border terrier represent breeds with an intermediate 
skull shape. Eighty-six landmarks (56 cranial, 30 mandibular) were placed across the 
skull isosurfaces by a single analyst to capture the subtle and extreme morphological 
variation seen both within and across breeds (Figure 3.1, 3.2 & 3.3).  
3.3.2 Geometric Morphometrics on Cohort 1  
To remove the potential confounding effects of differences in orientation, 
position and scale of the skull coordinates, a Procrustes fit for the whole skull was 
executed. Subsequently, a regression using the neurocranium centroid size on the 
symmetric Procrustes coordinates then removed the influence of size on form 
(allometry) to leave variation in shape alone. Finally, a principal component analysis 
was performed on the regression residuals.   
Whole head PC1 explains up to 63.52% of the total variation in the skull across 
study cohort 1 with each subsequent PC explaining an ever-reducing percentage of 
the variation (Table 3.1). Global changes in the morphology of the whole head are 
visualised using wireframe schematics (Figure 3.4A). As whole head PC1 becomes 
more negative the height of the cranium increases, the width of the skull broadens 
and the length of the skull becomes shorter in the rostrocaudal axis – all 
Table 3.1 – Principal Component Weightings for Cohort 1. Principal components successively explain 
smaller tranches of morphological variation (percentage) within the distance matrix generated from 
each of the whole head, rostrum and mandible. 
Principal 
Component 
% Variance Explained 
Whole Head Viscerocranium Mandible 
1 63.52 72.24 66.20 
2 8.82 5.15 8.54 
3 4.95 4.07 3.02 
4 2.29 2.41 2.60 




characteristics of the brachycephalic head conformation. Conversely, as whole head 
PC1 becomes more positive, the height of the cranium is reduced, the width of the 
skull becomes narrower and the length of the skull becomes longer – all  
characteristics of the dolichocephalic head conformation. A lollipop schematic for the 
whole head PC1 reveals the extent and direction of variation of each individual 
landmark from its mean position across the dataset (Figure 3.4B). Landmarks 
constituting the viscerocranium display the greatest variation relative to the rest of 
Figure 3.4 – Geometric Morphological Variation. Lateral and dorsoventral schematics of the (A & B) 
whole head and (C) viscerocranium summarising the geometric changes captured by principal 
component analysis. Wireframe diagrams depict the global geometric changes captured by negative 
and positive principal component 1 (“ve PC”) for the (A) whole head and (C) viscerocranium. Red 
circles indicate surface landmarks of the skull. Connecting blue lines are added to provide visual 
context to shape changes. (B) Lollipop diagram shows the mean position of each landmark (red 




the skull. To this end, the geometric analyses were repeated using the viscerocranium 
as an anatomical subset. Viscerocranium PC1 displayed the similar global 
morphological variation with negative PC1 accounting for a broader, shorter face 
whilst positive PC1 accounted for a longer, narrower face (Figure 3.4C). These are 
characteristics of brachycephaly and dolichocephaly, respectively. Despite capturing 
similar morphological trends, viscerocranium PC1 accounts for a greater percentage 
of the total variation across the foreface (72.24%) than whole head PC1 accounted 
for across the skull (63.52%) (Table 3.1). This suggests a modular localisation of 
variation such that the greatest morphological variation is restricted to the 
viscerocranium compared to the skull as a whole. The remaining principal 
components (PC2-5) are difficult to interpret due to the reduced level of phenotypic 
variation explained (data not shown). Later, the larger study cohort 2 will be used to 
interpret morphological changes captured by whole head PC2.  
The neurocranium centroid size was generated as a bi-product of the 
Procrustes fit and used in subsequent analyses as a proxy for body size. Here, the 
neurocranium centroid size appears to have minimal variation within breeds and 
gives an expected order to breeds within the cohort i.e. the miniature pinscher, toy 
poodle and Japanese Chin are some of the smallest breeds in this study which is 
reflected in their small neurocranium centroid size (Figure 3.5A). Conversely, the 
giant breeds which include breeds such as the Newfoundland, Great  
Dane and Leonberger have some of the largest neurocranium centroid sizes and 
appear to have an inflection in their neurocranium centroid sizes compared to the 
rest of the breed distributions. The distributions of PC1 for the whole head, 
viscerocranium and mandible all show a similar trend – brachycephalic breeds have 
negative PC1 scores and have a distinct inflection in the breed boxplot distributions 
compared to other breeds (Figure 3.5B-D). This reflected in the non-normal, bi-modal 
frequency distributions for each trait (Figure 3.5B-D insert). 
The neurocranium centroid size and PC1 scores for each anatomical 





Figure 3.5 – Morphology by Anatomical Subdivision. Boxplots of the (A) neurocranium centroid, (B) 





are used as phenotypic inputs for the genome-wide association analyses in Chapter 
4. 
3.3.3 Geometric Morphometrics on Cohort 2 
3.3.3.1 Methods to Remove Allometry  
Following the increased availability of study participants in the extended study 
cohort 2, new methods to account for allometry in the dataset were sought to 
increase the power of subsequent analyses. The neurocranium centroid size has 
proven to be an important proxy for body size and began to address removing the 
influence of allometry on shape variation in the skull. Despite this, the regression 
scores of the viscerocranium remain in strong correlation with neurocranium 
centroid size (R2=0.889), suggesting a component of size still remains in the dataset 
(Figure 3.6A). Here, two additional approaches to account for allometry were tested 
which used regressions pooled by subgroup including breed (Figure 3.6B) and 
combination of size-associated genetic markers (Figure 3.6C). Prior to this regression, 
the neurocranium centroid from the second cohort was applied in a genome-wide 
association analysis (Chapter 4). This resulted in nine QTL being associated with body 
size. The index marker of each of these loci were used as size-associated markers as 
Figure 3.6 - Parsing Shape from Size. The (A) neurocranium centroid size, (B) neurocranium centroid 
size pooled by breed and (C) the neurocranium centroid size pooled by nine morphological size-
related genotypes were used to regress the aspect of size from the viscerocranium. The resulting 
regression scores were plotted against the neurocranium centroid size. Pearson’s correlation 




part of the pooled regression. The extent of correlation between the neurocranium 
centroid size and the regression scores is reduced for both the breed (0.469) and size-
associated marker (0.267) indicating a reduced influence of allometry on the dataset. 
For this reason, the pooling of individuals by size-related markers as a method to 
account for allometry was used in subsequent studies of the whole head and 
viscerocranium. 
3.3.3.2 Principal Component Analysis 
Following the pooled regression described above, a principal component 
analysis was performed for both the whole head and viscerocranium datasets in 
study cohort 2. For the second cohort, there was an increase in the percentage of 
phenotypic variation explained by PC1 in both the whole head and viscerocranium 
dataset when using the pooled regression instead of universal regression (Table 3.2). 
The type of regression used seemed to have a minimal impact on the remaining 







Regression by Morphological 
QTL (new method) 
Whole Head 1 70.282 71.701 
Whole Head 2 5.12 4.82 
Whole Head 3 2.661 2.56 
Whole Head 4 2.369 2.327 
Whole Head 5 1.799 1.717 
Viscerocranium 1 78.823 79.962 
Viscerocranium 2 3.553 3.359 
Viscerocranium 3 3.306 3.075 
Viscerocranium 4 1.732 1.644 
Viscerocranium 5 1.561 1.453 
Table 3.2 – Principal Component Weightings for Cohort 2. Principal components successively explain 
smaller tranches of morphological variation within the distance matrix generated from each of the 
whole head and viscerocranium. Regressions have been performed using a single neurocranium 
centroid across the entire dataset (old method) and a within-group regression whereby individuals 





Plotting viscerocranium PC1 scores against the neurocranium centroid size 
allows for the morphological segregation of breeds. Breeds such as the French 
Bulldog and Pug cluster tightly together whilst breeds such as the Yorkshire Terrier 
and Labrador Retriever appear to have a greater degree of craniofacial variability 
(Figure 3.7A). Importantly, this breed-level clustering can allow for the visual 
inspection of the data to confirm breed designation. For example, a dog was labelled 
as a Smooth Collie however its viscerocranium PC1 score appeared as an outlier and 
so prompted the checking of its clinical records which confirmed that the dog was in 
fact a mixed-Collie dog (black arrows). The frequency distribution of viscerocranium 
PC1 scores forms a distinct bi-modal distribution with the “classic” brachycephalic  
Figure 3.7 – Second Study Cohort Phenotype Distribution. (A) Distribution of viscerocranium PC1 
values and neurocranium centroid scores for the second phase cohort. Example breeds are 
highlighted. Breed abbreviations: Pug (PUG), French Bulldog (FBUL), Boxer (BOX-), Great Dane 
(DANE), Labrador Retriever (LAB-), Smooth Collie (COLL), Yorkshire Terrier (YORK) and Border 
Terrier (BORT). (B) Breeds ordered by viscerocranium PC1 score. Black arrow indicates a dog 





Figure 3.8 – Whole Head PC2. (A) Lateral photographs of the Pitbull Terrier and St. Bernard dog 
skulls which represent klinorhynchy and airorhynchy, respectively. Rectangular boxes indicate the 
planes of the cranial base (left) and hard palate (right). (B) Lollipop diagrams of lateral and 
dorsoventral profiles of the whole head show the mean position of each landmark (red circles) and 
the direction and extent of variation captured across the second cohort by whole head PC2 (blue 
lines). (C) Wireframe diagrams depict the global changes in the lateral (top) and dorsoventral 
(bottom) outline of the whole head capture by positive and negative PC2. (D) Distribution of 
individual dogs scored by whole head PC2 and prebasial angle calculated from the geometric 
landmark data. Example breeds are coloured and appear to indicate a greater variability in 




breeds contributing the majority of the distinct population (Figure 3.7B). This is 
phenomenon is reflected in the boxplot distribution which sees a distinct inflection 
in the distribution for the brachycephalic breeds.  
The increase in population size for study cohort 2 and the inclusion of more 
diverse breeds has allowed for the interpretation of additional PCs such as whole 
head PC2. Visual inspection of whole head PC2 indicates it is likely capturing the 
variability in the angle of the hard palate relative to the neurocranium. The whole 
head PC2 axis is polarised by the Bull Terrier and Airedale Terrier which are breeds 
displaying klinorhynchy whilst breeds such as the Cavalier King Charles Spaniel have 
a greater extent of airorhynchy as has been shown in previous studies (Mitchell et al. 
2014; Knowler et al. 2017). The extremes of this klinorhynchy-airorhynchy axis can 
be seen in breeds such as the Bull Terrier and St Bernard, respectively (Figure 3.8A). 
Lateral lollipop plots of the whole head indicate that landmark variation occurs in the 
foreface relative to the neurocranium (Figure 3.8B). The effects of this are more easily 
visualised in the wireframe diagrams (Figure 3.8C). Here, the lateral outline of the 
skull can be seen to have a severely “downward-tilted” foreface as whole head PC2 
becomes more negative (klinorhynchy) whilst it is dorsally rotated as whole head PC2 
becomes more positive (airorhynchy). Meanwhile, the shape of the neurocranium 
appears to have minimal variation as the PC2 value varies. Previous studies have 
relied on the use of the prebasial angle to determine the extent of 
klinorhynchy/airorhynchy however here, the prebasial angle (degrees) has a greater 
variation within breeds than whole head PC2 (Figure 3.8D). This could suggest that 
the prebasial angle is a poor representation of the morphological variation in the 
palate angle and that a global analysis of the foreface relative to the neurocranium is 
required. 
3.3.3.3 The Use of Mixed-Breed Dogs 
For the first time, mixed-breed dogs have been used to assess canine 
craniofacial morphological variation. All morphological traits shown here 




angle) indicate that all mixed-breed dogs (red circles) occupy a smaller morphospace 
which exists entirely within that of the purebred population (Figure 3.9). At this 
morphological level, the mixed-breed population display similar characteristics to 
their purebred counterparts however it is anticipated that this will be the result of 
unique combinations of underlying genetic loci which will provide more power when 
later modelling the phenotypic effect size of these loci (see Chapter 4). Hopefully, the 
mixed-breed population will have also undergone more extensive recombination 
events than the purebred population which will allow for the refinement of derived 
haplotypes in later analyses.  
3.3.3.4 Sexual Dimorphism 
Sexual dimorphism is a common phenomenon across biology. To determine 
whether this is true across dogs in this dataset, the neurocranium centroid size was 
plotted by sex for the five most populated breeds – French Bulldog (25), Golden 
Retriever (26), Jack Russel terrier (18), Labrador Retriever (38) and Pug (29) (Figure 
3.10). All five breeds displayed significant sexual dimorphism with the male being 
larger than the female in each instance. Neuter data for all dogs was not available. 
Sex can be incorporated as a covariate for downstream genomic analysis. 
Figure 3.9 – Mixed-breed Dog Population. Distribution plots of (A) neurocranium centroid size 
against viscerocranium PC1 and (B) whole head PC2 against the prebasial angle for the second study 
cohort. Mixed-breed dogs are coloured in red and occupy a smaller morphospace which is entirely 







The results in this chapter support previous observations that the domestic dog 
is a highly morphologically diverse species. The establishment of the breed clubs 
within the last 200 years followed by heavy artificial selection has resulted in the 
exaggeration of morphological traits, which in many cases, have become breed 
defining (Wayne and Ostrander 2007; Club 2018b). Here, the focus was specifically 
on the skull and the variation in both its shape and size. New methods were sought 
to define and score this morphological variation with the ultimate goal of using these 
morphological scores to later identify their underlying genetic contributors in 
subsequent genome-wide association analyses.  
The data in this chapter have highlighted 3 major axes of morphological 
variation in the canine skull: brachycephaly-to-dolichocephaly, klinorhynchy-to-
airorhynchy and small-to-large morphological variation. Beyond this, visual 
inspection of the skulls suggest that variation also exists in other craniofacial features 
such as the curvature of the neurocranium, the formation of a neural ridge, the 
arches of the zygomatic bones, the angle of the mandibular arm (ramus), the depth 
Figure 3.10 - Sexual Dimorphism. Male (white) and female (grey) neurocranium centroid sizes 





of orbits and several others which are beyond the scope of this study. Landmarks 
were less ideally positioned to characterise these traits which are generally more 
subtle than the 3 major axes listed above and so would warrant a new selection of 
landmarks to study in the future. An additional assessment of the current data could 
also be to reduce the total number of landmarks used in this study to capture skull 
variation as rather paradoxically, having a very large number of landmarks can in fact 
reduce the statistical power or ability to detect subtle shape differences (Gunz et al. 
2013; Collyer et al. 2015). 
 The most prominent overarching axis of morphological variation described 
here has been the brachycephalic-to-dolichocephalic continuum in which skulls 
generally span from broad and short to long and narrow, respectively. These 
extremes of facial conformation were first described in human patients with 
craniosynostoses (Persing et al. 1989) but have since been observed across a wide 
range of mammalian species including across the wider Carnivora order (Sears et al. 
2007), and in domestic species such as the cat (Künzel et al. 2003; Schlueter et al. 
2009; Lyons et al. 2015), cow (Veitschegger et al. 2018), goat (Veitschegger et al. 
2018), sheep (Dantas et al. 2013), pig  (Veitschegger et al. 2018) and mice (Wang et 
al. 2005). This observation raises an interesting question whether or not a common 
pathway has been altered across species? The exploration of the genetic 
determinants of canine brachycephaly in Chapters 4 and 5 will begin to shed light on 
this.  
Here, the geometric morphometric analysis of the whole canine skull revealed 
a pronounced variation in the viscerocranium. A subsequent PC analysis showed an 
increase in the percentage of total phenotypic variation explained by PC1 for the 
viscerocranium compared to the whole head suggesting some of the greatest 
variation in brachycephalic dogs is restricted to the foreface. Similarly, the whole 
head PC2 captured the klinorhynchy-to-airorhynchy axis in which the morphological 
variation is restricted to the viscerocranium relative to the neurocranium. This 




that the viscerocranium and neurocranium are correlated, yet distinct morphological 
substructures. The modularity of the skull is not a novel concept – Fondon and 
Garner, 2004  investigated the angle of the hard palate compared to the cranial base 
in the Bull Terrier and established that despite variation in the morphology of the 
viscerocranium, the neurocranium remained relatively unchanged (Fondon and 
Garner 2004). A study of St. Bernard’s revealed that across all of the craniofacial 
variation, the majority was explained by an upward inclination of the palate relative 
the cranial base (airorhynchy) coupled with a broadening of the head, most notably 
around the nose (Drake and Klingenberg 2007). A subsequent study across almost 
700 domestic dog skulls confirmed the morphological distinction in variation of the 
neurocranium and viscerocranium (Drake and Klingenberg 2010). The distinction of 
these anatomical substructures is perhaps unsurprising based on the knowledge of 
embryonic craniofacial development. The bone of the viscerocranium and 
neurocranium are largely sourced from two distinct populations in early 
embryogenesis – the neural crest and paraxial mesoderm, respectively (see Section 
1.2). Differences in tissue origins could begin to explain the apparent disconnection 
in the behaviour of morphological variation across the two structures. It is possible 
to hypothesise that a genetic variant could specifically perturb a component of the 
viscerocranial developmental pathway whilst leaving the remaining neurocranial 
development relatively unaltered. Also, a possible explanation for the greater extent 
of viscerocranium variability compared to the neurocranium may be in part due to 
the tolerance of viscerocranial variation. Changes in the neurocranium, which houses 
the brain would be predicted to have more drastic effects on viability of offspring and 
so are less likely to be present in the variability of UK dogs. 
The diverse variation in the overall size of the canine skull introduces the 
confounding influences of allometry when attempting to investigate the subtleties of 
craniofacial shape change. Schoenebeck et al., 2012 demonstrated that a failure to 
remove the allometric component in skull form variation results in the contamination 
of genomic association studies with size-related QTL, a phenomenon replicated in 




breed average weight (kg) as an approach to remove allometry however this has the 
potential to fluctuate due to environmental factors and so may not truly reflect the 
influence of growth variation in the dog (Boyko et al. 2010). Superseding this was the 
use of centroid size regressions of the skull (Drake 2011; Schoenebeck et al. 2012). 
This use of a single linear regression was repeated here, however, the continued 
correlation between the neurocranium centroid size and the regression residuals of 
the viscerocranium suggested that an allometric component was still present in the 
data. Modifications to this procedure revealed that the pooling of individuals by their 
combination of size-related genetic markers improved the disentanglement of 
variation in craniofacial shape and its overall size (Klingenberg 2016). This procedure 
used the index markers from a genome-wide association test in Chapter 4 which were 
assumed to be tagging underlying causal variant(s). The advantages of this method is 
that it relieves the assumption that all dogs of the same size have the same 
combination of size-determining QTL and is thought to more accurately represent the 
changes in growth of individual dogs. A drawback of this approach is the requirement 
of a DNA sample for each dog – whilst this is not a concern for this study, it may prove 
to be a limitation for others. An interesting future experiment would be to repeat this 
protocol however, using definitive causal variants (once they are determined) rather 
than a tagging index marker which may not precisely capture the underlying variant 
genotype.  
Overall, the data in this chapter importantly demonstrates that craniofacial 
morphological variation exists at both an inter-breed and intra-breed level. Purebred 
dogs have largely been assumed to be morphological homogeneous, however this 
data challenges that. It remains to be seen whether this observation is representative 
of the wider breed populations or if it is restricted to the participants of this study. 
An explanation for this variability could be that many of the dogs attending clinical 
practices across the UK represent ‘family pets’ which are not thorough-bred show-
standard dogs and therefore liable to more extensive morphological variation. 
Another source of apparent intra-breed variability could be due to the owner-defined 




breeds from their owners and so it is possible that, for example, an owner miss-
recorded their dog as a Labrador Retriever when in fact it was a Golden Retriever. 
This mislabelling could begin to account for some of the apparent morphological 
variation within a designated breed however the likelihood of this is minimal due to 
the assessment of the genomic structure of all participants in Chapter 4. 
The analyses in this chapter have formulated a new protocol to improve the 
accountability for the detrimental effects of allometry on craniofacial form. In light 
of this, craniofacial shape variation has been observed to vary between breeds as 
expected but also within breeds which challenges the pre-held assumption that a 
breed represents a morphologically homogeneous population. Importantly, this 
individual-level morphological quantification can permit the determination of the 














Chapter 4: Genomic Assessment of Canine Morphology 
4.1 Introduction 
As explored in Chapter 3, the domestic dog represents a morphologically 
diverse species. This diversity, coupled with the simplified genomic architecture of 
the canine genome, have been exploited by many previous studies striving to find the 
genetic determinants of morphological variation. 
4.1.1 Leg Morphology 
Studies have explored a wide range of canine morphologies and shared success 
in identifying quantitative trait loci (QTL) or better still, putatively causal variants. 
One particular area of success has been in the mapping of leg length in dogs, namely 
in the form of the skeletal dysplasias. These are a broad collection of disorders that 
result in abnormal limb shortening such as that in asymmetric chondrodysplasia, a 
form of disproportional short stature that affects the long bones of the appendicular 
skeleton (Krakow 2015). A cross-breed analysis using a binary, long- versus short-
legged phenotype discovered the insertion of a fibroblast growth factor 4 (FGF4) 
retrogene into canine chromosome (CFA) 18 (Parker et al. 2009). This retrogene was 
discovered to be expressed in a variety of breeds including the Miniature dachshund, 
Basset hound and Pembrokeshire Welsh corgi. Intriguingly, an independent study 
similarly used a short- versus long-legged phenotype for skeletal dysplasia to distil a 
second FGF4 retrogene on CFA12 (Brown et al. 2017). This discovery was made using 
the Nova Scotia Duck Tolling Retriever but was subsequently shown to complement 
the breeds with skeletal dysplasia that did not have the CFA18 FGF4 retrogene such 
as the American Cocker Spaniel, Beagle and French Bulldog. Owing in part to the 
simple Mendelian inheritance patterns in specific breed pedigrees, mutations in the 
collagen alpha-2(XI) chain (COL11A2), integrin subunit alpha 10 (ITGA10) and solute 
carrier family 13 (SLC13A1) have been found to cause forms of dwarfism in the 
Labrador Retriever, Norwegian Elkhound and Miniature Poodle respectively (Neff et 
al. 2012; Frischknecht et al. 2013; Kyöstilä et al. 2013). Furthermore, oculo-skeletal 
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dysplasia, a combination of dwarfism and eye defects is known to be caused by a 
mutation in the collagen alpha-3(IX) chain (COL9A3) in Labrador Retrievers (Goldstein 
et al. 2010). 
4.1.2 Body Size Variation 
This current study has a vested interest in the variation in skeletal size of dogs. 
Here, the neurocranium centroid size has been used as a proxy of skeletal size to 
remove the allometric component of craniofacial variation in the dog. An extensive 
literature exists for the hereditary component to body size variation in the dog, the 
studies on which have adopted a number of different approaches to investigating. 
One of the earliest and largest effect loci was identified by Chase et al., 2003. There, 
investigations were focused on a single breed – the Portuguese Waterdog, a breed 
permitted to vary up to 50% in size by the American Kennel Club (Chase et al. 2002). 
Principal components of measurements derived from two-dimensional radiographs 
of individual dogs were used as a phenotypic input (Chase et al. 2002). This study 
identified a quantitative trait locus (QTL) on CFA15 to be associated with small size. 
Later, a localised effort to resolve the CFA15 locus was able to define a critical interval 
encompassing the insulin-like growth factor 1 (IGF1) gene (Sutter et al. 2007). A 
definitively causal variant at this locus was unable to be isolated however within the 
critical interval is a short interspersed nuclear element (SINE) which is an appealing 
candidate for causality but it exists amongst numerous other potentially causal 
variants. Interestingly, the insulin-like growth factor 1 receptor (IGF1R) has since 
been associated with the “toy” breeds such as the Chihuahua and Miniature Poodle 
(Hoopes et al. 2012). A missense variant within this gene was discovered by parsing 
breeds based on averages of estimated heights into “toy” and “non-toy” categories. 
Care was taken to remove dogs with the CFA18 FGF4 retrogene which induced 
asymmetric chondrodysplasia.  
In a separate study, associated variants in a further four positional gene 
candidates were reported to correlate with standard breed weights averaged across 
male and female dogs (Rimbault et al. 2013). These candidates included the growth 
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hormone receptor (GHR) and stanniocalcin 2 (STC2) genes on CFA4 and the SMAD 
family member 2 (SMAD2) and high mobility AT-hook 2 (HMGA2) genes on CFA7 and 
10, respectively. Allele frequencies at these four loci in addition to the IGF1 and IGF1R 
were modelled to account for up to 52.5% of the total variance in canine body size 
suggesting many more body size QTL are yet to be identified. The extensive genetic 
contribution to canine body size variation was alluded to in studies by the Boyko 
Laboratory which used over 1,800 dogs to identify seventeen loci significant or 
suggestive associations with breed average male weight (Hayward et al. 2016). This 
list included the six aforementioned positional candidate genes and a collection of 
other appealing positional candidate genes and novel loci which together, are 
predicted to account for up to 80% of the total variance in canine body size. Fine 
mapping at these seventeen genetic loci remains to be done however, the extensive 
hereditary component to canine body size variation is clear. 
4.1.3 Skull Shape Variation 
Like body size, the complex nature of craniofacial shape in the domestic dog 
has been alluded to by several previous studies. One of the first studies to do this was 
by Jones et al., 2008 which took linear measurements of the skull and snout from dog 
photographs to generate 145 breed average ratios (Jones et al. 2008). This identified 
an association between snout length and a QTL on CFA1 at 97,045,173 (CanFam2). 
Later, Bannasch et al., 2010 also identified a CFA1 locus (~59.435 – 59.485 Mb) which 
has been the only analysis to date to examine haplotypes within the region (Bannasch 
et al. 2010). The study screened 49 SNPs across 88 dogs seemingly defined as 
brachycephalic which were compared to a selection of 185 non-brachycephalic 
breeds. Using a number of assumptions, a critical interval was drawn at the CFA1 
locus which encompassed the thrombospondin 2 (THBS2) gene. Importantly, these 
assumptions may have been misguided. Firstly, their study expected that all 
brachycephalic dogs were fixed for the associated haplotype and therefore causal 
variant(s). Whilst this assumption is not unreasonable, the complex nature of the trait 
and known variability within breeds (see Chapter 3) may provide exceptions. 
Secondly, in reviewing the published haplotype analysis, it appears that the critical 
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interval may have been misinterpreted as the same haplotype appears to extend in 
both directions from the defined critical interval. No variant calling was performed 
within this interval which would be important if accurately genotyping at the locus is 
desired. 
Emphasising the importance of this CFA1 locus with craniofacial variation in the 
dog, the locus was detected by Boyko et al., 2010 who used breed average allometric 
measurements of the skull. Association analyses revealed markers to surpass 
genome-wide significance across eight chromosomes however the allometric nature 
of the phenotype undoubtedly also returned cryptic associations with body size 
variation. Despite this, two clear associations were made which include the 
aforementioned CFA1 locus and a new locus at chr5:35,359,028 (CanFam2). Beyond 
this, no fine mapping or positional candidate genes were identified.  
Finally, the most recent study assessing craniofacial variation in dogs was 
performed by Schoenebeck et al., 2012. This study is the only one to date to identify 
a putatively causal variant for canine brachycephaly. Specifically, a missense 
mutation in the bone morphogenetic protein 3 (BMP3) on CFA32 was identified in 
small brachycephalic breeds such as the Pekingese and Brussels griffon (Schoenebeck 
et al. 2012). This study used geometric morphometrics to analyse museum specimens 
to generate breed averages of skull shapes without allometry. Genotypes and 
phenotypes were disconnected as extant purebred show dogs were sampled as a 
source of DNA. Nonetheless, the power of this approach identified the only known 
putatively causal variant for canine brachycephaly.  
4.1.4 Resolving the CFA1 Canine Brachycephaly Locus  
The objective to this study was to address the shortcomings of the 
aforementioned works and in doing so, develop a new approach to isolating QTL and 
fine mapping them for complex canine morphologies. Specifically with regards to 
canine brachycephaly, collective drawbacks across these studies are observed in 
phenotyping, genotyping and the interpretation of the results.  
79 
 
Firstly, at a phenotypic level, several improvements to experimental design 
were implemented, as described in Chapter 3. In short, this included moving away 
from discrete phenotyping for head type. The use of “long” versus “short” face 
categorisation forces the assignment of dogs into two discrete groups which 
compromise the detection and resolution of the underlying QTL. Furthermore, the 
use of breed average phenotypes has its advantages, particularly when individual 
measurements are missing or in the presence of large environmental influences (e.g. 
body weight). However, in the instance of craniofacial shape variation, which has a 
higher hereditary component (Hunter et al. 1970; King et al. 1993; Johannsdottir et 
al. 2005), the use of breed averages is detrimental. Intrabreed craniofacial variation 
is detectable and, in some instances, notably diverse such as in the Labrador 
Retriever and Yorkshire Terrier (Chapter 3). This intrabreed variation is well 
documented and has even been the fundamental principle upon which the size-
related IGF1 locus was identified within the morphologically variable Portuguese 
Waterdog (Chase et al. 2002). Averaging the diverse craniofacial variation within 
breeds at a time in which one is attempting to determine the causes of this variation 
would undermine such the purpose of the study. Finally, the use of uncorrected 
morphological measurements can be confounded by the influence of allometry. 
Previous studies have begun to address this and methods upon which best to remove 
the influence of allometry were discussed in Chapter 3.  
Throughout the previous studies, individual-level genotypes have been 
separated from phenotypes. Even in the most recent and most successful analysis of 
canine craniofacial variation by Schoenebeck et al., used disconnected phenotypes 
and genotypes (Schoenebeck et al. 2012). The morphometrics of archived skeletal 
remains were analysed and used as surrogate phenotypes with DNA collected from 
modern-day extant show dogs. Evidently, this method was successful in identifying a 
variant in BMP3 to be associated with small brachycephalic breeds however in order 
to exploit the individual-level geometric morphometric approach to phenotyping, a 
corresponding source of DNA and subsequent microarray data must be acquired. 
Furthermore, acquisition of individual-level data permits the utilization of mixed 
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breed dogs – something that has never been adopted before. This inclusion of mixed 
breed dogs was hoped to break up the extensive linkage disequilibrium that 
encompasses selective sweeps across breeds to assist in the fine mapping for QTL 
and to help predict the proportion of variance explained by QTL.  
Finally, previous studies have assumed breeds sharing a physical characteristic 
do so because the underlying genetic drivers are shared by virtue of sharing alleles 
identical-by-descent (IBD). On the whole, this is likely to be true however it is not 
absolute. Exceptions include the presence of the IGF1 small haplotype in giant breed 
such as the Mastiff and Bernese Mountain Dog (Sutter et al. 2007), the BMP3 
brachycephalic missense mutation in the non-brachycephalic Scottish terrier 
(Schoenebeck et al. 2012) and the lack of the FGF5 long coat variant in the Afghan 
Hound (Housley and Venta 2006; Dierks et al. 2013). Such exceptions should be 
identified and tolerated during fine mapping, something that was not previously 
done when mapping the CFA1 brachycephaly locus (Bannasch et al. 2010). 
To this end, this chapter aimed to resolve the CFA1 QTL for canine 
brachycephaly through the adoption of modified techniques from previous studies. 
Precisely, this included the use of a previously acquired individual-level high-
definition non-allometric phenotype for craniofacial shape variation as an input for a 
genome-wide association analysis. Individual-level haplotypes were phased and used 
to define the CFA1 critical interval within which variants for brachycephalic breeds 
were called and filtered against non-brachycephalic dog’s that did not carry the 
associated haplotype. These same methods were then adopted to further contribute 
to and define the genetic loci associated canine body size, or in this instance, 
neurocranium centroid size.  
4.2 Materials and Methods 
4.2.1 Participants 
The same participants and study cohorts that were used to address 
morphological variation in Chapter 3 were used here. Briefly, 374 dogs were included 
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in the first study cohort which was subsequently expanded to 560 dogs. Every 
participant described here has a matching genotype and phenotype which is a 
distinction from previous studies that use surrogate phenotypes. Throughout this 
chapter, the use of study cohort one or two will be explicitly listed in text. 
4.2.2 Microarray Genotype Preparation 
gDNA for all participants in this study was extracted following the protocols 
described previously (see Chapter 2). gDNA quality and quantity was determined 
using the NanoDrop device and PicoGreen™ assay, respectively (see Sections 2.4.1 
and 2.5.3). All samples contained high quality gDNA with 260/280 ratios greater than 
1.6 and 260/230 ratios greater than 2.0. Samples were arrayed onto batches of 96-
well plate provided by Edinburgh Genomics, UK to give a final concentration of 50 
ng/µL once rehydrated in 50 µL deionised water following the use of a speed vac (see 
Section 2.5.6.1). Prepared plates were submitted to Edinburgh Genomics to be 
genotyped on the Illumina 170,000 marker CanineHD Whole-Genome Genotyping 
BeadChip. Genotype calls were mapped to CanFam3.1 coordinates (Broad, 
September 2011). PLINK (v1.07) was used to remove SNPs with minor allele 
frequencies (MAF) < 0.05 and individuals with > 0.1 missing markers (Purcell et al. 
2007). Genotypes were phased with SHAPEIT (v2.r837) using default parameters that 
include 500 states (Delaneau et al. 2012). Imputations were done with Minimac2 
(2014.9.15) using 40 rounds and 1,000 states (Fuchsberger et al. 2014). Post-
processing by fcGene (v1.0.7) removed genotypes with R2 < 0.3 and MAF < 0.05 
(Roshyara and Scholz 2014). In total, 139,260 SNPs remained for analysis.  
4.2.3 Genomic Structure Analysis 
The population structure of the first study cohort was assessed using 
STRUCTURE (v2.3.4) (Pritchard et al. 2000). SNP microarray data was first pruned to 
only keep markers with predicted linkage disequilibrium (R2 <0.5) using PLINK (v1.9) 
(Chang et al. 2015). Subsequently the pruned dataset was reformatted using the “--
recode structure” argument in PLINK (v1.9) to generate an appropriate input file. 
Default parameters were used to run STRUCTURE and the number of populations (K) 
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were varied to reflect the expected number of breeds. fastSTRUCTURE (v1.0) was 
used to assess the genomic structure of the second cohort (Raj et al. 2014). No data 
modification was required prior to the use of fastSTRUCTURE. Default parameters 
were used and the number of populations were varied to include 2, 3, 4 and 92 
populations. A maximum K value of 92 was used to reflect the 92 breeds in the study 
– each breed would be expected to have its own population membership. Graphics 
were generated using Microsoft Excel and modified in Adobe Photoshop CC 2015. 
4.2.4 Genome-wide Association Analysis 
The Genome-wide Efficient Mixed Model Association (GEMMA) (v0.94.1) was 
used to perform univariate linear mixed models for genome-wide association 
analyses (Zhou and Stephens 2012). During the analysis, a kinship matrix was 
generated using default parameters and subsequently incorporated to account for 
population structure. Covariates were also used in the analysis and varied between 
studies to further remove effects of population structure. The first study cohort used 
sex and up to ten genotype principal components (PC) to account for population 
structure. The genotypic PCs were generated using the “--pca” argument in PLINK 
(v1.9) and increasing numbers of PCs were applied as covariates to the association 
studies until genomic inflation was managed. To determine the level of genomic 
inflation, QQ-plots were plotted to visualise the relationship between expected and 
observed distributions of p-values which were quantified using the genomic inflation 
factor, lambda (λ) (Yang et al. 2011). The p-values of each association analysis (with 
different numbers of PC covariates) were sequentially input to Equation 4.1 until 
genomic inflation was reduced (λ≈1). A total of ten PCs were used for the 
neurocranium centroid size association analysis whilst five PCs were used for the 
viscerocranium and mandible analyses. To confirm that any remaining SNPs that 
deviate from the abline in the QQ-plot are the result of significant associations, index 
SNPs and markers in high linkage disequilibrium (r2 > 0.2) were pruned from the 
dataset, association analyses re-run and QQ-plots re-plotted.  
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In the second study cohort, the covariates were changed to include sex, age, CT 
image slice thickness (1 or 2 mm slices) and Hounsfield units used in the 
reconstruction of skull isosurfaces. Lambda scores and QQ-plots indicated minimal 
genomic inflation which negated the use of PCs as covariates in this analysis. A highly 
stringent Bonferroni correction was used to set the threshold for genome-wide 
significance (Equation 4.2). The number of markers used in the first and second study 
cohorts were 139,260 and 152,111 giving -logP value thresholds of 6.44 and 6.48, 
respectively. 
! = #$%&'( )*ℎ&,)(1 − 0, 1))*ℎ&,)(0.5, 1)  
Equation 4.1 – Genomic Inflation Equation. The genomic inflation factor (λ) is calculated using the 
above equation where p are the observed p-values for an association test and qchisq is the non-





Equation 4.2 – Bonferroni Correction Equation. The stringent Bonferroni correction threshold (-logP) 
for genome-wide significance is calculated by the above equation where the Total Markers are the 
number of markers used in the association analysis.  
 
4.2.5 Fine Mapping 
Manhattan plots focussing on each individual QTL and spanned the region of 
interest –1 Mb up- and downstream of the genome-wide significant markers. Linkage 
disequilibrium between each index marker and their surrounding 500 flanking 
markers were calculated using the PLINK (v1.9) LD statistic argument, “--r2”. Linkage 
disequilibrium values (r2) were used with the raw output from the GEMMA 
association analysis to generate zoomed Manhattan plots using a custom R script.  
In order to define the critical interval on CFA1, data was used from the first 
study cohort. Haplotype association analyses were used to refine the region of 
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interest surrounding significant markers. For a given phenotype, the PLINK (v1.07) “-
-hap-logistic” argument was used to with 3, 5 and 10 marker sliding windows. The 
analysis was carried out for ~1 Mb in both directions from the index marker. The raw 
text output file which includes p-values and the positions of the first and last SNPs in 
a haplotype were used to generate plots in RStudio. The haplotype with the greatest 
association and ~500 Kb flanking regions were used to define the region of interest. 
Individual-level haplotypes were assessed to define the critical interval. 
Genotypes were phased with SHAPEIT (v2.r837) (Delaneau et al. 2013). For the CFA1 
locus, CFA1 haplotypes for the region of interest spanning 55,628,389 – 56,503,947 
were ordered by viscerocranium PC1 with the most brachycephalic dogs at the top 
and lesser so at the bottom. Alleles were contrasted to the most frequent haplotype 
in the brachycephalic cohort (viscerocranium PC1 < -0.2). Within the viscerocranium 
PC1 < -0.2 subgroup, the critical interval boundaries were defined by a minimum of 3 
or more meiotic recombination events on either side. 
Critical interval boundaries established for all other QTL (including CFA5 for 
viscerocranium PC1 and all neurocranium associated QTL) were defined using data 
derived from the second study cohort. Haplotype association analyses were not used. 
For each of these QTL, methods were adapted from those described for CFA1. Firstly, 
haplotypes at QTL associated with the neurocranium centroid size were ranked by 
neurocranium centroid size (rather than viscerocranium PC1) from smallest to 
largest. Secondly, the origin of the most frequent haplotype to be used as a 
consensus sequence was modified (Table 4.1). For high frequency positions which 
were shared across many breeds as indicated by the distribution of the derived index 
markers, the smallest quartile of dogs (neurocranium centroid size < 126) were 
pooled together. Within this subgroup, the most common haplotype was used as a 
consensus sequence. For less frequent positions which were only present in a subset 
of breeds, the most common haplotype was found in a subset of breeds enriched 
with the derived marker allele. For example, the derived marker allele at the CFA5 
locus (chr5:33,750,479) was observed to be enriched in the American Bulldog, Boxer, 
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Bulldog, French Bulldog and French Mastiff. These breeds were grouped and the 
most frequent haplotype used as a consensus. This strategy was adopted to prevent 
alternative haplotypes at high frequencies which are not driving the genomic 
associations from introducing erroneous consensus haplotypes. In this example, the 
highly populous Pug, which was not observed to carry the derived marker allele 
would have introduced a high frequency haplotype to use as a consensus. This would 
have made it impossible to define a critical interval once all other alleles were 
contrasted to this false consensus. A full list of methods to defining population 
subgroups for consensus haplotype assignment is given in Table 4.1. Once the  
 
Phenotype Index Marker Consensus Source 
Viscerocranium chr1:55,983,871 Viscerocranium PC1 < -0.2 
chr5:33,750,479 American Bulldog, Boxer, Bulldog, French Bulldog, French Mastiff 
Neurocranium chr3:91,103,945 Smallest quartile Neurocranium centroid size (<126) 
chr4:67,109,434 
Pug, Border Terrier, Bichon Frise, Border 
Collie, Chihuahua, Cairn Terrier, 
Dachshund, Maltese Terrier, Miniature 
Schnauzer, West Highland White Terrier 
chr7:30,243,851 
Chihuahua, Border Terrier, Dachshund, 
Lhasa Apso, Maltese Terrier, Manchester 
Terrier, Papillion, Pekingese, Shih Tzu 
chr7:43,719,549 Smallest quartile Neurocranium centroid size (<126) 
chr10:8,183,593 Smallest quartile Neurocranium centroid size (<126) 
chr15:41,221,438 Smallest quartile Neurocranium centroid size (<126) 
chr34:18,540,901 
Border Terrier, Boston Terrier, Cairn 
Terrier, French Bulldog, Jack Russel 
Terrier, Maltese Terrier, Miniature 
Schnauzer, West Highland White Terrier 
Table 4.1 – Determining the Consensus Haplotype. For each phenotype QTL, the haplotypes are 
pooled together into an appropriate subgroup to identify the most common derived haplotype to 
contrast all other alleles to. For common index alleles, the extremes of the phenotypic continuum 
can be used. For rarer alleles, breeds that are enriched for the index allele are isolated to increase 
the likelihood of accurately capturing the derived haplotype. 
86 
 
consensus haplotype was identified it was used to contrast all other alleles. Critical 
interval boundaries were defined by 3 or more meiotic recombinations as done 
previously. 
4.2.6 Library Preparation and Sequencing 
All gDNA destined for whole-genome sequencing was quality checked using the 
Agilent TapeStation and surpassed DNA integrity numbers (DIN) of 8.0 (see Section 
2.4.4). Sequencing services were provided by Edinburgh Genomics, UK which in brief, 
included the following. DNA libraries were prepared using either SeqLab TruSeq Nano 
DNA library prep HT or Illumina TruSeq DNA nano DNA library kits. Eight 
brachycephalic dogs were resequenced on an Illumina HiSeq 2000 to approximately 
14-33X depth. Paired-end libraries had an average insert size of 550 bp and read 
length of 125 bp. A further thirty dogs were resequenced using the Illumina HiSeq X 
platform to > 40X depth with the paired-end library having an average insert size of 
450 bp and a 150 bp read length. DNA short-reads were aligned to the CanFam3.1 
reference sequence (Broad, September 2011) using the Burrows-Wheeler Aligner 
(BWA)-MEM software (v0.7.16a-r1181) (Li 2013). 
4.2.7 Variant Analysis (CFA1 Only) 
SNPs and small insertion/deletion (INDEL) variants were called within the CFA1 
critical interval (55,850,299-56,037,676) for the sequenced dogs using the Genomic 
Analysis Toolkit (GATK) (v3.7) (McKenna et al. 2010; DePristo et al. 2011; Van der 
Auwera et al. 2014). Variants were compared against those from four ancestral 
wolves in the Dog Genome SNP Database (DoGSD) and dogs in the Dog Biomedical 
Variant Calling Database (DBVCD). The DBVCD is a collection of canine whole genome 
sequences which allows contributors to share variant calls across the collection. At 
the time of use, the consortium was composed of 304 individuals representing 
modern dog breeds and a Basenji which have diverse range craniofacial 
morphologies. SNP and small INDEL variants across all individuals in this study were 
hard filtered using SnpSift (v4.0) using the criteria is Table 4.2 (Cingolani et al. 2012). 
For a variant to be retained for further consideration, it must satisfy all of these 
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criteria. The deep coverage and large insert sizes of the thirty-eight resequenced dogs 
permitted for the detection and filtering of large structural variants using Pindel 
(v0.2.3) (Ye et al. 2009). Structural variants were hard filtered using the criteria in 
Table 4.2. The filtering criteria for both SNP/INDEL and large structural variants were 
established by the presence or absence of the brachycephaly-associated haplotype 
across brachycephaly and dolichocephalic dogs with confirmed skull shapes. During 
variant filtering several logical assumptions were made. Firstly, brachycephalic dogs 
carrying the associated haplotype would be homozygous (or heterozygous) for the 
causal mutation(s) within the critical interval. Second, the sharing of a common 
haplotype  would  indicate  an  identity-by-descent  inheritance  of  the  same  causal  
Variant Breed Filtering Criteria 




















Pug Homozygous Derived 
American Bulldog 
French Bulldog 
Table 4.2 – Filtering criteria for CFA1. For each variant type to remain after filtering, they must satisfy 
all of the above criteria for each of the breeds (or wolf). 
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mutation(s) from a common ancestor. Third, the CanFam3.1 dog genome assembly 
is derived from a brachycephalic Boxer (which is homozygous for the associated 
haplotype) and so it is likely a carrier of, or fixed for the causal mutation(s) and so the 
variant would appear as a reference allele. Fourth, the causal mutation(s) are derived 
and therefore absent from the wild candid population, including the dog’s ancestor, 
the gray wolf. Lastly, dolichocephalic dogs without the associated haplotype cannot 
carry the causal mutation(s). 
4.3 Results 
4.3.1 Genomic Structure 
In addition to assisting QTL discovering and fine mapping of these loci, SNP 
microarray data can also be used to infer global trends of individuals at a genomic 
level. This population structure can prove to be detrimental during certain analyses 
such as a genome-wide association analyses but can be accounted for through the 
inclusion of Kinship matrices during testing (see Section 4.2.4). Here, fastSTRUCTURE 
has been used to visualise the population structure of all 560 dogs arrayed across 
both cohort one and two (Figure 4.1). During testing, the percentage membership of 
a dog’s genomic structure is assigned to a pre-set number of populations (K). When 
K = 2, the Pugs are identified as a distinct breed from others – this is likely due to the 
high representation of the breed in the test and the distinct homogeneity of the 
breed compared to more populous breeds in the study such as the Labrador retriever 
(Figure 4.1D). When K = 3, a broad collection of dog breeds begin to show 
membership to this population (Figure 4.1E). This includes breeds such as the Boxer, 
American Bulldog, Bulldog, Bull Mastiff, French Bulldog, Dogue de Bordeaux, Pitbull 
Terrier and Staffordshire Bull Terrier. Broadly, these breeds are representative of the 
Molosser category of dogs which are larger, well-muscled breeds (Parker et al. 2004). 
Sequential increases in population number continue to identify broad population 
structures, for example when K = 4, the retriever class begins to emerge which 














 Figure 4.1 – Population Structure of all Study Dogs. Each individual dog is represented by a single vertical bar separated by black lines with (A-C) mixed-breed and 
(D-F) owner-defined breeds being grouped together by broad black lines. The percentage assignment (y-axis) of each individual to a population cluster (K) is indicated 
by the coloured bars. The number of population clusters are (A,D) 2, (B,E) 3 and (C,F) 92. 
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Increasing the population number to the predicted number of breeds (K = 92) 
can indicate breed-level structures (Figure 4.1F). Numerous breeds such as the 
Bearded Collie, Chihuahua, Greyhound and Shih Tzu are assigned entirely to a single 
population indicating that individuals within these breeds are very alike at a genomic-
level and so likely represent dogs which closely adhere to the breed standard. Within 
the Pug population, one individual dog is distinct from the others as it has equal 
membership to the Pug population and another – the Shih Tzu (Figure 4.1F). This 
likely represents a first-generation offspring between a Pug and a Shih Tzu – a 
breeding combination increasing in popularity to generate a “Pug Zu”. Furthermore, 
a dog labelled  as  a  Labrador  Retriever  in  fact  has  ~100%  membership  to  the 
Flat Coat Retriever population suggesting that the clinical records for this dog are 
incorrect. Similar approaches to investigating potential breed composition can be 
applied to the mixed-breed dogs (Figures 4.1A, B and C). A notable proportion of 
mixed-breeds dogs have shared genomic structure with the purebred Staffordshire 
Bull Terrier. This observation is likely caused by the high number of Staffordshire bull 
terrier-like stray or abandoned dogs taken in by the Edinburgh Dog and Cat Home 
which visit the Hospital for Small Animals and formed part of this study cohort.  
Breeds with more diverse genomic structures include the Cairn terrier and 
Pitbull Terrier. It is unclear whether this observation is reflected across these entire 
breeds or if it’s restricted to a small population of individuals under less stringent 
breeding regulations that have been included in this study.  
4.3.2 Study Cohort 1 
In Chapter 3, geometric morphometric analyses of the canine skull were 
performed on 374 dogs which constituted study cohort 1. Here, the principal 
components (PC) of the whole skull, viscerocranium and mandible were used as input 
phenotypes for genome-wide association studies (GWAS). Importantly, each dog in 
the study that received CT imaging and subsequent geometric morphometric analysis 
also supplied a source of DNA for SNP microarray genotyping. This allowed for 
individually matched phenotypes and genotypes which negates the use of surrogate 
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or breed-average phenotype-genotype matches which have been adopted in 
previous studies (Jones et al. 2008; Bannasch et al. 2010; Boyko et al. 2010; 
Schoenebeck et al. 2012).  
4.3.2.1 Genome-wide Association Analysis 
An integral component of the current study design is the use of the 
neurocranium centroid size as a proxy for skeletal size and its subsequent use in 
removing the influence of allometry in this data. This body size proxy was necessary 
as patient weights (or other body size measurements) were not available for every 
study dog. To demonstrate that the neurocranium centroid size accurately reflects 
the skeletal size in the dog, a GWAS was performed using the centroid size as a 
phenotype (Figure 4.2A). In total, 32 markers were associated with the neurocranium 
centroid size which surpassed a stringent threshold for genome-wide significance set 
by a Bonferroni correction. The markers were distributed across five genomic loci on 
five different chromosomes (Table 4.3). Index markers for the QTL on canine 
chromosome (CFA) 7, 10 and 15 resided within introns of the SMAD family member 
2 (SMAD2), high-mobility group AT-hook 2 (HMGA2) and insulin-like growth factor 1 
(IGF1) genes respectively (Table 4.3). The index marker on CFA3 is intergenic and 
situated ~72 kb and ~176 kb upstream from the ligand-dependent nuclear receptor 
corepressor-like (LCORL) and condensin complex subunit 3 (NCAPG) genes 
respectively. The anaphase promoting complex subunit 13 (ANAPC13) is also 
downstream of the index marker. Each of the SMAD2, HMGA2, IGF1 and 
NCAPG/LCORL loci have been identified previously to be associated with body size 
variation in the dog and across species which confirms that the neurocranium 
centroid size is an appropriate proxy (Chase et al. 2002; Sutter et al. 2007; Boyko et 
al. 2010; Vaysse et al. 2011; Rimbault et al. 2013; Hayward et al. 2016). 
In a distinction from previous body size studies in the dog, here a signal for the 
fibroblast growth factor 4 (FGF4) retrogene on CFA18 has been detected with 
neurocranium centroid size. This is a surprising discovery as the FGF4 retrogene was 
first identified to correlate with limb shortening in breeds such as the Dachshund and 
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Basset hound. This current data suggests it may also have a role in regulating skull 
size too.  
The Manhattan plot for non-allometric viscerocranium PC1 revealed a single 
locus on CFA1 to be comprised of 3 markers surpassing genome-wide significance 
(Figure 4.2B). The index marker for this locus (chr1:55,983,871) is situated within an 
intron of the SPARC-related modular calcium-binding protein 2 (SMOC2) gene (Table 
Figure 4.2  – Study Cohort 1 GWAS. Manhattan plots for the (A) neurocranium centroid size, (B) 
viscerocranium PC1 and (C) mandible PC1. Markers surpassing the threshold for genome-wide 
significance as calculated by a Bonferroni correction are coloured red. Positional gene candidates are 
given above each QTL with intragenic markers in bold text. Insets: anatomical substructures analysed 
are highlighted in red. QQ-plots for the predicted (x-axis) and observed (y-axis) -log10[p-values] for 
association tests. P-values plotted using the entire marker dataset (black circles) and pruned dataset 
following the removal of significant markers and markers in high linkage disequilibrium (r2>0.2). 
Abline (y=x) plotted in red. Genomic inflation value (λ) shows minimal inflation across analyses. 
Distribution plots displaying the frequency (y-axis) of the phenotype scores (x-axis). 
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4.3). The same index marker was also significantly associated with non-allometric 
mandible PC1. This was the only marker to reach genome-wide significance for the 
mandible dataset.   
Across all GWAS, the genomic inflation factor, lambda (λ) is approximately 1 
(Figure 4.2). Lambda values of 1 indicate no genomic inflation. QQ-plots for each 
association test confirm that observed p-values adhere to the abline and only deviate 
Table 4.3 – Index Markers for Study Cohorts 1 and 2. Index markers discovered in the viscerocranium 
PC1 (V), mandible PC1 (M) and neurocranium centroid size (N) association tests for study cohorts 1 
and 2 (cohort given in brackets). Positional gene candidates are highlighted in bold when the index 
marker is intragenic. Alleles are given as reference > alternate. P-value of the index marker 
generated in the linear mixed model analysis. 
Dataset Position Candidate Gene Allele P-value beta 
V1 1:55,983,871 SMOC2 G > A 1.91 X10-20 -0.07 
M1 1:55,983,871 SMOC2 G > A 8.43 X10-10 0.02 
N1 
3:91,103,945 LCORL/NCAPG G > T 3.64 X10-9 10.22 
7:43,719,549 SMAD2 A > G 5.71 X10-13 -11.15 
10:8,183,593 HMGA2 C > T 3.06 X10-15 -14.06 
15:41,257,020 IGF1 C > T 1.73 X10-19 -16.34 
18:20,272,961 FGF4 retrogene A > C 3.31 X10-8 -11.41 
V2 
1:55,983,871 SMOC2 G > A 6.67 x10-39 -0.07 
5:33,750,479 NTRN1 G > A 2.26 x10-9 -0.04 
N2 
3:91,103,945 LCORL/NCAPG G > T 1.12 x10-9 8.99 
4:67,109,434 GHR T > C 6.08 x10-8 -5.07 
7:30,243,851 TBX19 A > G 3.19 x10-7 -5.32 
7:43,719,549 SMAD2 A > G 3.95 x10-14 -9.44 
10:8,183,593 HMGA2 C > T 3.01 x10-22 -14.37 
15:41,221,438 IGF1 A > G 4.39 x10-28 11.36 
18:20,310,833 FGF4 retrogene T > G 2.26 x10-12 -9.75 
34:18,540,901 IGF2BP2 A > C 1.15 x10-7 -6.79 
X:103,307,510 - C > T 9.12 x10-9 -6.81 
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to the right of the plot (black circles). This deviation largely disappears once the test 
is re-run having removed the markers surpassing genome-wide significance and any 
markers in linkage disequilibrium (r2 > 0.2) with them (grey circles). These tests 
conclude that there is minimal genomic inflation in this data, and thus no evidence 
of population substructure.  
4.3.2.2 Defining the CFA1 Critical Interval  
The objective of the first study cohort was to identify and resolve QTL 
associated with canine brachycephaly. The QTL on CFA1 represents a broad selective 
sweep that has been identified in several previous studies (Bannasch et al. 2010; 
Boyko et al. 2010; Schoenebeck et al. 2012). In the current analysis, the selective 
sweep was tagged by three markers which surpassed genome-wide significance. A 
further fourteen non-significant markers were in high linkage disequilibrium (r2 > 0.2) 
with the index marker (Figure 4.3A). To begin to refine this selective sweep, a 
haplotype association analysis using a 10-marker sliding window was performed for 
markers within ~1 Mb of the significant markers (Figure 4.3B). This revealed a 
collection of highly associated haplotypes within the window chr1:55,881,672-
56,020,217. Genotypes within this interval including ~500 kb flanking regions were 
phased. Since the viscerocranium PC1 distribution is bimodal (see insert of Figure 
4.2B) and that the majority of breeds within the smaller peak (PC1 < -0.20) are 
brachycephalic, an assumption was made that the causal variant and therefore 
associated haplotype would be enriched within subgroup. To this end, the most 
frequent haplotype across individuals with a viscerocranium PC1 < -0.20 was used as 
the consensus haplotype that all others would be contrasted to. The resulting 
haplotypes were plotted with alleles matching the consensus in light grey and 
alternate alleles in dark grey (Figure 4.3C). Haplotypes were ordered by 
viscerocranium PC1 score to prioritise the most brachycephalic dogs at the top and 
the lesser-so at the bottom. Boundaries of the haplotypes were defined by a 





Figure 4.3 – Defining the CFA1 Critical Interval. (A) Manhattan plot of the region surrounding the 
three markers surpassing genome-wide significance for viscerocranium PC1. Markers in linkage 
disequilibrium (r>0.2) with the index marker (chr1:55,983,871) are coloured. (B) Ten-marker sliding 
window haplotype association test for the same interval. A cluster of highly significant haplotypes 
(p = 9.95 x10-60) spanning CFA1 from 55,881,672 to 56,020,217 are associated with viscerocranium 
PC1. (C) Genotypes within this region and ~500 kb of flanking region were phased. The most 
frequent haplotype within this interval for the brachycephalic cohort (viscerocranium PC1 < -0.20) 
was used as a consensus haplotype that all others were contrasted to. Matching alleles are coloured 
light grey whilst alternate alleles coloured dark grey. Haplotype boundaries are defined by 3 meiotic 
recombinations. A 12 marker haplotype (red bar) flanked by a 187.7 kb critical interval (black bar) 
spanning chr1:55,850,299-56,037,676 was defined. Black arrows denote dogs that do not carry the 
associated haplotype. Red arrow denotes a chromosome with a possible novel recombination 
event. The critical interval spans the SMOC2 gene.  
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A twelve-marker haplotype (red bar) was defined by the 187.4 kb critical 
interval (black bar) which extended between chr1:55,850,299-56,037,676 (Figure 
4.3C). This haplotype was overrepresented amongst the brachycephalic cohort 
(viscerocranium PC1 < -0.20) and was present in 63 of 74 (85.1%) chromosomes. 
Conversely, the haplotype was observed amongst just 28 of 674 (4.2%) chromosomes 
of mesocephalic to dolichocephalic skull shapes (viscerocranium PC1 > -0.20). 
Suggestive of an effect, a student’s t-test revealed a highly significant difference  
 
between the viscerocranium PC1 scores between carriers and non-carriers (p = 4.86 
x10-49). Interestingly, the associated haplotype was completely absent (homozygous 
ancestral) from three individuals that were classified as brachycephalic, albeit less-
extreme brachycephalic dogs (Figure 4.3C). This included two Dogue de Bordeaux and 
a Chihuahua (black arrows). The fastSTRUCTURE analysis of these dogs (Figure 4.1F) 
revealed a higher degree of admixture between these individuals than others in their 
designated breeds indicating that they may in fact be partly outbred. A Japanese Chin 
did not have the full-length 12 marker haplotype (red arrow) however it is unclear 
whether this may be due to a recent meiotic recombination event that hasn’t 
accumulated sufficiently across dogs or if in fact, this chromosome of the Japanese 
Chin does not carry the causal mutation.  
Eight of the twelve marker haplotype are situated within introns of the SMOC2 
gene whilst the remaining four markers span up to ~43 kb downstream of the gene 
(Figure 4.3C). No other genes are annotated within the critical interval.  
4.3.2.3 Variant Calling and Filtering 
To identify causal variants within the CFA1 critical interval, eight brachycephalic 
dogs including an American Bulldog, Boxer, Pug, Cavalier King Charles Spaniel, 
Affenpinscher, Bull Mastiff, French Bulldog and French Mastiff were whole genome 
sequenced. A further thirty non-brachycephalic breeds were also sequenced. SNPs 
and small INDELS were called across these dogs and compared against those in the 
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ancestral gray wolf and wider DBVCD consortium and filtered on the presence of the 
associated haplotype (see Section 4.2.7).  
Within the 187,377 bp critical interval on chromosome one, 3,674 SNPs and 
small indels were called (Table 4.4). After hard filtering, using the criteria in Section 
4.2.7, four SNPs situated within introns 1, 7 (x2) and 12 of SMOC2 remained. 
Structural variants were also called within the same 187,377 bp critical interval. 
Before filtering, a total of 162 structural elements were called which were filtered to 
a single ~1,500 bp insertion within intron 8 of SMOC2. This insertion is a fragment of 
a long interspersed nuclear element type 1 (LINE-1). 
The biological significance of the five remaining putatively causal variants 
within SMOC2 are explored in Chapter 5. This includes the embryological localisation 
of mouse and chicken Smoc2, the effects of the variants on transcriptomic profiles 
and modelling of the phenotypic effects. 
 
 
4.3.3 Study Cohort 2 
The continued recruitment of participants has permitted for the expansion of 
the study from 374 dogs in cohort 1 to 560 in cohort 2. Coupled with modifications 
to the effectively removing the allometric component to the geometric 
morphometric data (see Section 3.3.3.1), the increase in participants and 
diversification of breeds available have increased the power of this study.  
Software GATK/SnpSift Pindel 
Variant type SNPs/INDELS Structural variants 
Bases pairs analysed 187,377 187,377 
Pre-filtering 3,674 162 
Post-filtering 4 1 
Table 4.4 – Variant Filtering Summary. SNPs/INDELS and structural variants were called within the 
same CFA1 critical interval (chr1:55,850,299-56,037,676) for canine brachycephaly. The total 
variants called were filtered using criteria in Table 4.2. Post-filtering variants have passed the 
filtering criteria and are putatively causal.  
98 
 
4.3.3.1 Genome-wide Association Analysis 
Previously, 32 markers distributed across 5 QTL surpassed genome-wide 
significance for the neurocranium centroid size (Figure 4.2). This included the 
positional candidate genes SMAD2, HMGA2, IGF1, LCORL/NCAPG locus and the FGF4 
retrogene. These same QTL were identified in the current analysis in addition to a 
further 4 novel QTL for this study positioned on CFA4, 7, 34 and X (Figure 4.4A). The 
index markers on CFA4 and CFAX are positioned within introns of the growth 
hormone receptor (GHR) and muscleblind-like splicing regulator 3 (MBNL3) genes 
respectively (Table 4.3). Meanwhile the index marker on CFA7 (chr7:30,243,851) is 
positioned ~10 kb downstream of the T-box transcription factor 19 (TBX19) gene 
whilst the closest gene to the CFA34 marker (chr34:18,540,901) is insulin-like growth 
factor 2 mRNA-binding protein 2 (IGF2BP2).  
These data continue to demonstrate that the neurocranium centroid size 
effectively acts as a proxy to body size by identifying previous body size-associated 
loci. Each of the QTL on CFA4, 7 and 34 have been identified previously (Boyko et al. 
2010; Rimbault et al. 2013; Hayward et al. 2016). Several positional candidate genes 
have been alluded to on the X chromosome however none have identified the MBNL3 
gene.  
With regards to the association analysis of viscerocranium PC1, the CFA1 
SMOC2 locus was identified again (Figure 4.4B). Here, the same index marker at 
position chr1:55,983,871 was identified as previously described however the total of 
markers surpassing genome-wide significance increased from 3 to 5 (Table 4.3). In 
addition to this locus, a further 5 markers surpassed genome-wide significance at a 
QTL on CFA5. The index marker for this locus is positioned within an intron of the 
netrin 1 (NTRN1) gene. Previous studies investigating the brachycephalic phenotype 
also discovered a QTL on CFA5 however those loci were positioned ~4 Mb upstream 
from the locus described here (Boyko et al. 2010; Schoenebeck et al. 2012). 
Suggestive peaks begin to emerge for the viscerocranial dataset and includes 
CFA9, 18, 24 and 30 (Figure 4.4B). Here, suggestive peaks are QTL that have multiple 
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markers in close proximity that are approaching, but don’t reach the Bonferroni 
threshold. These peaks tend to be distinctive from the surrounding markers in the 
Manhattan plots and are identified purely by visual inspection of the plots. Index 
markers for each of these QTL reside in introns of interesting positional candidate 
genes. This includes histone deacetylase 5 (HDAC5, chr9:19,267,017), zinc finger 
protein GLI3 (GLI3, chr18:7,835,560), agouti-signalling protein (ASIP, chr24: 
23,386,821) and coronin 2B (CORO2B, chr30:32,662,210).  
In the neurocranium centroid size dataset, a marker at the CFA1 SMOC2 locus 
is close to achieving genome-wide significance whilst a suggestive peak is emerging 
Figure 4.4 – Study Cohort 2 GWAS. Manhattan plots for the (A) neurocranium centroid size and (B) 
viscerocranium PC1 score for the second study cohort. Markers surpassing the threshold (dashed 
line) for genome-wide significance as calculate by a Bonferroni correction are coloured red. 
Positional gene candidates are given above each QTL with bold text denoting intragenic index 
markers. Additional QTL identified in this study compared to the first study population are marker 
by black arrows. Insets: Distribution plots displaying the frequency (y-axis) of the phenotype scores 
(x-axis).QQ-plots for the predicted (x-axis) and observed (y-axis) -log10[p-values] for association 
tests. P-values plotted using the entire marker dataset (black circles) and pruned dataset following 
the removal of significant markers and markers in high linkage disequilibrium (r2>0.2). Abline (y=x) 
plotted in red. Genomic inflation value (λ) shows minimal inflation across analyses. 
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at the start of CFA1 (chr1:16,255,217) (Figure 4.4A). Interestingly, the melanocortin 
4 receptor (MC4R) is in close proximity to this region which is known to be a key 
regulator of body weight (Huszar et al. 1997; Ollmann et al. 1997). Furthermore, the 
suggestive peak emerging on CFA4 (chr4:39,159,873) resides within the STC2 gene. 
4.3.3.2 Defining Critical Intervals 
Viscerocranium Shape 
The second, larger study cohort provides an opportunity to revisit and define 
new critical intervals for QTL associated with changes both viscerocranial shape and 
neurocranium centroid sizes. For the viscerocranial dataset, the index marker on 
CFA1 continues to tag the large selective sweep in the region with 40 markers being 
in high linkage disequilibrium (LD) (r2 > 0.2) (Figure 4.5A). Despite this, the inclusion 
Figure 4.5 – Defining Critical Intervals for Brachycephaly – Zoomed Manhattan plot for QTL on (A) 
CFA1 and (B) CFA5. Markers are coloured by the degree of linkage disequilibrium with the index 
marker. Haplotype analysis identified a critical interval in grey (top box) which with an overview of 
the annotated genes within this interval (box below). 
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of more brachycephalic breeds in the study cohort, particularly French Bulldogs 
which have introduced new, previously unseen haplotypes in the region permitted 
for the CFA1 critical interval to be refined further (Table 4.5). The interval now spans 
175,640 bp and continues to encompass the SMOC2 gene and the variants called 
within in Section 4.3.2.3. Interestingly, two additional markers surpassing genome-
wide significance were identified ~1 Mb downstream of the index marker 
(chr1:57,371,701 and chr1:57,790,010). These markers are not in LD with the index 
marker and it is unclear whether these they are tagging a second QTL on CFA1 or are 
an extension of that already defined. The vestigial like family member 2 (VGLL2), 
proto-oncogene receptor tyrosine kinase 1 (ROS1) and discoidin, CUB and LCCCL 
domain containing protein 1 (DCBLD1) genes are annotated here. 
On CFA5, a total of 49 markers are in high LD with the index marker and span 
up to a ~1 Mb upstream of its position (Figure 4.5B). This extensive LD is reflected in 
the haplotypes in that whilst the index marker is positioned within the NTRN1 gene, 
the haplotype that encompasses it is vast and cannot be refined further from ~2 Mb 
interval (Table 4.5). These large haplotypes are enriched in breeds such as the French 
Bulldog, French Mastiff and Boxer but are completely absent in the Pug. There are 
>50 genes annotated in this region.  
CFA Critical Interval Size (bp) Gene Candidate 
1 55,862,036 – 56,037,676 175,640 SMOC2 
5 31,714,339 – 33,788,841 2,074,502 NTRN1 
3 91,097,987 – 91,327,127 229,140 LCORL/NCAPG 
4 66,984,116 – 67,148,328 164,212 GHR 
7 30,178,588 – 30,308,120 129,532 TBX19 
7 43,515,166 – 43,948,370 433,204 SMAD2 
10 8,270,435 – 8,397,696 127,261 HMGA2 
15 41,188,905 – 41,232,547 43,642 IGF1 
34 18,475,392 – 18,737,870 262,478 IGF2BP2 
Table 4.5 – Critical Interval Summary. A list of critical intervals and their sizes defined at each of the 
morphological QTL identified in the second study cohort. Positional gene candidates are listed as 
the only genes annotated within the critical interval. In instances where multiple genes are 




Neurocranium Centroid Size 
 Two markers on CFA3 surpassed genome-wide significance for the 
neurocranium centroid size which reside upstream of the LCORL gene. These two 
markers represent the extent of LD within the region and are enriched in large breeds 
such as the French Mastiff, Bernese Mountain Dog, Great Dane and Akita (Figure 
4.6A). The LCORL, NCAPG and ANAPC13 genes are annotated in their entirety within 
the 436,887 bp critical interval (Table 4.5, Figure 4.6A). 
A further two significant markers are positioned on CFA4 which show minimal 
LD with markers in their immediate vicinity (< 400 Kb) (Figure 4.6B). The relatively 
small critical interval (164,212 bp) encompasses a haplotype that is enriched in many 
small breed dogs including several of the terriers (Cairn, Maltese, Border) as well as 
breeds such as the Dachshund and Bichon Frise (Table 4.5). Approximately 125 Kb of 
the 5’ end of the GHR gene is situated within this haplotype in addition to the 3’ end 
of the coiled-coil domain containing protein 152 (CCDC152).  
Three markers are in modest LD with the single index marker at the first QTL 
on CFA7 (Figure 4.6C). A small haplotype at this locus, 129,532 bp is size is enriched 
for toy breed dogs such as the Chihuahua, Papillion and Pekingese however it also 
exists in unexpected breeds such as the Rhodesian Ridgeback, German Shepherd Dog 
and the Husky (Table 4.5). It is unclear why the haplotype would exist across these 
breeds. Since the critical interval is small, the haplotype in these large breeds may 
represent an ancestral version of the haplotype that hasn’t been broken or lost. This 
critical interval encompasses the TBX19 gene as well as a vesicle transport protein, 
SFT2D2.  
At the second QTL on CFA7, markers show LD over a broad range, 
approximately 1 Mb in length (Figure 4.6D). At the centre of this selective sweep is a 
433,204 bp haplotype with an index marker residing in the SMAD2 gene (Table 4.5). 
This haplotype is present in a range of small size dog breeds such as the Yorkshire 
Terrier, Pug, Chihuahua and Lhasa Apso.  
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Markers spanning up to 1.5 Mb on CFA10 display high LD with the index marker 
within the QTL (Figure 4.6E). Interestingly, the 127,261 bp critical interval does not 
encompass the index marker like all other defined critical intervals associated with 
morphological variation in this study (Table 4.5). The reason for this is unclear. 
Nonetheless, this haplotype is enriched in small dog breeds such as the Border terrier, 
Figure 4.6 –  Defining Critical Intervals for Size – Zoomed Manhattan plot for QTL on (A) CFA3, (B) 
CFA4, (C,D) CFA7, (E) CFA10, (F) CFA15, (G) CFA34 and (H) CFAX for neurocranium centroid size. 
Markers are coloured by the degree of linkage disequilibrium with the index marker. Haplotype 
analysis identified a critical interval in grey (top box) which with an overview of the annotated genes 




Chihuahua, Jack Russel Terrier, and Yorkshire Terrier. The 5’ end of the HMGA2 gene 
and ~80 Kb of its upstream sequence is within this interval.  
The QTL on CFA15 is largely comprised of eleven densely positioned markers in 
high LD all of which surpassing genome-wide significance around the index at 
chr15:41,221,438 (Figure 4.6F). A further three markers were in LD with the index 
and also surpassed genome-wide significance albeit ~500 Kb upstream. The critical 
interval at this locus is the smallest defined in this study, spanning just 43,642 Kb 
(Table 4.5). Approximately 29 Kb of the IGF1 gene is captured by this haplotype which 
is enriched amongst many small dog breeds.  
Two markers on CFA34 were significantly associated with neurocranium 
centroid size. Both these two markers were in very high LD with one another as well 
as a seven markers within the vicinity (Figure 4.6G).  The haplotype is predominantly 
enriched in a small number of terrier breeds such as the West Highland White Terrier, 
Cairn Terrier and Maltese Terrier. The 262,478 bp critical interval encompasses the 
5’ end of the IGF2BP2 gene in addition to its neighbouring gene, transformer 2 beta 
homolog protein (TRA2B), the latter of which has been linked with both body mass 
index (Table 4.5) (Pihlajamäki et al. 2011; Kaminska et al. 2016). 
Finally, ten markers surpass genome-wide significance for neurocranium 
centroid size on CFAX. These markers span over 1.5 Mb and the index marker alone 
is in high LD with 78 other markers on the X chromosome (Figure 4.6H). It is unclear 
whether these markers are tagging a single, very large QTL or is in fact made up of at 
least two smaller QTL. As a result, it isn’t possible to define a critical interval on the X 
chromosome and so many compelling positional candidate genes exist. The extensive 
haplotype sharing is explained by the reduced number of recombination events that 
can occur on the X chromosome due to YX haplodiploidy in males, which is then 




Common dog traits such as brachycephaly are believed to predate the 
establishment of the regimented breed boundaries and are thought to be the result 
of identity-by-descent genetics. Due to the complex nature of these traits, the 
occasional ‘outlier’ within breeds which are not fixed for the causative variant have 
undermined previous attempts to resolve the QTL. Furthermore, extensive linkage 
disequilibrium within breeds has prevented the separation of co-inherited variants. 
To avoid this, for the first time this study has utilised individual-level phenotypes 
including those of mixed-breed dogs to distil our understanding of morphological 
QTL. 
4.4.1 Face Shape 
The selective sweep on CFA1 associated with canine brachycephaly has been 
recognised since the early days of dog GWAS however the resolution of the locus and 
its causal variant have remained elusive until now (Jones et al. 2008; Bannasch et al. 
2010; Boyko et al. 2010; Schoenebeck et al. 2012). Here, a ~187 Kb haplotype 
encompassing the SMOC2 gene was observed to be enriched in brachycephalic dogs. 
SMOC2 is a compelling positional candidate gene for canine brachycephaly. It belongs 
to a family of matricellular proteins – the BM-40 (or osteonectin) family which were 
first identified to be expressed in bone (Whitson 1981; Vannahme et al. 2003). Since 
then, SMOC2 has been shown to be expressed across a variety of tissues where it is 
thought to facilitate the remodelling of extracellular matrix by interacting with 
various growth signals (Göhring et al. 1998; Kupprion et al. 1998; Brekken and Sage 
2000; Zhang et al. 2008; Maier et al. 2008; Feng et al. 2009). Loss of smoc2 in 
zebrafish causes midface hypoplasia whilst different missense mutations within the 
gene have been implicated with severe dental abnormalities in humans (Bloch-Zupan 
et al. 2011; Alfawaz et al. 2013; Melvin et al. 2013). Here, five intronic variants 
including four SNPs and one structural variant (LINE-1) within SMOC2 were 
associated with brachycephaly. Interestingly, following the increase in size of the 
study population, the critical interval surrounding at the SMOC2 locus was further 
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refined from ~187 Kb to ~175 Kb highlighting the power and importance of finding 
rarer haplotypes which have undergone meiotic recombination. Despite this, the 
same five variants remained within this new interval. The functional effects of these 
variants on the transcriptomic profiles of brachycephalic dogs as well as modelling of 
their phenotypic effects sizes are investigated in Chapter 5.  
Beyond CFA1, a second signal reaching genome-wide significance was detected 
on CFA5 with an index marker residing in the NTRN1 gene (chr5:33,750,479). Two 
previous independent studies similarly identified a CFA5 QTL within this region 
however it was situated in an intergenic region 4.4 Mb upstream (Boyko et al. 2010; 
Schoenebeck et al. 2012). Due to the very large ~2.1 Mb critical interval defined in 
this study, it is possible that both of these markers are tagging the same selective 
sweep. Whilst the critical interval could not be more accurately defined, NTRN1 itself 
is a compelling positional gene candidate. NTRN1 is a diffusible signalling protein 
found in the extracellular matrix which is best characterised as a potent axonal 
guidance molecule (Cirulli and Yebra 2007; Masuda et al. 2009). Recent studies have 
suggested a more varied function for NTRN1 including roles in the morphogenesis of 
various organs such as the ear (Salminen et al. 2000), pancreas (Hebrok and Reichardt 
2004) and lungs (Liu et al. 2004) where it acts through regulating cell adhesion, 
migration and survival (Cirulli and Yebra 2007). Specifically with regards to 
craniofacial development, NTRN1 has been shown to be strongly expressed in the 
palatal shelves (Leslie et al. 2015) with several associations between the gene and 
risks of developing non-syndromic cleft lip and/or cleft palate (Beaty et al. 2010; Sun 
et al. 2015; Velázquez-Aragón et al. 2016). Interestingly, albeit in murine cochlear 
hair cells, the NTRN1 gene is expressed as a direct result of IGF1 signalling which could 
provide a fascinating interaction between pathways predicted to regulate both 
craniofacial shape development and overall body size in dogs (Hayashi et al. 2013; 
Yamahara et al. 2017). 
Furthermore, a collection of compelling positional gene candidates underlie 
suggestive associations with craniofacial shape variation including HDAC5, GLI3, ASIP 
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and CORO2B. Most strikingly in this list is GLI3 – a gene known to cause Greig 
syndrome, a form of craniosynostosis characterised by a prominent forehead, wide-
spaced eyes and a broad nasal bridge in humans (see Section 1.3.1) (Wild et al. 1997; 
Kalff-Suske et al. 1999). Meanwhile, HDAC5 belongs to a class of histone deacetylase 
enzymes which have been shown to limit osteoblast differentiation through the 
inhibition of Runx2 signalling (Kang et al. 2005; Schroeder and Westendorf 2005) – a 
pathway already known to regulate bone maturation and craniofacial development 
across mammals (see Chapter 1) (Yoshida et al. 2004; Fondon and Garner 2004; 
Abzhanov et al. 2007; Takarada et al. 2015). The ASIP gene encodes the Agouti 
signalling protein which regulates coat pigmentation across domestic species 
including the cow (Girardot et al. 2005), pig (Drögemüller et al. 2006), horse (Rieder 
et al. 2001) and dog (Berryere et al. 2005; Dreger and Schmutz 2011). Up to six 
distinct coat variations have been attributed to alleles at this locus and mice have 
been shown to have transcripts with four alternate first exons (Vrieling et al. 1994; 
Dreger and Schmutz 2011). Beyond pigmentation, a dominant Agouti allele in mice 
results in the ubiquitous expression of the protein and the onset of obesity (Huszar 
et al. 1997; Ollmann et al. 1997). The same mutant mice also have a marked increase 
in linear growth, giving them a long anteroposterior axis whilst also reducing the size 
and shape of the mandible (Suto 2008; 2009). These morphological observations 
coupled with the wide variation in pigmentation highlight the complex nature of the 
Agouti locus. A role for the neuronal tissue-enriched actin cytoskeleton regulator, 
CORO2B in craniofacial development is less clear due to the limited studies 
(Nakamura et al. 1999; Rogg et al. 2017).  
This data speculatively supports the role of GLI3, HDAC5 and ASIP in canine 
craniofacial morphological variation. Unfortunately, due to the apparent rarity of 
these alleles in this data (or limited phenotypic size effect), it makes it difficult to 
speculate further on the functional roles these genes may have in the dog. In 
comparative human studies, a common approach to validate the role of QTL in a 
given trait is to split the study population into discovery and replication cohorts (Liu 
et al. 2012; Adhikari et al. 2016). Such an approach can aid in the statistical 
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interrogation of QTL but have required considerable population sizes (>2,000). Like 
the many other canine studies, this thesis has not adopted a discovery and replication 
experimental design simply due to the limited number of participants (~500) (Jones 
et al. 2008; Bannasch et al. 2010; Boyko et al. 2010; Schoenebeck et al. 2012). If the 
study population for this experiment continues to grow, it may warrant the inclusion 
of a replication cohort in subsequent tests which may give more power to interrogate 
each of these QTL. 
4.4.2 Body Size (Neurocranium Centroid Size) 
By necessity, this study was unable to assess changes in canine craniofacial 
shape without first addressing the confounding influences of allometry. Here, the 
neurocranium centroid size was used a proxy to skeletal size which also provided an 
opportunity to explore the genetic contributions to the neurocranium itself. 
Following its application as a GWAS phenotypic input, a combined total of eleven 
significant and suggestive QTL were identified which have almost all been previously 
linked with body size variation within the dog and across species. This includes IGF1 
(Boyko et al. 2010; Vaysse et al. 2011; Rimbault et al. 2013; Hayward et al. 2016), 
HMGA2 (Zhang et al. 2008; Boyko et al. 2010; Song et al. 2010; Rimbault et al. 2013; 
Fusco et al. 2015; Hayward et al. 2016), SMAD2 (Boyko et al. 2010; Rimbault et al. 
2013; Hayward et al. 2016), GHR (Ayling et al. 1997; Rimbault et al. 2013; Cui et al. 
2015; Hayward et al. 2016), STC2 (Gagliardi et al. 2004; Boyko et al. 2010; Rimbault 
et al. 2013) and the LCORL/NCAPG locus (Vaysse et al. 2011; Liu et al. 2013; Tetens 
et al. 2013; Sahana et al. 2015; Hayward et al. 2016). In the dog, variants tagging each 
of these loci have been reported with some interesting propositions such as a SINE in 
second intron of IGF1 and a variant in the 5’ UTR of HMGA2. However, the critical 
intervals surrounding these loci have never been explicitly defined in the literature 
despite profound efforts to fine map them (Rimbault et al. 2013). An exception 
applies to the IGF1 locus which was refined to a 20-marker haplotype spanning ~65 
Kb at chr15:41,205,752-41,271,109 (CanFam3.1). Here, using individual-level 
haplotype this interval has been reduced to ~43 Kb.  
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Other positional gene candidates associated with size include the melanocortin 
receptor (MC4R) which is antagonised by the Agouti signalling peptide. 
Perturbations, within this pathway have already been shown to regulate obesity (see 
above) (Huszar et al. 1997; Ollmann et al. 1997). Meanwhile, TBX19 is a transcription 
factor expressed in the pituitary where its knockdown causes a loss of 
adrenocorticotropic hormone (ACTH) which in turn can modulate body weight 
(Pulichino et al. 2003; Eriksson and Mignot 2009). As an interesting side note,  
alterations in the hypothalamus-pituitary-adrenal axis can also affect behaviours and 
have been hypothesised to at least partly be driving domestication across species (Fu 
et al. 2016; Hekman et al. 2018; Fallahshahroudi et al. 2018). In the case of TBX19, it 
is unlikely that behavioural traits have been captured in the neurocranium size. 
Finally, IGF2BP2 (also abbreviated IMP2), which is involved in the post-transcriptional 
regulation of IGF2 and is expressed throughout the adult mouse (Yisraeli 2004; Dai et 
al. 2011). Knockout IGF2BP2 mice display an increased resistance to diet induced 
obesity and are much leaner than their wildtype littermates (Dai et al. 2015). 
However, focussing on the IGF2BP2 locus highlights one of the fundamental 
problems in the field of canine genetics. A marker (chr34:18,559,537) positioned ~18 
Kb from the CFA34 index marker reported here (Table 4.3) was previously associated 
with body weight by Hayward et al., (Hayward et al. 2016). Their study performed no 
haplotype analysis or attempts to refine a critical interval and yet the published 
results labelled the underlying causal gene as IGF2BP2. As highlighted here in Figure 
4.6G, now that fine mapping of the locus has been performed, the critical interval 
encompasses another gene, TRA2B in its entirety. This gene is equally compelling to 
cause changes in body weight as reduced TRA2B expression and alternate splicing of 
its second exon are associated with changes in weight in humans (Pihlajamäki et al. 
2011; Kaminska et al. 2016). The use of gene candidate names to identify QTL is 
understandable and simplifies the use of a coordinate-based system however 
without adequate fine mapping or the identification of causal variants, the labelling 




Associations on the X chromosome have been linked to variation in canine body 
size previously however their resolution have proven extremely difficult due to the 
high homozygosity along the chromosome following the propagation of popular sires 
(Boyko et al. 2010; Vaysse et al. 2011; Hayward et al. 2016; Plassais et al. 2017). Two 
of these studies have highlighted the immunoglobulin superfamily member 1 (IGSF1) 
as a compelling candidate to be associated with large dog breeds. Other noteworthy 
findings include the insulin receptor substrate protein 4 (IRS4) and acyl-CoA 
synthetase long-chain family member 4 (ACSL4) genes to be associated with large 
dogs and heavily muscled dogs respectively. These associations have putatively 
causal variants listed with them however their implications on gene function such as 
transcriptomics were not analysed. The association in this current study has an index 
marker within the MBNL3 gene which is less than 1 Mb away from any of the IGSF1 
and is thought to antagonise myogenesis in mice (Poulos et al. 2013). It is possible 
that whilst both of these positional gene candidates are compelling, the markers from 
both studies may in fact be tagging the same selective sweep in which case further 
assessment at this locus is needed. Interestingly, before these studies, a broad 
interval spanning both the MBLN3 and IGSF1 genes has also been linked to driving 
sociability and aggressiveness in dogs (Vaysse et al. 2011; Zapata et al. 2016). It 
remains unclear whether the same positional gene candidates could drive body size 
and behavioural traits variation or if multiple causal genes are co-segregating. 
Ultimately, both reduced size and aggression have been characteristics selected for 
throughout domestication. 
It is intriguing that many of the known functions of these genes are to drive 
alterations in body weight or muscling whilst the phenotype used here to identify 
these loci has its origins in the size of the neurocranium – a skeletal structure. 
Changes in skeletal structure may alter body weight however the inverse is not 
necessarily true. A possible hypothesis is that these positional gene candidates have 
roles beyond soft tissue (muscling) and metabolic (weight) effects and in fact also 
drive changes in skeletal structure too. An alternate hypothesis is that there is a 
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cryptic covariation between dogs with increased mass and those with larger 
neurocranium. Such a relationship is currently unclear.  
Finally and unexpectedly, the FGF4 retrogene locus on CFA18 was associated 
with neurocranium centroid size. Previously, the locus was first identified to control 
asymmetric chondrodysplasia across short-legged breeds such as the Basset hound 
(Parker et al. 2009). The locus was subsequently associated with variation in canine 
body weight but as discussed above, this could be explained by shorter bones and 
therefore lower leg mass in dogs (Hayward et al. 2016). This data suggests for the 
first time that the FGF4 retrogene may also be involved in the formation and 
therefore variation of bony structures such as the skull.  
Collectively, these data must, like all genomic association studies, be taken at 
face value until causal variants can be identified and their functional effects fully 
characterised. Here, compelling positional candidate genes based upon their known 
biological functions have been discussed, however, until further downstream 
experiments are carried out these genes are purely speculative. Furthermore, whilst 
clear associations have been drawn and their underlying critical intervals defined, in 
some instances it remains unclear precisely what morphological trait is driving them. 
For example, are all the viscerocranium PC1 associations being driven by the 
shortening of the face or is there some cryptic cosegregation with another trait? 
Could viscerocranium PC1 also be capturing traits such as klinorhynchy which is a 
common feature of brachycephalic dogs? The Agouti locus emerged as a suggestive 
peak – is this determining head shape or could the brachycephalic dog breeds in this 
study have an overrepresentation of a specific coat colour variant? The ambiguity in 
phenotypes can also extend to the bony neurocranium centroid which has identified 
loci previously known to drive soft tissue traits such as muscling and body weight.  
In order to confirm that the CFA1 locus associated with canine brachycephaly 
is indeed dictating facial length, Chapter 5 will investigate the role of the five 




Chapter 5: Characterisation of SMOC2 on Craniofacial 
Variation 
5.1 Introduction 
In the previous chapter, a critical interval for canine brachycephaly was defined 
on chromosome 1 which encompassed the SMOC2 gene. Subsequent variant calling 
and filtering identified five intronic variants within the gene which represent 
putatively causal variants for canine craniofacial variation. This variant list included 
four SNPs and the insertion of a truncated long interspersed nuclear elements class 
1 (LINE-1). 
LINE-1s are a highly abundant form of retrotransposon thought to make up as 
much as 19% of the dog genome (Lindblad-Toh et al. 2005). Full length LINE-1 
retrotransposons can be up to ~6 Kb in length and contain two open reading frames 
(ORF) (Beck et al. 2011). ORF1 encodes a nucleic acid binding protein which has been 
shown to have a nucleic acid chaperone activity (Callahan et al. 2011). Meanwhile, 
ORF2 encodes a protein with endonuclease and reverse transcription activities which 
enables the elements to mobilise in a “cut and paste” fashion with preferential 
targeting of TTAAAA hexanucleotide insertion sites (Feng et al. 1996; Jurka 1997; 
Hohjoh and Singer 1997; Beck et al. 2011). Despite the high abundance of LINE-1 
elements in mammalian genomes, very few are thought to be active, largely due to 
5’ truncations causing the loss of the ORFs during “abortive” retrotransposition or 
the introduction of inactivating mutations (Han et al. 2002; Gilbert et al. 2005; Kopera 
et al. 2016). In the average human it is thought that there may be between 80 and 
100 full-length LINE-1s (Brouha et al. 2003) with approximately half which display 
highly active of “hot” retrotransposition capabilities (Brouha et al. 2003). 
Interestingly, there is a higher number of more recent LINE-1 activity in dogs 
compared to humans, which may be a by-product of the distinct canine 
domestication process and begin to explain the rapid diversification within the 
species (Wang and Kirkness 2005).  
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The mobilisation and reintegration of these large genetic elements around a 
genome can unsurprisingly have detrimental effects. Many LINE-1 elements are 
situated either in introns or intergenic regions but can have significant impacts 
beyond this (Szak et al. 2002). As a result of the transposition, LINE-1s can cause large 
deletions, genomic inversions, intrachromosomal duplications, interchromosomal 
translocations and introduction of additional non-LINE-1 sequence such as SINEs and 
retrogenes (Symer et al. 2002; Gilbert et al. 2005). If these genomic alteration occurs 
in proximity to genes, the function of those genes could be compromised. For 
example in humans, the insertion of a LINE-1 into an exon of the factor VIII gene 
results in a complete loss of function of the protein and causes haemophilia whilst 
the insertion of a different LINE-1 into the dystrophin gene causes exon skipping and 
the onset of Duchenne muscular dystrophy (Kazazian et al. 1988; Narita et al. 1993). 
The introduction of LINE-1 elements into introns can also modify transcripts either by 
offering alternative splice sites which has been shown to cause retinitis pigmentosa 
2 and granulomatous disease (Schwahn et al. 1998; Meischl et al. 2000), or 
alternatively causing premature transcript truncation by introducing a 
polyadenylated tail (Perepelitsa-Belancio and Deininger 2003). Intronic LINE-1 
elements have also been shown to cause a reduced expression of the endogenous 
gene, possibly by causing transcriptional elongation and the increasing the likelihood  
 
Disease Gene Mechanism Reference 
Retinopathy MERTK Unknown (Everson et al. 2017) 
Cleft Palate DLX6 Premature transcript 
truncation 







(Smith et al. 
2010) 
Haemophilia B Factor IX 
Gene downregulation through 






(Choi et al. 
1999) 
Table 5.1 – LINE-1 Associated Diseases in the Dog. A list of diseases attributed to a LINE-1 insertion 
within or adjacent to positional candidate genes. When known, the mechanism through which the 
LINE-1 is believed to act upon its associated gene is listed.  
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of the RNA polymerase disengaging from the DNA (Han et al. 2004). Alternatively, 
any of the structural genomic modifications could affect upstream regulatory 
elements and modify gene expression.  
Comparatively, a diverse range of dog diseases have been linked to the 
insertion of LINE-1 elements within or adjacent to genes (Table 5.1). The mechanism 
through which the LINE-1 insertions act upon their associated gene are less well 
characterised but nonetheless present compelling cases for causality of their 
respective diseases. 
In this chapter, the objective is to test the hypothesis that SMOC2 is the most 
compelling gene candidate for canine brachycephaly and that the insertion of the 
LINE-1 within the gene is the causative variant.  
5.2 Materials and Methods 
5.2.1 Genomic DNA Extraction from Gonadal Tissue (stored in RNAlater®) 
In collaboration with Friendship Animal Hospital (Washington, DC USA), Dr. 
Schoenebeck collected gonad tissue from healthy dogs undergoing neutering 
surgery. Samples were donated with owner consent. Gonadal tissue was preserved 
in RNAlaterÒ and stored at -80 °C. In order to permit a targeted mRNA extraction 
from testis, gDNA was first extracted and genotyped for the SMOC2 LINE-1 insertion 
as described previously. The protocol for extracting gDNA from RNAlater®-stored 
tissue was adapted from ThermoFisher Scientific 
(http://www.thermofisher.com/uk/en/home/references/protocols/nucleic-acid-
purification-and-analysis/rna-protocol/genomic-dna-preparation-from-rnalater-
preserved-tissues.html). A digestion buffer was prepared containing 1.8 mL 1 M Tris 
(pH 8.0), 4.0 mL 0.5 M EDTA, 0.5 mL SDS (20%) and 13.7 mL deionised water. On lint-
free paper, a testes samples approximately 0.5 cm3 in size were cut using a scalpel 
and any remaining RNAlater was removed. The testes samples were minced well with 
a scalpel blade and placed in 2 mL microfuge tubes with 1.5 mL digestion buffer and 
37.5 µL 20 mg/mL Proteinase K. The samples were vortexed for 2 seconds before 
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incubating on a heat block at 55 °C for 4 hours. Once digestion was complete, samples 
were divided into 750 µL volumes before adding 750 µL phenol chloroform (Thermo 
Fisher, 15593-031) and inverting rapidly for 2 minutes at room temperature. Samples 
were centrifuged at 16,000 G for 10 minutes. The DNA-containing upper aqueous 
layer was transferred to a fresh microfuge tube and the phenol chloroform 
separation step was repeated twice more. After the third phenol chloroform step, 
the upper aqueous phase was transferred to a fresh 1.5 mL microfuge tube 
containing 50 µL 3M sodium acetate (pH 5.2) (Amresco, E498) and 500 µL 95% 
ethanol. Samples were mixed by inversion and incubated at room temperature 
overnight to allow full gDNA precipitation. Samples were centrifuged at 16,000 G for 
5 minutes, supernatant removed and pellets washed with 500 mL 70% ethanol for 5 
minutes. Samples were centrifuged again and pellets allowed to air dry once the 
ethanol was removed. gDNA was rehydrated in 200 µL Tris EDTA. 
5.2.2 Total RNA Extraction from Frozen Testes in RNAlater™ 
Testes were selected for messenger RNA (mRNA) extraction due to the 
unattainability of appropriate embryonic-stage tissue. SMOC2 was assumed to be 
expressed in the testes based on evidence in other species (Pazin et al. 2009; Uhlén 
et al. 2015). In total, nine dogs were selected for RNA extraction representing three 
individuals for each of the SMOC2 LINE-1 genotypes – homozygous ancestral (1 Italian 
Greyhound, 1 Whippet, 1 Yorkshire Terrier), 3 heterozygotes (1 Papillion, 2 Cavalier 
King Charles spaniels) and 3 homozygous derived (1 Bulldog, 1 French Bulldog, 1 Pug). 
Prior to RNA extraction, all equipment was cleaned using RNaseZap™ (Ambion, 
AM9780). For each RNA preparation, each sample was weighed whilst frozen to 
ensure it did not exceed 100 mg. Any remaining RNAlater™ was removed using lint-
free paper prior to adding the sample to 1 mL chilled TRIzol™ (Life Technologies, C-
15596026EB) in a Matrix D lysis tube containing 1.4 mm ceramic spheres (Fisher 
Scientific, MBR-247-110Y) on wet ice. Lysis tubes were secured in the FastPrep™-24 
device and run at a speed of 4 m/s for 20 seconds. Homogenised samples were stored 
on ice before being incubated at room temperature for 5 minutes. Samples were 
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shaken vigorously for 15 seconds with 200 µL BCP (Sigma, B9673) and incubated for 
a further 3 minutes at room temperature. Samples were centrifuged at 12,000 G for 
15 minutes at 4 °C and the upper RNA-containing aqueous phase was transferred to 
a fresh microfuge tube. Total RNA samples were cleaned using the RNeasy Lipid 
Tissue Mini Kit (Qiagen, C-74104EB) following the manufacturer’s instructions. 
Briefly, one volume of 70% ethanol was added to the RNA samples and vortexed for 
2 seconds. A maximum of 700 µL sample was added to a RNeasy Mini spin column in 
a 2 mL collection tube and spun at 10,000 G for 15 seconds at room temperature. The 
effluent was discarded and any remaining sample was re-run using the same column. 
Buffer RW1 (700 µL) was added to the column and centrifuged at 10,000 G for 15 
seconds – the effluent was discarded. Buffer RPE (500 µL) was added to the column, 
spun for 15 seconds and the effluent was discarded. A further 500 µL of RPE was 
added to the column, spun for 2 minutes and the effluent was discarded. The column 
was spun for a further 2 minutes to remove residual buffer. The column was placed 
in a 1.5 mL collection tube and 30 µL water was added. The column was left at room 
temperature for 30 seconds before the centrifuging at 10,000 G for 1 minute to elute 
the RNA. The manufacturer’s optional DNase step was not used.  
5.2.3 Total RNA Quantification and Quality Assessment  
Quantification was performed using the Qubit® RNA Broad Range Assay Kit (Life 
Technologies, Q10210). One 0.5 mL microfuge tube was labelled per sample and two 
for standards. Working solution was prepared in a plastic bijoux tube by diluting the 
Qubit® RNA BR Reagent 1:200 in Qubit® RNA BR buffer. The final volume of working 
solution accommodated for 200 µL per microfuge tube prepared previously. To 
prepare the standards, 10 µL of the appropriate Qubit® standard was added to 190 
µL working solution in the labelled microfuge tubes and mixed by vortex for 2 
seconds. To prepare the samples, 1 µL of each sample was added to 199 µL working 
solution in the appropriately labelled microfuge tubes and mixed by vortex for 2 
seconds. Samples were incubated for 2 minutes at room temperature. All steps were 
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carried out with minimal exposure to light. The RNA Broad Range setting was selected 
on the Qubit® device, standards were read followed by samples. 
RNA quality was quantified using the TapeStation 2200 (Agilent Technologies). 
RNA ScreenTape sample buffer (Agilent Technologies, 5067-5577) and RNA 
ScreenTape Ladder (Agilent Technologies, 5067-5578) were allowed to equilibrate to 
room temperature for 30 minutes before vortexing for use. The working ladder was 
prepared by mixing 5 µL RNA sample buffer with 1 µL RNA ladder. Total RNA samples 
were thawed on ice before 1 µL was added to 5 µL RNA sample buffer. Tubes were 
spun down and vortexed for 1 minute at 2000 rpm. Tubes were spun down and 
incubated at 72 °C for 3 minutes and then placed on ice for 2 minutes. Samples were 
spun down and loaded into the TapeStation instrument with fresh pipette tips and 
an RNA ScreenTape (5067-5576). An RNA integrity number equivalent (RINe) of ~8.0 
and above is considered to represent RNA with minimal degradation. 
5.2.4 RNA Sequencing and Analysis 
In total, nine RNA samples were selected for sequencing and included three 
representatives from the three SMOC2 LINE-1 genotypes – homozygous ancestral (1 
Italian Greyhound, 1 Whippet, 1 Yorkshire Terrier), 3 heterozygotes (1 Papillion, 2 
Cavalier King Charles Spaniels) and 3 homozygous derived (1 Bulldog, 1 French 
Bulldog, 1 Pug). All RNA samples exceeded RINe values of 0.8 and were submitted to 
Edinburgh Genomics, UK for sequencing. Briefly, TruSeq standard RNA libraries were 
prepared for each of the nine total RNA samples following the manufactures 
guidelines. Barcoded libraries were sequenced on three lanes of an Illumina HiSeq 
4000, producing 150 bp paired-end reads.  
The Splice Transcripts Alignment to a Reference (STAR) software (v2.5.1b) was 
used to align FASTQ files containing the RNA short-read data to an indexed 
CanFam3.1 reference sequence (CanFam3.1, ENSEMBL release-85) using default 
parameters (Dobin et al. 2012). Annotated junctions were downloaded from 
ENSEMBL. Read alignment was performed in two passes as recommended by the 
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manufacturer. Picard tools (v2.18.5) was used to add read groups, merge .bam files 
by sample and mark duplicate reads (http://broadinstitute.github.io/picard). 
FeatureCounts, an analysis tool of the RSubread package (RSubread v1.22.3 installed 
on R), was used to quantify mapped reads to genes (Liao et al. 2013). Differential 
expression analysis was conducted at the gene level using the R package DESeq2 
(v1.12.4) by comparing three homozygous SMOC2 LINE-1 carriers compared to three 
non-carriers (Love et al. 2014). Detection of allelic imbalance in gene expression was 
made possible by three heterozygous dogs (2 Cavalier King Charles spaniels and 1 
Papillion) which had a silent exonic single nucleotide variant (SNV) segregating with 
the LINE-1 insertion. RNAseq data was visualised using the Integrative Genomics 
Viewer (IGV) (Robinson et al. 2011). 
5.2.5 Reverse Transcription  
Complementary DNA (cDNA) was produced from 1 µg total RNA using the 
SuperScript III First-Strand SuperMix kit (Invitrogen). One µL 50 µM oligo(DT) primer 
was mixed with 1 µL annealing buffer and 1 µg total RNA and made up to 8 µL with 
DNase/RNase-free water. Samples were incubated in a thermocycler at 65 °C for 5 
minutes in and then immediately placed on ice for a minimum of 1 minute. The 
samples were collected by briefly centrifuging before adding 10 µL 2X First-Strand 
Reaction Mix and 2 µL SuperScript™ III enzyme mix on ice. Samples were vortexed 
and collected by centrifuging before incubating at 50 °C for 50 minutes. The reaction 
was terminated at 85 °C for 5 minutes before chilling on ice.  
5.2.6 Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
5.2.6.1 Primer Design 
In order to design primers for RT-qPCR the predicted transcript sequences were 
downloaded from the Ensembl genome browser 
(http://www.ensembl.org/index.html) for SMOC2 (ENSCAFT00000001348.4), DACT2 
(ENSCAFT00000050141.2) and THBS2 (ENSCAFT00000046608.2). Downloaded mRNA 
sequences were annotated by including square brackets, “[]” between each exon-
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exon boundary as indicated by colour changes in the Ensembl transcripts. Annotated 
sequences were uploaded to the Roche Universal Probe Library’s Assay Design Centre 
(https://lifescience.roche.com/en_gb/brands/universal-probe-library.html#assay-
design-center). The software does not have a canine-specific setting and so the 
“Other organism (paste sequence only)” option was selected with automatic 
selection of intron-spanning primer design being selected (Table 5.2). The primer 
sequences for the housekeeping gene, MRPS7 were acquired from Maccoux et al., 
2007 (Maccoux et al. 2007). All lyophilised primers were resuspended in deionised 
water to a final concentration of 100 µM. Probes from the Roche Universal Probe 
Library were recommended for each primer pair. 
5.2.6.2 Primer Efficiency  
All RT-qPCR was performed using the Roche LightCyclerÒ 480 device with the 
LightCyclerÒ 480 Multiwell Plate 96 following the manufacturer’s instructions. For 
each reaction, 4.7 µL cDNA was added to 5 µL Roche Probe Master Mix, 0.1 µL 10 µM 
forward & reverse primer mix and 0.2 µL of the appropriate probe. Serial dilutions of 
prepared cDNA samples were used to optimise the protocol with technical triplicates 
being used. Table 5.3 lists the thermocycler conditions including a pre-incubation 
step for the un-purified cDNA.  
Table 5.2 – RT-qPCR primers. A list of exon-spanning primers designed to target specific genes. 
Primers were designed using the Roche Assay Centre which recommended the appropriate Roche 
Universal Probe to use.  
 




(Marchant et al. 
2017) (R)TGGGATGAACACCTGCTGTA 
SMOC2 E10/11 (F)CGCGCTCTCTACCGACAT #73 (Marchant et al. 
2017) (R)GGGGTCGGGTTCTGAGAG 

















Raw text files containing crossing point (Cp) values were exported from the 
Roche LightCyclerÒ software and imported into Microsoft Excel for analysis. The 
slope between Cp and Log10 cDNA dilution was calculated using the “=SLOPE” 
function in Excel. Primer efficiency was then calculated using Equation 5.1.  
 Under optimum conditions, a primer with 100% efficiency would generate two 
new templates for every reaction cycle. Perfect efficiency is rare and so primers with 






Equation 5.1 – Amplification efficiency. The equation used to calculate the amplification efficiency 
of a primer pair using the slope of the curve between the crossing point (Cp) and the log10 cDNA 
dilution.  
5.2.6.3  Relative Gene Expression 
Only primers targeted at the housekeeping gene, MRPS7 and the 5’ and 3’ 
targets of SMOC2 had appropriate efficiencies for relative transcript quantification. 
RT-qPCR was performed using the master mix and thermocycler protocol as 
described previously (section 5.2.6.2). Biological and technical triplicates were used 
for cDNA dilutions of 1:100. Relative expression ratios (R) were calculated and 
corrected for primer efficiency using Equation 5.2 (Pfaffl, 2001). 
 
Stage Temperature (°C) Time Cycles 
Pre-incubation 95 10 minutes x1 
Amplification 
95 10 seconds 
x45 60 30 seconds 
72 1 second 
Cooling 40 30 seconds x1 
Table 5.3 – LightCyclerÒ Programme. Temperature and duration of stages in the standard 











Equation 5.2 – Efficiency-corrected Normalised Expression. Changes (D) in crossing point (Cp) scores 
for target (SMOC2) and reference (MRPS7). D Cp scores were calculated by subtracting the average 
for each gene in homozygous LINE-1 (Derived) from homozygous non-LINE1 carriers (ancestral).  
5.2.7 Evolutionary Conservation 
The Evolutionary Conserved Region Browser (https://ecrbrowser.dcode.org/) 
was used to assess the degree of sequence conservation across species. The Human 
genome (hg19) was used as the base genome with SMOC2 gene coordinates 
chr6:168,841,831-169,068,674. Default settings were used to compare the Zebrafish, 
Chicken, Mouse, Cow, Dog and Rhesus Macaque sequences.  
5.2.8 In situ Hybridisation 
In situ hybridisations for mouse and chicken Smoc2 were performed by Lynn 
McTeir, The Roslin Institute, The University of Edinburgh following the Nieto et al., 
1996 protocol (Nieto et al., 1996). Mouse (C57BL/6) and chicken (Isa Brown) embryos 
used for histology were surplus biomaterial harvested prior to this study. Mouse and 
chick work was performed in accordance to animal use guidelines of the Roslin 
Institute.  
5.2.9 Mouse Skull Morphology Assessment 
Lateral and dorsoventral radiographs of four C57BL/6NJ background controls 
and eight Smoc2-/- mice (Smoc2tm1.1(KOMP)VIcg allele produced by The Jackson 
Laboratory, USA) aged 13 weeks were landmarked in ImageJ (v1.50g) using the 
PointPicker plugin (male = 5, female = 7) (Schneider et al. 2012). Nine lateral and 
fifteen dorsoventral landmarks of the murine skull were selected for their 
reproducibility across radiographs. The 2D landmark coordinates were exported from 
ImageJ and imported to MorphoJ. The lateral and dorsoventral landmarks were 
analysed separately but both used the same approach. A generalised Procrustes fit 
was used to appropriately superimpose, scale and orientate the landmarks. A 
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covariance matrix was calculated using the Procrustes distance matrix prior to 
principal component analysis. A two-tailed Student’s t-test assessed the distribution 
of whole head PC1 scores for sex and Smoc2 background. Additional phenotypic 
detail for these mice are available from the International Mouse Phenotyping 
Consortium (http://www.mousephenotype.org). 
5.3 Results 
5.3.1 Putatively Causal SMOC2 Variants 
The critical interval defined previously (Chapter 4) on CFA1 (55,850,299 - 
56,037,676) for viscerocranium PC1 (brachycephaly) spans the SMOC2 gene. 
Following SNP, small INDEL and large structural variant calling and hard filtering five 
putatively causal variants remained which included four SNPs and one large 
structural insertion (Table 5.4). 
The remaining four SNPs are situated within introns 1, 7 and 12 of SMOC2 whilst 
the structural variant resides in intron 8 (Figure 5.1A). The structural variant is a 1,531 
bp insertion which is present in the brachycephalic Boxer reference genome. All four 
SNPs appear to be in complete linkage disequilibrium with the structural insertion. 
PhastCon scores downloaded from the UCSC genome browser indicate minimal (~0) 
conservation of each of the SNPs for which data was available for across the dog, 
mouse, rat and human genomes (Figure 5.1B). Suggestive that the SNPs are unlikely 
to be situated in a regulatory region, the candidacy for the SNPs to be putatively 
causal for canine brachycephaly is poorly supported from this data. 




GATK / SnpSift SNPs / INDELS 187,377 3,674 4 
Pindel Structural Variants 187,377 162 1 





The remaining 1,531 bp structural insertion is a 3’ truncated fragment of a long 
interspersed nuclear element class 1 (LINE-1). Canine LINE-1 are large (>6,000 bp) 
retrotransposons known to be mutagenic in both dogs and humans (Miki et al. 1992; 
Lander et al. 2001). An intact LINE-1 is composed of two open reading frames (ORF), 
5’ and 3’ untranslated regions (UTR) and a polyadenylated tail (poly(A)) (Figure 5.2A). 
During the complete retrotransposition of a LINE-1, target site duplications (TSD) are 
introduced and flank the insertion site. Here, the insertion associated with 
brachycephaly is a truncated, 1,506 bp fragment containing the 3’ UTR and part of 
ORF2 in addition to a poly(A) tail which may have been the result of “abortive” 
retrotransposition (Gilbert et al. 2005). No target site duplications could be detected. 
The ancestral allele does not carry the LINE-1 insertion.   
A multiplex touchdown PCR protocol was established to genotype all dogs used 
in the discovery phase GWAS using study cohort 1 for the SMOC2 LINE-1 insertion. 
The LINE-1 insertion was found in 91.5% of brachycephalic dogs with viscerocranium  
Figure 5.1 – Remaining Variants after Filtering. (A) All four remaining SNPs in the viscerocranium 
PC1 critical interval following filtering are located within the SMOC2 gene. (B) Coordinates of each 
SNP (listed as CanFam3.1 in brackets) are converted to CanFam2.0 and used to plot PhastCon scores 
(y-axis) for 200 bp in both directions from the SNP (x-axis). PhastCon scores were downloaded from 
the UCSC Table Browser. No PhastCon scores were available for SNP2. From the available data, no 
SNPs reside in highly conserved positions across dog, human, mice and rat genomes. Alleles are 




Figure 5.2 – SMOC2 LINE-1 Distribution. (A) Schematic of a full-length canine LINE-1 element 
consisting of 5’ and 3’ untranslated region (UTR), open reading frames 1 and 2 (ORF1/ORF2) and a 
polyadenylated tail (poly(A)) flanked by target site duplications (TSD). The structural variant within 
SMOC2 is 1,506 bp in length (in addition to a poly(A) tail) and has a 99.1% match to the consensus 
sequence of a canine LINE-1. Distribution of the SMOC2 LINE-1 fragment for (B) viscerocranium PC1 
and (C) neurocranium centroid size across all individuals. (D) Ventral-dorsal schematic view of a 
canine hard palate and its constituent bones. Schematic not drawn to scale (E) Length and width of 
the canine palate and constituent bones normalised by the neurocranium centroid size for 
homozygous ancestral (white), heterozygous (grey) and homozygous derived (black) individuals for 
the SMOC2 LINE-1 insertion. Modified from: (Marchant et al. 2017). 
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PC1 scores < -0.2, whilst just 2.1% of mesocephalic to dolichocephalic 
(viscerocranium PC1 > -0.2) dogs (Figure 5.2B). Meanwhile, the LINE-1 insertion 
appears to have no correlation with the neurocranium centroid size (Figure 5.2C). To 
investigate whether the SMOC2 LINE-1 genotype correlates with physical 
measurements of the skull, the length and width of the canine hard palate and its 
constituent bones were calculated using appropriate landmarks (Figure 5.2D). A 
dose-effect was observed across all linear measurements with two copies of the 
SMOC2 LINE-1 correlating with shorter (along the body axis) and wider 
(perpendicular to the body axis) bones of the palate (Figure 5.2E). The greatest effect 
was observed in the length of the palatine bone.   
5.3.2 Effects on SMOC2 Transcription 
5.3.2.1 Quantitative PCR 
LINE-1 retrotransposons are known to be capable of affecting local gene 
expression through a variety of methods. Mechanisms include the introduction of 
premature stop codons or polyadenylation signals, providing alternative splice sites 
and stimulating RNA polymerase disengagement from DNA through transcriptional 
elongation (Speek 2001; Han et al. 2004; Estécio et al. 2012). To investigate the 
potential effects of the SMOC2 LINE-1 fragment on nearby genes, total RNA 
extractions from testes samples of nine dogs representing dolichocephalic (x3), 
mesocephalic (x3) and dolichocephalic (x3) dogs were extracted and analysed. RT-
qPCR targeted at both the 5’ (exon 2/3) and 3’ (exon 10/11) ends of SMOC2 displayed 
a comparable dose-dependent down-regulation for each additional copy of the 
SMOC2 LINE-1 (Figure 5.3A). Individuals homozygous for the LINE-1 had a ~5-fold 
reduction in total SMOC2 transcripts compared to their ancestral counterparts. 
Individuals carrying a single copy of the insertion displayed an intermediary 
expression profile. RT-qPCR could not confirm the expression levels of the gene-
neighbours of SMOC2, thrombospondin 2 (THBS2) or dishevelled binding agonist of 
beta catenin 2 (DACT2).  
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5.3.2.2 RNAseq Analysis 
To confirm the RT-qPCR findings and to identify any other mRNA expression 
perturbations, total mRNA of the same nine dogs was submitted for RNAseq analysis. 
A comparison between homozygous LINE-1 carriers and non-carriers identified a 
Figure 5.3 – SMOC2 Transcript Analysis. (A) Efficiency-corrected relative expression of SMOC2 both 
up- and downstream of the LINE-1 insertion for individuals homozygous ancestral (AA), 
heterozygous (AD) and homozygous derived (DD) for the SMOC2 LINE-1 insertion (<0.05 *; <0.01 
**; <0.001 ***). (B) RNAseq analysis revealed genes displaying a significant reduction in transcript 
count in SMOC2 LINE-1 homozygous carriers compared to non-carriers (red). Genes neighbouring 
SMOC2 are coloured green. (C) Schematic diagram of gDNA spanning exons 8 and 9 of SMOC2, 
including the LINE-1 insertion. mRNA transcripts include the canonical splicing of SMOC2 (i) 
followed by the three most abundant SMOC2 isofroms when the LINE-1 element is present (ii-iv). 
All isoforms have premature stop codons prior to exon 9. C/T indicates the SNP in exon 8. (D) Exons 
1-13 of SMOC2 contribute to a follistatin-like module (FS), thyroglobulin-like modules (TY), a unique 
SMOC module, an extracellular calcium-binding module (EC) and a signal peptide (SP). Modified 
from: (Marchant et al. 2017). 
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similar downregulation of SMOC2 (3.1-fold change) (Figure 5.3B). Three further genes 
were also identified to have a down-regulation in homozygous carriers which 
included urotensin 2B (UTS2B) and two novel long non-coding RNAs 
(ENSCAFG00000039143 and ENSCAF00000035778). None of these genes are located 
on CFA1. No expression changes could be detected in the genes neighbouring 
SMOC2, THBS2 and DACT2.  
Figure 5.4 – SMOC2 Isoform Sequences. mRNA and amino acid sequences for the canonical (ancestral) 
SMOC2 transcript and the six isoforms identified in dogs that are carriers of the LINE-1 element. 
Coloured bars indicate the contributions of SMOC2 exons (E), introns (I) and LINE-1 element into the 
mature mRNA transcript. All alternative isoforms are predicted to code for premature stop codons 
(*).Modified from: (Marchant et al. 2017). 
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The assessment of the RNAseq data revealed that all individuals expressed the 
canonical, 13 exon SMOC2 transcript, regardless of their LINE-1 genotype status 
(Figure 5.3C). For homozygous ancestral individuals, this canonical transcript was 
exclusively expressed however individuals that carried copies of the LINE-1 insertion 
(either heterozygous or homozygous), expressed multiple different isoforms of 
SMOC2. Using primers targeted against the LINE-1 fragment and exon 8 of SMOC2, 
three abundant splice forms of SMOC2 across all three individuals homozygous for 
the LINE-1 insertion were confirmed. Three further rarer transcripts were observed 
in the RNAseq data of homozygous and heterozygous carriers of the LINE-1 (Figure 
5.4). In every instance, the alternative SMOC2 transcripts have a canonical sequence 
spanning from exons 1 to 8 however the transcript then splices into a variety of 
positions within intron 8 prior to reading into the LINE-1 fragment itself. All 
alternative transcripts characterised are predicted to introduce a premature stop 
codon following exon 8 (Figure 5.4). It is unclear whether this truncated transcript 
can produce a mature protein, and if so, what the full effects it may have on its 
function. However, the protein product is predicted to terminate within the 
thyroglobulin-like domain and would have no extracellular calcium-binding domain 
(Figure 5.3D).  
The comparison of mRNA and gDNA sequencing revealed that each of the 
different splice sites within intron 8 of SMOC2 are preceded by an adenine and 
guanine residue (AG) – an almost invariant characteristic of mammalian splice 






Table 5.5 – Splice Site Sequence for SMOC2 Isoforms. The seven most frequent transcripts identified which correspond to those in Figure 5.4. The silent variant at 
chr13:55,939,143 is listed as C or T. Upper-case letters indicate sequence included in mRNA. Lower-case letters indicate intron sequence that is not included in 
mature mRNA transcripts. Bold letters are the consensus splice donor (gt) and splice acceptors (ag) sites. Three dogs for each SMOC2 LINE-1 genotype status were 
used for RNAseq analysis - homozygous derived; Bulldog (BULD), French Bulldog (FBUL) and Pug (PUG); heterozygous Cavalier King Charles Spaniel (CKCS) x2, 
Papillion (PAPI); homozygous ancestral Italian Greyhound (ITGY), Whippet (WHIP) and Yorkshire Terrier (YORK). The percentage of splice variant read count of the 
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5.3.2.3 Allele-specific Expression 
Using the RNAseq data, a silent T/C substitution 
(ENSCAFT00000001348.4:c.699T>C) was observed at position 13:55,939,143 in exon 
8 of SMOC2 (Figure 5.3C). Both the T and C alleles at this locus are observed across 
individuals that are ancestral for (do not have) the SMOC2 LINE-1 insertion. 
Conversely, whenever the SMOC2 LINE-1 is observed, it is always accompanied by the 
silent T-allele in exon 8 (Figure 5.3C). This suggests that the T/C silent variant predates 
the insertion of the SMOC2 LINE-1 element which occurred into just the T-allele.  
This observation permits the inference of allele-specific SMOC2 expression 
under certain conditions i.e. whenever the T/C allele is heterozygous. This was the 
case in three dogs. Firstly, a Yorkshire Terrier (dog 9) was homozygous ancestral (AA) 
for the SMOC2 LINE-1 insertion whilst being heterozygous for the T/C allele (Table 
5.5). SMOC2 transcripts from this dog had a percentile ratio of 54:46 for the T and C-
allele, respectively suggesting an equal contribution from both alleles to the final 
SMOC2 transcript count. This would be expected since there is no LINE-1 insertion 
present to disrupt transcription.  
 
Dog Breed SMOC2 LINE-1 
Genotype 
Percentage Transcripts  
T-allele C-allele 
1 Bulldog DD 100% 0% 
2 French Bulldog DD 100% 0% 
3 Pug DD 100% 0% 
4 Papillion  AD 100% 0% 
5 Cavalier King Charles Spaniel AD 24% 76% 
6 Cavalier King Charles Spaniel AD 25% 75% 
7 Italian Greyhound AA 100% 0% 
8 Whippet AA 100% 0% 
9 Yorkshire Terrier AA 54% 46% 
Table 5.6 – Allele-specific Expression of SMOC2. RNAseq data was generated for nine dogs for the 
homozygous derived (DD), heterozygous (AD) and homozygous ancestral (AA) genotypes of SMOC2.  
The sequencing of the C/T silent mutation in exon 8 is given as a percentage of the total read counts 
for the 55,939,143 base position. The LINE-1 element is found on the T-allele which suggests the 
decrease in transcript abundance is from the LINE-1 carrying haplotype. Modified from: (Marchant 




In contrast, two Cavalier King Charles Spaniels (dog 5 and 6) were heterozygous 
for both the LINE-1 insertion and the T/C allele (Table 5.5). In both cases, SMOC2 
transcripts had percentile ratios of approximately 25:75 for the T and C alleles, 
respectively. In both of these incidences, the transcripts harbouring the T-allele are 
derived from the SMOC2 LINE-1 containing strand. Therefore, this data suggests that 
the SMOC2 LINE-1 insertion is acting in-cis to reduce the total transcript count of the 
gene. The mechanism for this action is unclear however the LINE-1 element may 
decrease transcriptional activity, induce nonsense-mediated decay following the 
production of truncated transcripts, or both. 
5.3.3 Species Conservation of SMOC2 
Morpholino studies using zebrafish suggest that smoc2 is involved in 
chondrogenesis of the head (Bloch-Zupan et al. 2011; Melvin et al. 2013). In order to 
Figure 5.5 – Species Conservation of SMOC2. (A) The Evolutionary Conserved Regions of human 
SMOC2 spanning chr6:168,841,831 - 169,068,674 (hg19 construct) are poorly conserved in the 
Zebrafish, Chicken and Mouse compared to the Dog, Cow and Rhesus Monkey. Orange indicates 
conserved intronic sequence, green indicates conserved repetitive elements. Despite this, Smoc2 
mRNA is expressed in the first pharyngeal arch of the (B) mouse and (C) chicken embryo. Smoc2 
expression is observed in the mandibular process (black arrow) and maxillary process (red arrow) of 




investigate the role for SMOC2 across evolutionary conserved species, the genomic 
sequence of SMOC2 across species was compared to humans (Figure 5.5A). This 
revealed that the Rhesus Macaque had the greatest degree of sequence conservation 
across the species assessed then followed by the dog and cow. Surprisingly, the 
zebrafish, chicken and mouse showed a striking reduction in the level of 
conservation.  
Despite this, Smoc2 mRNA is expressed in the pharyngeal arches of the mouse 
and chicken embryo (Figure 5.5B&C) (Liu et al. 2007). Specifically, the Smoc2 mRNA 
Figure 5.6 - Smoc2-null Mice Have Dysmorphic Skulls. (A) Dorsoventral radiographs of mice aged 13 
weeks indicating the position of fifteen landmarks across the skull. (B) Lollipop diagram denotes the 
mean position of landmarks (red circles) and the extent and direction of landmark variation (blue 
bars) for whole head PC1. The whole skull PC1 values for Smoc2-null (red) and control (black) mice 
segregate significantly by (C) genotype but not (D) sex. (E) The non-normalised hard palate lengths 
of Smoc2-null mice are significantly shorter than their WT counterparts whilst no significant 




appears to be localised to the mandibular process and the maxillary process of the 
first pharyngeal arch.  
Previous to this study a Smoc2 null mouse was generated at the Jackson 
Laboratory, USA and phenotyped as part of the International Mouse Phenotyping 
Consortium (IMPC). Smoc2-/- mice were viable and reached sexual maturity however 
the lines were no longer kept. As part of the phenotyping screen, radiographs of the 
skulls were archived. Two-dimensional geometric morphometric analysis was used 
to assess the variability between the Smoc2-/- and wild type (WT) littermates. Fifteen 
symmetric landmarks captured the variability across the whole skull prior to a 
Procrustes fit and whole-head principal component (PC) analysis comparable to that 
carried out in the dog skull reconstruction analysis (Figure 5.6A). Whole-head PC1 
accounted for 51.15% of the total variability across the mouse skulls assessed. In the 
negative direction of whole-head PC1, the length of the skull along the body axis is 
reduced whilst skull width is widened (Figure 5.6B). This morphological change is 
comparable to the changes observed in the brachycephalic canine skull. Principal 
component 1 segregates significantly by Smoc2 genotype with Smoc2-/- mice having 
shorter and broader (brachycephalic-like) skulls compared to their WT littermates 
(Figure 5.6C&E). Meanwhile, there was no significant correlation between PC1 and 
sex (Figure 5.6D&E). 
5.4 Discussion 
The data presented in this chapter confirms SMOC2 and its associated LINE-1 
insertion as highly compelling candidates for causing canine brachycephaly. Absolute 
proof of causality could not be shown, which remains a challenge within the field of 
canine genetics due to the inaccessibility of appropriate tissues, scarcity of cell lines 
and technical challenges of generating surrogate animal models.  
SMOC2 (SPARC-related modular calcium-binding protein 2) is secreted to the 
extracellular matrix across a wide variety of early embryonic tissues including the 
heart, lungs, kidneys and developing skeleton (Termine et al. 1981; Feng et al. 1996; 




matricellular proteins which are collectively defined by their extracellular calcium-
binding domain and a follistatin-like domain. A distinction of SMOC2 is the addition 
of two thyroglobulin-like domains and a unique SMOC module (Vannahme et al. 
2003). It is thought that SMOC2 is under the control of hedgehog signalling and itself 
can regulate the expression of bone morphogenetic protein (BMP) target genes 
(Mommaerts et al. 2014). Furthermore, due to the interaction of SMOC2 with cell 
surface integrins and vascular endothelial growth factor (VEGF), platelet-derived 
growth factor (PDGF) and basic fibroblast growth factor (bFGF), it is thought to act as 
a mediator between growth factors and their receptors (Rocnik et al. 2006; Liu et al. 
2007; Maier et al. 2008). As a result SMOC2 has been shown to control cellular 
adhesion, migration, mitogenesis and differentiation (Rocnik et al. 2006; Liu et al. 
2007; Maier et al. 2008; Peeters et al. 2018). 
Originally, SMOC2 was first identified in bone where it is known to have a 
differential expression across the long-bone growth plates (Zhang et al. 2008). 
Mounting evidence suggests that SMOC2 plays an important role in craniofacial 
development across species. A zebrafish knockdown study of smoc2 caused 
craniofacial hypoplasia which may act, in part through BMP pathways (Melvin et al. 
2013; Mommaerts et al. 2014). Smoc2 is prominently expressed in the pharyngeal 
arches of both the developing chicken and mouse embryos. Over the course of 
embryonic days 10.5 and 12.5 which sees dynamic facial growth in the mouse, Smoc2 
is shown to have a differential expression in the frontonasal and 
maxillary/mandibular prominences – both of which give rise to craniofacial skeletal 
tissue (Feng et al. 2009). The findings of this thesis further support the importance of 
SMOC2 in craniofacial development.  
The geometric morphometric analysis of mouse radiographs have shown that 
Smoc2-/- mice have dysmorphic skulls and that they cluster distinctly from their WT 
littermates. Interestingly, the global effects on skull morphology in the mouse are far 
less striking than those seen in the domestic dog. An explanation may be that the 




morphology, a phenotype that is known to be complex and likely to have multiple 
contributing variants that are enriched and reaching fixation in the breeds giving a 
more apparent extreme phenotype compared to the knockout mouse. Also, the 
allometric disparity between the mouse and the dog may in some part dilute the 
phenotypic effects of a Smoc2 loss of function mouse. Furthermore, challenges of 2D 
geometric morphometrics makes defining morphological changes in these data more 
difficult. Namely, variation the positional origin of the image acquisition can alter the 
apparent positioning of points from one another in 2D compared to 3D image 
analysis, an affect known as parallax (Mullin and Taylor 2002). Furthermore, 3D skull 
isosurfaces provide a more reliable, repeatable phenotype capture compared to 
radiographs which can be harder to interpret. Nevertheless, the Smoc2-/- mouse 
skulls are dysmorphic and a larger follow-up assessment of 3D morphological 
variation would distil the dysmorphology by shedding light on the regions of the skull 
most affected by Smoc2 loss of function.  
RNA profiles were analysed in order to investigate the potential effects of the 
LINE-1 on SMOC2 biology and function in craniofacial development. In these studies 
testes were used as a source of total RNA. Embryonic tissues such as the pharyngeal 
arches or healthy adult craniofacial tissues would have made for a more appropriate 
source of RNA, however these are unattainable when working with the domestic dog. 
The decision to use testes was based upon the ease of access and sufficient supply of 
healthy tissue as well as knowing that SMOC2 was expressed in the testes of other 
species (Pazin et al. 2009; Uhlén et al. 2015). An assumption was made that the LINE-
1 insertion would have a global effect on SMOC2 expression irrespective of tissue 
origin. Whilst the LINE-1 was incorporated into SMOC2 transcripts and a reduction in 
total read count of the LINE-1 carriers was observed, it remains to be seen whether 
these effects are consistent across tissues and would need future confirmation.  
Interestingly, in addition to SMOC2, the RNAseq analysis also highlighted a 
downregulation of urotensin 2B (UTS2B, ENSCAFT00000022282.3, chr34: 




(ENSCAFT00000053759.1, chr15:49,296,364-49,338,229; ENSCAFT00000050250.1, 
chr20:7,300,269-7,309,695). None of these genes are situated on CFA1 so the 
likelihood of an interaction between the LINE-1 and these genes is low. UTS2B is a 
potent neuropeptide expressed in a variety of tissues including the kidneys, heart and 
bladder where it is best characterised for its activity as a vasoconstrictor (Matsushita 
et al. 2001; Merlino et al. 2013). A link between UTS2B and the lead candidate gene, 
SMOC2 is unclear. To date, nothing is known about the novel long non-coding RNAs.  
The RT-qPCR experiments confirmed a similar downregulation of SMOC2 in the 
homozygous carriers of the LINE-1 insertion compared to individuals without a copy 
(ancestral) with a five-fold change (compared to 3 in the RNAseq data). Through the 
use of RT-qPCR, a stepwise, downregulation of SMOC2 was observed such that every 
copy of the LINE-1 allele would have a dose effect on the total SMOC2 transcript 
count. A comparable expression profile of SMOC2 both up- and downstream of the 
LINE-1 insertion was also confirmed – previous studies have indicated that there may 
be a greater number of transcripts containing upstream sequence compared to 
downstream of the LINE-1 (Han et al. 2004). Follow up experiments (discussed in 
Chapter 7) would be needed to confirm the dose-effect of LINE-1 genotypes on 
SMOC2 expression given the standard error in the current RT-qPCR data. 
With regards to the precise molecular mechanism of the LINE-1 insertion, the 
RNAseq data supports evidence for the introduction of multiple splice acceptors in 
the presence of the LINE-1. All resulting alternative isoforms identified here are 
predicted to introduce a premature stop codon after exon 8 of the canonical 13 exon 
SMOC2 transcript. The resulting hypothesis is that through nonsense-mediated 
decay, these alternative transcripts are targeted and degraded giving a reduced total 
SMOC2 count. No transcripts truncated at exon 8 were identified – all isoforms 
extended into different positions of intron 8 and the LINE-1 suggesting that a 
premature polyadenylation and transcription termination is less-likely to be the 
cause of loss of SMOC2 expression. Finally, through the identification of a silent C/T 




ancestral SMOC2 allele (without LINE-1) can either have the silent C or T variant whilst 
every instance of the derived SMOC2 allele (with LINE-1) has the T-variant in exon 8, 
suggestive that the exonic variant predates the introduction of the LINE-1 into the 
region. Through the comparison of the total transcript counts in individuals 
heterozygous for the silent C/T variant, the allelic contribution in the presence and 
absence of the LINE-1 insertion could be inferred. Absolute transcript counts were 
not reported, instead a ratio between alleles which indicates that SMOC2 
ancestral:derived (without LINE-1:with) allelic contributions are approximately 
75:25. 
Whilst it’s believed that the targeted degradation of transcripts is their most 
plausible fate, it remains unclear as to whether the alternative transcripts may 
contribute to a mature protein. If a protein product is created it would be predict to 
terminate partway through the thyroglobulin-like domain and lack its extracellular 
calcium-binding domain (Vannahme et al. 2003). The function of this potentially 
truncated thyroglobulin domain is unclear however the extracellular calcium binding 
domain has been shown to be active in mice and to instigate a conformational change 
of the protein when bound to a calcium ion (Vannahme et al. 2003). The absence of 
this domain would undoubtedly have an effect on the hypothetical protein product 
function, although the precise nature of which is unclear. This function may act in a 
dominant negative fashion but further experimentation would be needed to assess 
this. 
In leveraging the diverse craniofacial form of dogs, SMOC2 and its associated 
LINE-1 element are believed to dictate the brachycephalic phenotype. Hopefully, this 
information can be selectively used to further explore craniofacial anomalies and 
associated diseases in both dogs and humans. 
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Chapter 6: Characterisation of Upper Airway Syndrome in 
Norwich Terriers 
6.1 Introduction 
In the previous chapter, the brachycephaly-associated LINE-1 in SMOC2 was 
characterised in an attempt to understand more about the contributors to 
craniofacial variation in the dog. The confounding effects of the brachycephalic skull 
shape have long been considered the major predisposing factor to BOAS however 
heterogeneity in disease presentation both across and within breeds suggest that 
other factors may also be involved. To assist in deciphering disease aetiology, the 
Norwich Terrier became of interest.  
The Norwich Terrier is not considered to have a classically brachycephalic skull 
shape and yet it presents with Upper Airway Syndrome (UAS), a disease which has 
many of the same hallmarks as BOAS. These hallmarks include an elongated and 
thickened soft palate, everted laryngeal saccules and oedema of the upper airways 
(Koch et al. 2003; Torrez and Hunt 2006; Dietschi et al. 2010; White 2011; Johnson et 
al. 2013). In this chapter, the cause of UAS in the Norwich Terrier has been 
determined which has important ramifications for the management of the condition 
in Norwich Terrier as well as providing new perceptions for BOAS susceptibility in 
brachycephalic breeds.  
All work contained within Section 6.2 is a word-for-word copy of a manuscript 
recently submitted to the journal, PLoS Genetics (submitted: 23 July 2018). All 
analyses described were performed by Thomas Marchant with the exception of 
performing and grading endoscopic examinations (Dr Elisabeth Dietschi, Dr Ulrich 
Rytz and Dr Peter Schawalder), extraction of DNA and assistance with Sanger 
sequencing (Sheida Hadji Rasouliha). The manuscript was prepared by Thomas 
Marchant with contributions from Dr Jeffrey Schoenebeck, Dr Dylan Clements and 
Prof Tosso Leeb. All figures were generated by Thomas Marchant. Affiliations of all 
contributors are given in the manuscript. All supplementary materials for the 
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submitted manuscript have been added in Appendix 1. All references cited in this 
manuscript are listed in Section 6.2.9 using the journal’s Vancouver style. Additional 
methods, results and discussions that were not included in the manuscript have been 
written specifically for this thesis and have been added in Sections 6.3 and 4.4. 
6.2 Submitted Manuscript 
6.2.1 Title Page 
An ADAMTS3 Missense Variant is Associated with Norwich Terrier Upper Airway 
Syndrome 
Thomas W. Marchant1, Elisabeth Dietschi2, Ulrich Rytz3, Peter Schawalder3, Sheida 
Hadji Rasouliha2, Ronan S. Harrington1, Michaela Drögemüller2, Jeffrey Kidd4, Elaine 
A. Ostrander5, Amanda Warr1, Mick Watson1, David Argyle1, Gert Ter Haar6†, Dylan 
N. Clements1, Tosso Leeb2 & Jeffrey J. Schoenebeck1* 
1. The Roslin Institute and Royal (Dick) School for Veterinary Studies, University of 
Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK. 
2. Institute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland. 
3. Department of Clinical Veterinary Medicine, Division of Small Animal Surgery, 
Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland. 
4. Department of Human Genetics, University of Michigan Medical School, Ann 
Arbor, Michigan 48109, USA. 
5. Cancer Genetics and Comparative Genomics Branch, National Human Genome 
Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. 
6. Department of Clinical Sciences and Services, Royal Veterinary College, 
Hertfordshire AL9 7TA, UK 
 
†GTH current contact details: Specialistische Dierenkliniek Utrecht, Middenwetering 
19, Utrecht, 3543 AR, NE 




In flat-faced dog breeds, air resistance caused by skull conformation is believed 
to be a major determinant of brachycephalic obstructive airway syndrome. The 
clinical presentation of BOAS is heterogeneous, suggesting determinants 
independent of skull conformation contribute to airway disease. Norwich Terriers, a 
mesaticephalic breed, are predisposed to Upper Airway Syndrome (UAS), a disease 
whose pathological features overlap with BOAS. Our health screening clinic examined 
and scored the airways of 401 Norwich terriers by laryngoscopy. Genome-wide 
association analyses of UAS-related pathologies revealed a genetic association on 
canine chromosome 13 (rs9043975, p=7.79x10-16). Whole genome resequencing was 
used to identify causal variant(s) within a 414 kb critical interval. This approach 
highlighted an error in the CanFam3.1 dog assembly, which when resolved, led to the 
discovery of a c.2786G>A missense variant in exon 20 of the positional candidate 
gene, a disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAMTS3). 
In addition to segregating with UAS amongst Norwich Terriers, the ADAMTS3 
c.2786G>A risk allele frequency was enriched among the BOAS-susceptible French 
and (English) Bulldogs. Previous studies indicate that ADAMTS3 loss of function 
results in lymphoedema. Our results suggest a new paradigm in the understanding of 
canine upper airway disease aetiology: airway oedema caused by disruption of 
ADAMTS3 predisposes dogs to respiratory obstruction. These findings will enhance 
breeding practices and could refine the prognostics of surgical interventions that are 
often used to treat airway obstruction. 
6.2.3 Author Summary 
Respiratory diseases are prevalent across the dog, particularly in 
brachycephalic breeds such as the Bulldog and French bulldog. The flat facial 
conformation of these breeds have long been assumed to be the major predisposing 
factor however the underlying genetics of their respiratory condition has never been 
elucidated. Here, we became interested in the Norwich terrier, a breed presenting 
with many of the same respiratory disease symptoms as the Bulldog. A distinction, 
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however, is that the Norwich terrier is not considered to be a brachycephalic breed 
and so presented an opportunity to disseminate respiratory disease from head 
conformation. We performed a genome-wide association analysis for respiratory 
disease severity in the Norwich terrier and resolved an association on chromosome 
13 to a missense mutation in ADAMTS3. Variation in this gene have been previously 
shown to cause an oedematous phenotype – a disease characteristic in the airways 
of Norwich terriers and brachycephalic dogs alike. We screened over 100 breeds for 
the ADAMTS3 variant and found it to be enriched in the Norwich terrier, Bulldog and 
French bulldog. This discovery changes how we view respiratory disease 
predisposition in the dog, offers potential genetic screens and highlights a new 
biological function for ADAMTS3.  
6.2.4 Introduction 
Among dogs, brachycephaly describes the head conformation of many popular 
breeds including the Bulldog, French Bulldog and Pug. This trait is grossly 
characterised by the concurrent rostrocaudal shortening and mediolateral widening 
of the skull and is accompanied by skin folds of the face. The structural discordance 
between the reduced facial skeleton and its overlying soft tissues such as the 
wrinkled skin folds underpins these breeds’ iconic looks, but these artificially selected 
aesthetics are under increasing scrutiny for their association with health problems 
including breathing difficulties. 
It is thought that soft tissues of the upper respiratory tract such as the nostrils, 
nasal turbinates and soft palate do not scale proportionately with reductions in the 
midface skeleton [1]. Misconfiguration of respiratory soft tissue restricts airflow and 
increases negative pressure within the airway [1,2]. This predisposes brachycephalic 
dogs to Brachycephalic Obstructive Airway Syndrome (BOAS). Dogs diagnosed with 
BOAS can have stenotic nares, elongated soft palates and oversized, caudally 
protruding nasal turbinates [2-7]. Airway resistance caused by these soft tissue 
anomalies is believed to induce pathological remodelling of additional tissues 
including tonsil and laryngeal saccule eversion, oedema of the nasopharynx, 
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laryngeal collapse, tracheal hypoplasia and exacerbation of the thickening and 
elongation of the soft palate [2,8,9]. Collectively, these perturbations severely impact 
the wellbeing of affected individuals by increasing their respiratory effort, resulting 
in laboured breathing, intolerance to heat/exercise, cyanosis and collapse [6,7]. 
The clinical assessment of the respiratory obstruction is often based on the 
grading of clinical symptoms, diagnostic imaging, and more recently, whole-body 
barometric plethysmography [6,10,11]. Treatment options for BOAS include anti-
inflammatory medication which can reduce swelling/oedema acutely, however 
corrective surgery is often required to alleviate the condition [12]. Rhinoplasty of the 
nares, excision of the caudal aspect of the soft palate and aberrant turbinates, 
removal of the laryngeal saccules and tonsillectomy are the most common surgical 
procedures, which generally have mixed prognoses [2,3,6,12-14]. The number of 
patients requiring surgical treatment is expected to rise notably with the rapid 
increase in popularity of brachycephalic breeds. The costs and morbidity of surgical 
treatment are a welfare concern for both owners and their dogs, with complications 
reported in up to 25% and mortality in as many as 5% of cases treated surgically [14]. 
We and others have studied the underlying genetics of canine skull shape 
variation [15-19]. Variants in the BMP3 and SMOC2 genes are associated with canine 
brachycephaly, however the contribution of these variants to BOAS pathogenesis is 
unclear. Moreover, variants in both of these genes appear largely fixed among 
brachycephalic breeds that are at greatest risk of developing BOAS and yet the 
incidence and severity of BOAS differs between them [11,20]. BOAS heterogeneity 
may also be influenced by environmental and epigenetic factors, as well as other 
genetic modifiers segregating among dog populations. Under this premise, we 
became interested in the presentation of a respiratory condition remarkably similar 
to BOAS which has been identified in Norwich Terriers. 
As their name suggests, Norwich Terriers originate from south eastern UK 
where they were used for rodent control. Today, Norwich Terriers are recognised by 
all major kennel clubs and are known for their short, stocky build and prick ears. 
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Dietschi et al. first described the presentation of Upper Airway Syndrome (UAS) in 
the Norwich Terrier. Although they are not considered a brachycephalic breed, 
affected Norwich Terriers present many of the hallmarks of BOAS including elongated 
and thickened soft palates, oedema of the nasopharynx and everted laryngeal 
saccules [21,22]. The closely related Norfolk Terrier, a breed that officially split from 
the Norwich Terrier in 1964, is seemingly unaffected by UAS, suggesting genetic 
predisposition in the Norwich Terriers  
Moreover, anecdotes from breeders regarding more recent dog generations, 
suggested that some Norwich Terriers appeared shorter-faced than those from 
earlier generations (personal communication to JS). Indeed, Koch et al. postulated 
that selective breeding is driving Norwich Terriers to become brachycephalic [9]. 
Spurred on by these observations, and the possibility of uncovering genetic modifiers 
that increase respiratory obstruction risk, we sought to understand the genetic basis 
of Norwich Terrier UAS. 
6.2.5 Methods 
6.2.5.1 Participants and Upper Airway Assessment 
All animal experiments were performed according to the local regulations. The 
dogs in this study were examined with the consent of their owners. The study was 
approved by the “Cantonal Committee for Animal Experiments” (Canton of Bern; 
permits 22/07, 23/10, and 75/16) and the R(D)SVS Veterinary Ethical Review 
Committee (20 16, University of Edinburgh). A full description of the upper 
assessment was described previously [22]. In short, the upper respiratory tracts of 
401 Norwich Terriers and 12 Norfolk Terriers were assessed in situ during endoscopic 
examination and scored retrospectively from video footage. All evaluations were 
conducted by a single veterinary surgeon. Subsequently, each of the ten phenotypic 
components of the airway (soft palate length, soft plate thickness, laryngeal saccule, 
cartilage shape, cartilage stability, cartilage position, oedema of the oropharynx, 
oedema of the pharynx, oedema of the cricoid mucosa and shape of the trachea) 
were scored on a range from 1 to 4 representing ‘normal’, ‘mild’, ‘moderate’ and 
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‘severe’ respectively by authors PS, ED and UR. A custom R script was used to 
generate Pearson’s correlation and dendrogram. Individual phenotype scores were 
weighted and summed to give the total airway score. 
Two-hundred and thirty-three Norwich Terriers (109 male, 124 female) 
representing the extremes of upper airway phenotypes formed the study cohort. 
Participants varied in age from 7 to 188 months (median = 18 months). 
6.2.5.2 Skull Shape Assessment 
The geometric morphometric analysis of 3D skull reconstructions generated 
from computer tomography scans have been described previously [18]. Linear 
measurements of the hard palate were made, and the influence of allometry 
regressed using the neurocranium centroid size. Principal component analysis of the 
viscerocranium of 565 dogs representing 96 UK Kennel Club registered breeds 
permitted the comparison of face shapes.  
6.2.5.3 Genotyping and Genomic Analysis 
Whole blood samples were taken and stored in EDTA at 4 °C prior to gDNA 
extraction following the whole blood protocol of the Nucelon BACC Genomic DNA 
Extraction Kit (RPN-8502, GE Healthcare Life Sciences). Genotypes were generated 
using the Illumina 170,000 SNV CanineHD bead chip by Edinburgh Genomics, UK and 
mapped to the CanFam3.1 coordinates.  
SNVs with minor allele frequencies < 0.05 and individuals with missingness > 
0.1 were removed using PLINK (v1. 90) [52]. Genotypes were imputed using a two-
step process that included pre-phasing by SHAPEIT [53] and imputation by IMPUTE2 
[54]. A total of 105,130 SNVs were used by GEMMA (v0.94.1) in a univariate linear 
mixed model to perform genome-wide association analyses [55]. A kinship matrix 
was implemented during the analysis with age and sex used as covariates. A 
Bonferroni correction threshold was used to determine statistically significant SNVs 
(-log10 [0.05/105,130] = 6.32). The linkage disequilibrium of significant SNVs with all 
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other markers in a 50 variant window was calculated using the independent pairwise 
test in PLINK (v1.90).  
Phased haplotypes encompassing the index SNV (TIGRP2P185081_rs9043975) 
at chr13: 61,255,943 were ordered by the UAS severity. The order was dictated by 
the four phenotypes returning significantly associated index SNVs (laryngeal saccule 
> cartilage position > oedema of the cricoid mucosa > oedema of the oropharynx) 
such that dogs with the most severe grade of all four phenotypes were positioned at 
the top. A consensus risk haplotype was the most frequent haplotype within the most 
severe scoring dogs, appearing in 98 of 162 chromosomes from severely affected 
dogs. Risk alleles were coloured based on whether they matched this consensus 
haplotype. The critical interval boundaries were defined by three or more meiotic 
recombination events across the severely affected Norwich Terriers.  
6.2.5.4 Sequencing and Variant Analysis 
Four Norwich Terriers representing upper airway phenotypic extremes were 
whole genome sequenced to an average coverage of 15.9x. Two Norwich Terriers 
were homozygous for the disease-associated haplotype with one severely affected 
and the second apparently unaffected. The remaining two dogs did not have the 
disease-associated haplotype and were unaffected. DNA libraries were prepared 
using the TruSeq DNA PCR-free Library Preparation Kit. The Illumina HiSeq 2500 
system sequenced 125 bp paired-end libraries with and average insert size of 419 bp. 
Reads from each resequenced Norwich Terrier were aligned to CanFam3.1 assembly 
using BWA-MEM [56] and variants within the critical interval chr13:61,166,179 - 
61,579,985 were called for the CanFam3.1 and Zoey2.3 assembly using Platypus 
(v0.8.1) [57]. Two Norwich Terriers homozygous for the disease-associated haplotype 
with differing phenotypes were selected with the potential of discovering the 
ancestral haplotype prior to the introduction of the causal variant(s). To this end, for 
positions that had calls for all four Norwich Terriers, filtering criteria required 
variant(s) to be homozygous and exclusive to the affected dog however this returned 
no variants. We hypothesised that the unaffected dog homozygous for the disease-
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associated haplotype was still subclinical due to the age of scoping at 1.2 years. 
Subsequently, filtering criteria required variants to be homozygous derived in the 
disease-haplotype carrying dogs and homozygous ancestral in those not carrying it. 
 Norwich Terrier DNA and CanFam3.1-aligned RNAseq reads were viewed in 
IGV [58] which revealed an error in the reference sequence [18]. To resolve this error, 
we compared the local assembly of a Great Dane produced from PacBio long reads 
(unpublished data, author JK). In addition, we generated a de novo assembly from 
three bacterial artificial chromosomes (BACs) originally used for the CanFam3.1 
assembly. BACs spanning the critical interval were sourced from the BACPAC 
Resource Center, Children’s Hospital Oakland Research Institute, California, USA 
(CH82-24F19, CH82-379O18 and CH82-101M10). Following BAC isolation 
(PhasePrep™ DNA Kit, Sigma-Aldrich, NA0100), a DNA library was prepared from an 
equimolar mix of the three BACs for a single 1D barcode-free gDNA sequencing run 
using the Oxford Nanopore Technologies MinION platform (SQK-LSK109, R9.4). A 
pipeline including Albacore (v2.0.1), Canu (v1.5) and Nanopolish (v0.8.4) was used to 
base call, construct contigs and improve consensus sequence respectively. The 
consensus sequences of both long-read platforms were in agreement and resolved 
the error underlying exon 20 of ADAMTS3, though neither platform’s base calling 
resolved a ~40 bp intronic stretch of G's downstream of exon 20. 
Norwich Terrier short-read and RNAseq data from a previous study (European 
Nucleotide Archive study accession PRJEB17926) were realigned to the new 
consensus using BWA-MEM and STAR (V2.5.1) respectively with default parameters 
[18,59]. The RNAseq data was used solely to confirm exonic structure whilst the 
DNAseq data was used to repeat variant calling as previously described.  
Protein sequences of ADAMTS3 homologs (HGNC:219) across species were 
downloaded from Ensembl and aligned using a ClustalW multiple alignment [60]. A 
low quality canine ADAMTS3 transcript (XP_539311) was identified however its 
predicted amino acid sequence surrounding the exon 20 missense variant was 
substantially different from any other species – likely due to 133 bp of exon 20 
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missing from the CanFam3.1 assembly. To this end, the predicted amino acid 
sequence for the Norwich Terrier was created using comparative RNAseq alignment 
from 9 dogs, representing 8 breeds which were in full agreement for exon structure 
[18]. Residue positions are relative to the start codon. The thrombospondin-like 
domain (PS50092) was predicted using PROSITE database of protein domains [61]. 
To genotype the ADAMTS3:c.2786G>A variant, forward 
(ACACACGAACCCAGGCACAC) and reverse (GGCCTGGGAGCACTGCAC) primers were 
designed to amplify the region. PCR products were Sanger sequenced by Edinburgh 
Genomics, UK. All breeds used for genotyping were owner-reported. 
6.2.6 Results 
6.2.6.1 Distinct Skull Morphology 
There is a remarkable overlap in the clinical presentations of respiratory tract 
disorders across several breeds including the Bulldog, French Bulldog, Pug, Shih Tzu 
and Norwich Terrier. Despite this, the Norwich Terrier is not considered to be a 
brachycephalic breed and is morphologically distinct from the other aforementioned 
Figure 6.1 - Morphology and Respiratory Distress. (A) Standardised measurements of the canine 
hard palate infer an intermediate rostrum shape for the Norwich and Norfolk Terriers between the 
extreme brachycephalic (Pug) and dolichocephalic (Smooth Collie). Mann-Whitney-Wilcoxon and 
Kolmogorov-Smirnov tests <0.05 *; <0.01 **; <0.001 ***. (B) Geometric morphometric analysis of 
96 domestic dog breeds reveals that the Norwich and Norfolk Terriers occupy a distinct 
morphospace from the brachycephalic breeds, such as the Pug that are susceptible to BOAS. Size is 




breeds. Linear measurements of the Norwich Terrier hard palate revealed 
intermediate palate dimensions between the extremes of facial morphology 
represented by the brachycephalic Pug and dolichocephalic Collie (Figure 6.1A). 
Furthermore, geometric morphometric analysis of the canine rostrum revealed that 
the Norwich Terrier occupies a morphospace distinct from classic brachycephalic 
breeds such as the Pug (Figure 6.1B). For both linear measurements and geometric 
morphometrics, our data do not indicate a gross morphological difference between 
the Norwich and Norfolk Terrier. 
6.2.6.2 Norwich Terrier Upper Airway Assessment 
In 2000, an upper airway screening programme for Norwich Terriers was 
established at the Vetsuisse Faculty of the University of Bern in Switzerland. The 
programme uses laryngoscopic videos to score ten components of the airway which 
are combined to give an overall grade of the condition [22]. To date, 401 Norwich 
Terriers in addition to 12 Norfolk Terriers were screened. Two-thirds (65.8%) of 
Norwich Terriers had clinical presentations of UAS ranging from ‘mild’ to ‘severe’ 
whilst all Norfolk Terriers were unaffected (Figure 6.2A). We selected 233 Norwich 
Terriers (109 male, 124 female) representing phenotypic extremes of the phenotypic 
distribution for our study (Figure 6.2B). Everted laryngeal saccules (81, 35%) and 
elongated soft palates (33, 14%) were the most common severely-graded phenotype 
and were only graded as normal in 11 (5%) and 43 (19%) dogs respectively (Table 
6.1). Meanwhile, cartilage stability (125, 54%) and trachea shape (112, 48%) were the 
most common normal-graded phenotypes. All unique phenotype pairings display a 
positive Pearson’s correlation coefficient (range: 0.018 to 0.720, median: 0.344) with 
the exception of the cartilage shape and oedema of the pharynx phenotypes (r = -
0.116) (Supplementary Figure 1). Cartilage position and cartilage stability had the 
highest correlation of any phenotype pair (r = 0.720).  
Between 2003 and 2007, The Swiss Terrier Club discouraged breeding dogs 
exceeding a ‘moderate’ upper airway phenotype. From 2007 onwards, upper airway  
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screening was mandatory for all breeding pairs in Switzerland. As a testament to the 
coordinated efforts between veterinarians and breeders, the Swiss screening 
programme observed a reduction in the number of severely affected Norwich 
Terriers from 44.0% of those born between 1988-1997 to 8.6% for those born in 
2006-2014 (Figure 6.2C). The success of the screening programme underscores the 
heritability of UAS and suggests that the disease indeed segregates within this 
population. With cases of UAS reported across continents, the need to develop 
portable, cost-effective screening strategies became imperative. In order to further 
reduce the disease prevalence across the Norwich Terrier population and to provide 
insights into the pathophysiology of respiratory diseases that affect the upper 
airways of dogs, we sought to establish the genetic underpinnings of the condition.   
Table 6.1 Norwich Terrier Phenotype Scores. Each upper airway phenotype is graded as ‘normal’, 
‘mild’, ‘moderate’ or ‘severe’ following the assessment of endoscopy videos. Two-hundred and 
thirty-three Norwich Terriers were assessed with counts for each phenotype and severity grading 
(percentage across phenotype). 
Upper Airway Phenotype Normal Mild Moderate Severe 





























































































6.2.6.3 Genome-wide Association Analysis 
Genome-wide association analyses (GWAS) were performed for each of the ten 
upper airway phenotypes. Four phenotypes including eversion of the laryngeal 
saccule, oedema of the cricoid mucosa, oedema of the oropharynx and cartilage 
position returned markers with genome-wide significance (Figure 6.3A, 
Supplementary Figure 2). The threshold for genome-wide significance was 
established by Bonferroni correction (-log10 [0.05/105,130] = 6.32). Regardless of 
phenotype, all association tests highlighted the same ~2.9 Mb quantitative trait locus 
(QTL) spanning 58,941,974 – 61,830,084 bp on canine chromosome (CFA) 13 with an 
index marker (TIGRP2P185081_rs9043975) at chr13:61,255,943 (Figure 6.3B, 
Supplementary Table 6.1). Markers within this broad QTL display high levels of 
linkage disequilibrium (r2 > 0 .2). Due to the modest correlation between individual 
traits (Supplementary Figure 1), many markers (35/57) are significantly associated 
with at least two phenotypes (Supplementary Table 1). Principal components analysis 
of genotypes did not reveal phenotype-related substructure within the study cohort,  
 
Figure 6.2 - Upper Airway Syndrome across Norwich Terriers. (A) All Norfolk Terrier upper airway 
scores were considered clear (n=12), whilst 277 Norwich Terriers (n=416) were diagnosed with 
clinical Upper Airway Syndrome. (B) Two-hundred and thirty-three Norwich Terriers representing 
the extremes of those screened made up the study cohort. (C) Breeding recommendations based on 






Figure 6.3 - Refinement of CFA13 Critical Interval. (A) The CFA13 QTL was identified across four upper 
airway phenotypes including laryngeal saccule score. (B) Marker associations for all phenotypes 
which returned at least one association surpassing the Bonferroni correction threshold (4.75 x 10-7) 
are overlaid. Point shapes represent phenotypes whilst colour indicates the degree of linkage 
disequilibrium (r2) with significant markers. (C) Genotypes were phased for individual Norwich 
Terriers (horizontal bars) and ordered by the upper airway phenotypes. Only severely affected dogs 
are shown. Alleles are coloured white, orange and red for homozygous consensus for the risk allele, 
heterozygous and homozygous alternate alleles, respectively. A 413.8 kb critical interval was 
defined by at least 3 meiotic recombination events. The index marker (chr13:61,255,943) is 
identified by an arrowhead.  The critical interval encompasses the ADAMTS3 gene.  
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adding confidence that the signal on CFA13 was truly associated with the disease 
(Supplementary Figure 3). 
6.2.6.4 Critical Interval Refinement 
Genotypes extending ~1 Mb in both directions from the genome-wide 
significant markers on CFA13 were phased. Individual dogs were ranked by their 
disease severity and critical interval boundaries were defined by three meiotic 
recombinations. This revealed a 413 kb haplotype spanning chr13:61,166,179 – 
61,579,985 to be shared across most severely affected Norwich Terriers (Figure 6.3C). 
The disease-associated haplotype was homozygous in 75.3% (61/81) of severely 
affected dogs whilst it was homozygous in just 18.4% (28/152) of moderately-to-
unaffected dogs (Supplementary Figure 4). This critical interval spans the entirety of 
the disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAMTS3) 
gene, in addition to ~114 kb and ~41 kb of sequence up and downstream of the gene, 
respectively. No other protein coding genes were annotated within the critical 
interval. 
6.2.6.5 Identifying Candidate Causal Variants 
To search for putative causal variants, we whole genome sequenced four 
Norwich Terriers representing the extremes of UAS phenotypes. This included two 
dogs that were homozygous for the CFA13 risk haplotype – one severely affected by 
UAS and the second seemingly unaffected. The remaining two dogs did not carry the 
CFA13 risk haplotype and were clinically unaffected. A total of 2,276 variants were 
called within the 413,806 bp critical interval and subsequently filtered (see Methods), 
however no variants (SNVs or indels) were compelling candidates for causality based 
on location and/or interspecies conservation (Table 6.2, Supplementary Table 2). 
Following visual inspection of the whole genome sequences alongside aligned 
RNAseq data from a previous study [18], we observed a gap in short-read coverage 
across all DNAseq and RNAseq datasets at exon 20 of ADAMTS3 suggesting an error 









Table 6.2 Variant Calling. Summary of the variants called across the four resequenced Norwich 
Terriers using Platypus within the critical intervals of the (A) CanFam3.1 and (B) newly created 
consensus sequence. Variants are filtered by the presence/absence of the risk haplotype. 
 
local assembly for the CFA13 critical interval using long-read sequencing (see 
Methods). DNA- and RNA-seq short reads were aligned to the new consensus 
sequence and revealed that exon 20 of ADAMTS3 extended an additional 133 bases 
beyond what was present in CanFam3.1 (Supplementary Figure 5B). Subsequent 
variant calling of the new 413,020 bp critical interval identified 1,834 variants. 
Variants were filtered based on allelic segregation between the disease-associated 
and alternate haplotypes, leaving a total of 80 single nucleotide variants (SNVs) and 
small indels. All remaining variants are in complete linkage disequilibrium (r2 = 1). 
Two of the remaining variants are exonic – a synonymous variant in exon 21 and a 
missense variant in the newly defined exon 20 (c.2786G>A) (Supplementary Table 2). 
The missense variant is predicted to change an amino acid of ADAMTS3 from an 
arginine to histidine, p.(Arg929His). This arginine is positioned within a 
thrombospondin-like domain and is invariable across mammalian species and close 
gene paralogs, suggesting evolutionary constraint (Figure 6.4). Accordingly, a 
substitution at this position is predicted to be “probably damaging” and “not 
tolerated” by PolyPhen-2 and SIFT, respectively [23,24]. 
6.2.6.6 Genotype-Phenotype Association 
We genotyped all Norwich and Norfolk Terriers screened in the study for the 
c.2789G>A variant and did not observe the allele among the Norfolk Terrier 
  CanFam3.1 New Consensus 
Interval (bp) 61,166,179 - 61,579,985 1,164,985 - 1,578,005 
Size (bp) 413,806 413,020 
Called 2,276 1,834 
Passed Filters 231 80 
Intronic 234 78 
Exonic 1 2 
Protein Changing 0 1 
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population (n=12), as expected since UAS was not diagnosed in dogs of this breed. 
However, the risk allele was homozygous in 132 (32.9%) and heterozygous in 195 
(48.6%) individuals from the Norwich Terrier cohort (n=401). Dogs homozygous for 
the c.2786G>A allele had a significantly greater total upper airway score than those 
heterozygous (p = 9.10 x 10-17) or homozygous (p = 3.08 x 10-20) for the ancestral allele 
(Figure 6.5A). Seventeen Norwich Terriers were seemingly unaffected by UAS, two of 
which were homozygous for the c.2786G>A risk allele and nine were heterozygous 
(Figure 6.5A). Of note, many of the unaffected Norwich Terriers were young (range 
11 to 39, median: 14 months old) at the time they were screened. In contrast, the 
ADAMTS3 genotype does not segregate with weight (Figure 6.5B). Interestingly, by 
applying the Swiss Norwich Terrier club breeding guidelines to all 401 screened 
Norwich Terriers, 74.1% of those prevented from breeding are homozygous for the 
variant, whereas only 22.0% of Norwich Terriers permitted to breed have this 
genotype (Figure 6.5C).  
Figure 6.4 - Amino Acid Conservation across Species. Predicted amino acid sequences of the 
thrombospondin-like domain of vertebrate homologs surrounding the p.R929H missense variant in 
ADAMTS3 (black arrow). Sequences are conserved across species at the position of the missense 





Over 1,300 dogs representing up to 114 diverse breeds including 
representatives of brachycephalic breeds diagnosed with BOAS were screened for 
the c.2789G>A variant (Supplementary Table 3). The disease allele frequency (AF) 
was observed in the Norwich Terrier (AF = 0.57, n = 401), Bulldog (AF = 0.85, n = 41), 
French Bulldog (AF = 0.12, n = 23), Staffordshire Bull Terrier (AF = 0.125, n = 8), 
German Spitz (Mittel) (AF = 0.06, n = 8) and Pomeranian (AF = 0.06, n = 8) suggesting 
the variant may influence BOAS in the French and English Bulldogs. The p.(Arg929His) 
allele frequency in the human Exome Aggregation Consortium (ExAC) is less than 
0.000017 [25]. 
6.2.7 Discussion 
The incidence of UAS amongst the Norwich Terrier population presented a 
unique opportunity to identify disease modifiers that may be shared across 
brachycephalic and non-brachycephalic breeds alike. Leveraging laryngoscopic 
phenotyping, we identified and refined a QTL to an interval that encompasses a single 
positional candidate gene, ADAMTS3. The ADAMTS proteins are a 19-member family 
of protease enzymes [26,27]. Due to the high sequence similarity, ADAMTS3 is 
Figure 6.5 - Genotype-Phenotype Correlation of the ADAMTS3:c.2786G>A Missense Variant. 
Distributions of (A) total airway scores and (n = 401) (B) weight (n = 250) for the ADAMTS3 
c.2786G>A allele across screened Norwich Terriers. Individuals are coloured by age quartile at the 
time of upper airway screening. (C) Under the Swiss Terrier Club guidelines, 78% of the Norwich 
Terriers screened would be permitted to breed whilst 22% would be prohibited. The ADAMTS3 




categorised in a distinct subgroup of procollagen N-proteinases with ADAMTS2 and -
14 [28-30]. ADAMTS3 is expressed in a variety of tissues including cartilage where it 
has a substrate specificity for procollagen type II, which it cleaves to stimulate the 
maturation into collagen II, the major isoform of cartilage [31-35]. In recent years it 
has become clear that in addition to its role as a procollagen II N-proteinase, 
ADAMTS3 also has an important signalling function. ADAMTS3 proteolytically 
activates vascular endothelial growth factor-C (VEGF-C), thereby regulating 
lymphangiogenesis [36,37]. Loss of this signalling function in humans causes 
Hennekam lymphangiectasia-lymphedema syndrome 3, a condition characterised by 
lymphedema and distinct facial features including hypertelorism and a flat nasal 
bridge [38,39]. This oedematous phenotype is reflected in two different Adamts3 
knockout mouse lines which were reported to have severe defects in lymphatic 
development [40-42]. Both knockout lines resulted in perinatal lethality with Ogino 
et al., reporting death was due to apparent breathing problems. Interestingly, this 
line also presented with abnormal rib development and significantly 
anteroposteriorly shortened skulls [40]. Whilst these studies did not specifically 
examine the tissues of the upper airways, the oedematous phenotype draws parallels 
with our observations in affected Norwich Terriers with skeletal changes possibly 
providing a cryptic selection pressure within the breed. Alternatively, the UAS 
phenotypes associated with ADAMTS3 c.2786G>A variant suggest that it predisposes 
dogs carrying the mutant allele to oedema of the upper airway. This may explain why 
morphologically diverse breeds (Bulldog and Norwich Terrier), which are predisposed 
to respiratory conditions, carry the ADAMTS3 929His allele. In particular, the oedema 
hypothesis explains why Norwich Terriers carrying the derived allele are at higher risk 
of developing UAS whilst not possessing the traditional brachycephalic phenotype 
which has long been assumed to be the primary predisposition to the disease. 
The missense variant reported here (c.2786G>A) could not be separated from 
a further seventy-nine SNVs and small indels during filtering due to the long-range 
linkage disequilibrium in the dog [43,44]. None of the additional intronic variants 
were compelling based on their position of cross-species conservation. Conversely, 
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arginine 929 in ADAMTS3 is highly conserved across orthologs and its close paralogs, 
ADAMTS2 and ADAMTS14, from diverse vertebrates. Arginine 929 is located in the 
third of four thrombospondin type 1 (TSP1) repeats within ADAMTS3. The TSP1 
repeats are thought to contribute to substrate binding and interactions with the 
extracellular matrix [45,46]. Although the variant site is outside the catalytically 
active metalloproteinase domain of ADAMTS3, the canine Arg929His substitution 
could theoretically alter substrate affinity and/or its modulation of downstream 
signalling pathways. The exact functional impact of the Arg929His substitution 
requires further investigation.  
Beyond primary lymphedema, associations have been made between 
ADAMTS3 and osteoarthritis, heart disease, cancer and schizophrenia in humans [47-
50]. A rare coding variant in exon 12 of ADAMTS3 was also associated with reduced 
human adult height [51]. Variation in height has also been observed in the dog, albeit 
with variants in a distant family member, ADAMTS17, which were associated with 
various eye diseases (Rickets et al., in press). We saw no correlation between the 
ADAMTS3:c.2786G>A genotype with body weight or height, for which only a subset 
of individuals had measurements available (data not shown). 
The ADAMTS3 929His allele associated with UAS in the Norwich Terrier was also 
detected in French and English Bulldogs diagnosed with BOAS suggesting ADAMTS3 
may be important for effective respiratory function. Our data might suggest that UAS 
pathogenesis occurs later in life, however such speculation needs to be tested in a 
longitudinal study.  Longitudinal studies could also assess possible correlations 
between the risk allele and complications during corrective upper airway surgery, 
where oedema of the upper airway can predispose to a respiratory crisis, or post-
operative prognosis in dogs.  
Identification of the ADAMTS3 929His allele association with UAS in Norwich 
Terriers is critically important to help explain the mechanism of a common disease 
process which is poorly understood, providing a diagnostic marker to identify 
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6.3 Supporting Information 
6.3.1 Methods 
Within this submitted manuscript, the experimental materials and methods 
were streamlined to be in keeping with the style required by the journal. Here is an 
extended description for procedures and additional results that were not included in 
the manuscript. 
6.3.1.1 Participants  
All animal experiments were performed according to local regulations. The 
dogs recruited at The University of Bern which included the Norwich and Norfolk 
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Terriers were approved by the “Cantonal Committee for Animal Experiments” 
(Canton of Bern; permits 22/07, 23/10, and 75/16). Dogs recruited from the 
University of Edinburgh were approved by the R(D)SVS Veterinary Ethical Review 
Committee (20 16, University of Edinburgh). All dogs in this study were examined 
with the consent of their owners.  
As part of the ethical approval, this study identified archived records of patients 
that had visited The Hospital for Small Animals, The University of Edinburgh, and 
received a BOAS diagnosis but had not been invited to join this study. To identify 
suitable candidates for recruitment, records were searched in the Tristan Veterinary 
Practice Management software (v1.8.3.914, Orion Engineering Services). The 
‘Research’ tab of the Tristan software was used to find patients diagnosed with BOAS. 
Search parameters included ‘Dogs’ of any breed or sex that had attended the HfSA 
since January 2008 that are thought to be alive (‘Alive only’) and had the term ‘BOAS’ 
in their appointment notes. A candidate list of dogs from the two searches were 
provided to Professor Richard Mellanby and Susan Campbell who made contact with 
owners directly. A PERFORMAgene™ saliva swab with instruction for its use, a 
consent form, a prepaid return envelope and a short summary of the project aims 
were sent to owners who were willing to be involved.  
6.3.1.2 Bacterial Artificial Chromosome (BAC) Isolation 
In order to generate a new reference sequence for the CFA13 critical interval, 
the critical interval coordinates (chr13:61,166,179-61,579,985) were entered into the 
University of California Santa Cruz (UCSC) online Genome Browser Gateway 
(https://genome.ucsc.edu/cgi-bin/hgGateway). Using the “In Other Genomes 
(Convert)” tool under the “View” menu of the genome browser, the critical interval 
was converted from the Sep. 2011 (Broad CanFam3.1/canFam3) coordinates to May 
2005 (Broad/canFam2) coordinates. Under the browser control parameters, “BAC 
End Pairs” were displayed in full from the drop down menu for the CanFam2 critical 
interval (chr13:64,104,713-64,517,949). BACs were selected that would overlap one 
another and extend beyond the boundaries of the critical interval to ensure that all 
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sequences within the region could be captured by at least one BAC once they are 
tiled together. In total, three overlapping BACs (IDs: CH82-2F19, CH82-379O18, 
CH82-101M10) were selected and ordered from the BACPAC Resource Center based 
at the Children’s Hospital Oakland Research Institute 
(https://bacpacresources.org/home.htm). Three LB agar stab cultures of DH10B 
E.coli containing each BAC clone were received.  
A 25 mg/ml stock of chloramphenicol (Corning, 56-75-7) was prepared by 
adding 40 mL deionised water to the dried powder provided by Corning. LB agar 
plates containing 12.5 µg/mL chloramphenicol were prepared by melting 500 mL LB 
agar in a microwave for 5 minutes and adding 250 µL 25 mg/mL stock 
chloramphenicol. The melted chloramphenicol LB agar was poured into the base of 
petri dishes (101R20, Thermoscientific) to cover the bottom of the dish (~20 mL). 
Once the plates were set, they were inverted to prevent condensation forming on 
the surface of the agar. Plates were sealed in ParafilmÒ (P7793-1EA, Sigma-Aldrich) 
and stored at 4 °C until use. A liquid broth containing a final concentration of 12.5 
µg/mL chloramphenicol was prepared.  
A pipette tip was used to inoculate the BAC stab cultures on to the 
chloramphenicol LB plates before the plates were incubated overnight at 37 °C 
(economy incubator size 2, Gallenkamp). Isolated colonies were picked from the 
plates using a pipette tip and dropped into a 15 mL Falcon™ tube containing 5 mL 
liquid LB (12.5 µg/mL chloramphenicol) and incubated in a shaking incubator (Innova 
4000, New Brunswick Scientific) at 37 °C for 8 hours at 300 rpm. This starter culture 
was added to 1 L capped conical flasks containing 200 mL liquid LB (12.5 µg/mL 
chloramphenicol) and incubated for 16 hours at 37 °C at 300 rpm in a chest incubator 
(Innova 4330, New Brunswick Scientific). In order to isolate the BAC clones from the 
cultures were followed the midi-scale preparation protocol for the PhasePrep™ BAC 
DNA Kit (Sigma-Aldrich, NA0100). The midi-preparation protocol does not perform 
optimally beyond a cell mass of 1,000. To ensure each culture containing BAC clones 
did not exceed this, a fluorimeter was used to calculate absorbance.  
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To operate the Ultrospec fluorimeter (2100, Amersham Biosciences), 5 mL of 
each liquid culture were added to fluorimeter vials (FB55147, FisherBrand) in 
addition to a control vial containing the stock liquid LB that hadn’t been cultured. The 
control vial was placed in position 1 of the fluorimeter and samples placed in 
subsequent slots ensuring that the clear transparent side of the vials were placed in 
parallel to the light source. The fluorimeter lid was closed and the device was turned 
on. Absorbance settings were selected. And the OD600 readouts were recorded. The 
cell mass was calculated for each sample by multiplying the OD600 absorbance by the 
total culture volume (200 mL) (Table 6.3).  
To isolate the BACs from cultures, each 200 mL midi-culture was split into four 
50 mL Falcon™ tubes and pelleted in a centrifuge at 4,000 G for 15 minutes. Each 
pellet was resuspended in 3 mL RNase A/Resuspension Solution from the 
PhasePrep™ BAC DNA Kit and transferred to a clean 50 mL Falcon™ tube. Cells were 
lysed by adding 12 mL Lysis Solution, inverting five times and incubating at room 
temperature for a maximum of 5 minutes. The cell lysis reaction was neutralized with 
12 mL chilled Neutralization Solution and inverting ten times before being incubated 
on ice for 10 minutes. The cell debris was pelleted by centrifuging at 15,000 G for 30 
minutes at 4 °C. The clear BAC-containing supernatant was transferred to a fresh 50 
mL Falcon™ tube using large orifice pipette tips (LW4040, PastetteÒ). The 
supernatant was mixed with 22 mL room temperature isopropanol and gentle mixed 











1.762 352.4 156.3 1.71 1.31 133 
BAC2 
(CH82-379O18) 




1.748 349.6 211.8 1.73 1.45 138 
Table 6.3 – BAC Isolation. A fluorimeter was used to quantify the absorbance (OD600) of each BAC-
containing culture and used to predict their cell mass. Once the BACs were isolated, the NanoDrop 
and Qubit devices were used to calculate BAC concentrations and infer DNA quality.  
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by inversion before centrifuging at 15,000 G for 20 minutes at 4 °C. The supernatant 
was carefully discarded before the pellet was washed for 5 minutes with 10 mL room 
temperature 70% ethanol and centrifuged at 15,000 G for 5 minutes at 4 °C. The 
supernatant was removed and the pellet was allowed to air dry for 5 minutes. The 
pellet was resuspended by gently swirling with 5 mL Elution Solution. Any residual 
RNA was  
degraded by adding 5 µL RNase Cocktail and incubating at 60 °C for 15 minutes. The 
salt content was adjusted by adding 400 µL Sodium Acetate Buffer Solution and 
mixing gently. Impurities and endotoxins were removed by mixing with 0.9 mL 
Endotoxin Removal Solution for 30 seconds before being incubated on ice for 15 
minutes. The tube was incubated in a 37 °C water bath for 5 minutes before 
centrifuging at 4,000 G for 5 minutes at room temperature. The clear upper purified 
BAC-containing phase was transferred to a fresh 15 mL Falcon™ tube containing 5.4 
mL room temperature DNA Precipitation Solution. The sample was mixed thoroughly 
by inversion before centrifuging at 15,000 G for 30 minutes at 4 °C. The supernatant 
was removed and the pellet was washed with 5 mL room temperature 70 % ethanol 
before collecting at the bottom of the tube by centrifuging briefly. The supernatant 
was removed and the pellet was washed and centrifuged again with 2 mL 70 % 
ethanol for 2 minutes. All ethanol was removed with a pipette and the pellet was 
allowed to air dry for 10 minutes. BAC clones were resuspended in 40 µL deionized 
water and stored at 4 °C until later use. 
6.3.1.3 BAC Quantification and Confirmation 
A NanoDrop 1000 was used to estimate the concentration of BAC clones in 
samples and to assess their quality/purity (see Section 2.4.1). The Qubit™ dsDNA 
broad range quantification kit was used to confirm BAC clone concentrations 
following the protocol outlined previously (see 2.4.2). Results of the BAC 
quantification are listed in Table 6.1. 
In order to confirm the correct BAC clone was received/isolated, primer pairs 
were designed to amplify small ~100 bp fragments unique to the 5’ and 3’ ends of 
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the insert for each BAC clone. Within the CanFam2 critical interval of the UCSC online 
Genome Browser Gateway, the BAC of interest was selected from the genome 
browser window. In the “Genomic Alignment of Early Replication Cosmid Ends” 
section, links were given to sequences of the 5’ and 3’ ends of the BAC inserts. These 
sequences were copied to the Primer3 online primer design toolkit as previously 
described (see Section 2.5.4). All parameters were kept as previously described with 
the exception of the “Product Size Ranges” which was modified to 80-120 bp. Primer 
pairs were BAC-specific and were predicted to generate amplicons of known sizes 
between 80 and 120 bp. A standard thermocycler programme was used for all primer 
pairings and their respective purified BAC preparations (see Section 2.5.2). A 52 °C 
primer annealing temperature and 30 second extension time was used. When the 
PCR products were ran on a 2% agarose gel (see Section 2.5.6.2), all primer pairs 
generated amplicons of the expected for their respective BAC clones indicating the 
correct clones have been supplied and isolated. 
6.3.1.4 BAC Sequencing 
The three BAC clones were selected to have overlapping sequences which 
would allow for the production of a single continuous reference sequence for the 
CFA13 critical interval. This means the three isolated BAC clones could be pooled into 
a single sample to sequence on a single run of the Oxford Nanopore MinION. A 
minimum of 2 µg DNA in 45 µL was required. In order to achieve this, 18.8 µL, 25.8 
µL and 18.1 µL of BAC1, BAC2 and BAC3, respectively were pooled in a DNA LoBind 
Microfuge tube (Eppendorf, 022431048) to give a final quantity of 2.5 µg of each BAC 
(based on Qubitâ quantification, see Table 6.1). This exceeded the total volume of 
45 µL so the pooled sample was purified using AMPureXP beads (NG2001, Promega). 
An equal volume of AMPureXP beads (62.7 µL) was added to the pooled sample 
which was mixed on a rotator (BMR5010-E, Benchmark Scientific) for 5 minutes at 
room temperature. The sample was briefly collected using a centrifuge and then 
placed on a DynaMag™-2 magnetic rack (12321D, ThermoFisher Scientific) for 5 
minutes to allow the beads to pellet. The supernatant was discarded and the pellet 
was washed twice with 200 µL 70% ethanol by pipetting over the pellet whilst still on 
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the magnet. The pellet was dried for 1 minute and then resuspended in 46 µL 
nuclease free water. The purified pooled sample was quantified using the Qubitâ 
(see Section 2.4.2) to give a concentration of 112 ng/µL.  
The purified pooled BAC sample (45 µL) was repaired by incubating at 20 °C 
with 8.5 µL nuclease free water, 6.5 µL FFPE Repair Buffer and 2 µL FFPE Repair Mix 
(NEB M6630, New England Biolabs) for 15 minutes. The DNA was isolated from the 
reaction mix by adding 62 µL AMPureXP beads and incubating for 5 minutes on a 
rotator at room temperature. The mixture was briefly pooled by centrifugation and 
placed on a magnetic rack to pellet the DNA-bound AMPureXP beads. The 
supernatant was removed and the pellet was washed twice with 200 µL 70% ethanol 
whilst in the magnet rack before being allowed to dry for 1 minute. The pellet was 
resuspended in 46 µL nuclease free water. The resuspension was quantified using the 
Qubitâ (see Section 2.4.2) to give a concentration of 80 ng/µL. 
To add 3’ A-tail ends to the DNA, the 45 µL sample was placed in a strip tube 
with 7 µL Ultra II End-Prep buffer, 3 µL Ultra II End-Prep enzyme mix (NEB E7595, New 
England Biolabs) and 5 µL nuclease free water before mixing by inversion and 
spinning down. The mix was incubated at 20 °C for 30 minutes before 65 °C for 30 
minutes. The reaction mixture was transferred back to a DNA LoBind microfuge tube 
where it was mixed with 60 µL AMPureXP beads and incubated on a rotator for 5 
minutes at room temperature. The sample was pooled through centrifugation and 
pelleted using a magnetic rack. The supernatant was removed and the pellet was 
washed twice with 200 µL 70% ethanol whilst in the magnetic rack before being 
allowed to dry for 1 minute. The pellet was resuspended in 31 µL nuclease free water. 
The resuspension sample was quantified using the Qubitâ (see Section 2.4.2) to give 
a concentration of 59.4 ng/µL. 
DNA fragments were ligated by incubating the 30 µL resuspension with 20 µL 
Adaptor mix and 50 µL NEB Blunt/TA Master mix (NEB M0367, New England BioLad) 
at room temperature for 20 minutes. Forty µL AMPureXP beads were added and 
incubated on a rotator for 5 minutes at room temperature. The mixture was pooled 
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briefly by centrifugation and pelleted on a magnetic rack. The supernatant was 
discarded and 140 µL ABB beads were added and mixed by flicking. The sample was 
pooled by centrifugation and pelleted on the magnetic rack. The supernatant was 
removed and the addition of 140 µL ABB beads was repeated. The beads were 
resuspended by flicking, collected by brief centrifugation and pelleted on a magnetic 
rack. The supernatant was removed and the pelleted beads were resuspended in 15 
µL ELB and incubated for 10 minutes at room temperature. Finally, the sample is 
pelleted on the magnet and the eluate was transferred to a new DNA LoBind 
microfuge tube. The library sample was quantified using the Qubitâ (see Section 
2.4.2) to give a concentration of 87.8 ng/µL. 
To prepare the MinION and Flow Cell (SQK-LSK109, R9.4) for sequencing, the 
MinION Flow cell was inserted into the MinION device by sliding the end up the 
supporting clip and pressing down so the electrical port connects. The MinKNOW 
software was opened and the Flow Cell ID number (SQK-LSK109, R9.4) was entered 
before clicking “Execute” for the quality control step. Following QC, a total of 897 
pores were available for sequencing. Priming buffer was prepared by mixing 480 µL 
running buffer (RBF) and 520 µL nuclease free water. The priming port of the MinION 
Flow Cell was opened and an empty P1000 pipette, mounted on a pipetman was held 
vertically over the priming pore. The volume adjust dial on the pipetman was turned 
slowly until a few microliters of storage buffer was drawn out of the Flow Cell. The 
Flow Cell was slowly primed with 800 µL priming buffer so as to ensure that no 
bubbles were introduced. The Flow Cell was left to incubate with priming buffer for 
5 minutes. The SpotON port was opened and 200 µL priming buffer was loaded into 
the priming pore.  
Meanwhile, the library was prepared for loading by mixing 35 µL running buffer 
(RBF), 25.5 µL Library Loading Beads (LLB), 12 µL library prep and 2.5 µL nuclease free 
water. A total volume of 75 µL of the library mixture was loaded into the SpotON pore 
in a continuous dropwise fashion. Both the SpotON and priming ports were closed 
carefully. The MinION device lid was closed and the sequencing run was activated 
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(without base-calling) using the MinKNOW software. The Oxford Nanopore MinION 
device coupled with the MinKNOW software generated a total of 7.59 Gb data in the 
form of 69,454 raw reads in FAST5 file output. This raw output was base-called used 
the Albacore (v2.0.1) software prior to constructing contigs with Canu (v1.5) and 
“polishing” the consensus sequence with Nanopolish (v0.8.4). All three stages used 
default parameters with each programme.  
6.3.2 Results 
The age of onset is an important factor to determine to ensure that UAS-
susceptible dogs carrying the ADAMTS3:c.2786G>A allele are not screened prior to 
disease onset. All 401 Norwich Terriers in the study were screened once and their 
age at the time of screening plotted (Figure 6.1). At all ages, homozygous carriers for 
the derived ADAMTS3 allele appeared to have an increased severity compared to 
heterozygous and non-carriers of the allele (Figure 6.1A). Heterozygous carriers 
appeared to have a non-clinical presentation matching the non-carriers until the age 
range of 24-29 months. With the exception of 6-11 months of age, the homozygous 
carriers of the ADAMTS3 allele have a significantly increased total airway score 
compared to all other genotypes (Figure 6.1B). A significant difference between the 
total airway score of heterozygous and non-carriers of the ADAMTS3 allele only 




The assessment of the Norwich Terrier upper airway syndrome has proven to 
give significant insights into not just the suspected cause of the disease in the 
Norwich Terrier, but also a possible disease modifying risk factor in brachycephalic 
dogs. Known links between deleterious events in ADAMTS3 and oedematous disease 
phenotypes have been shown previously (Brouillard et al. 2017) which have made 
the ADAMTS3:c.2786G>A variant discovered here a compelling candidate. 
Figure 6.6 – Age of Upper Airway Syndrome Onset. Upper airway scores of all Norwich Terriers 
plotted at the age of scoping and coloured by ADAMTS3:c.2786G>A genotype. (A) Trend lines 
of disease severity for each genotype and (B) comparison of genotypes at each age point 




Unfortunately, due to various limitations including the access of specific tissues and 
the quantity of available data, several follow-up experiments could not be 
completed. 
One follow-up experiment is to comprehensively characterise the skeletal 
morphologies of the Norfolk and Norwich Terriers and the carriers of the 
ADAMTS3:c.2786G>A variant therein to determine whether the risk allele alters 
skeletal morphology, as might be expected based on human and mouse data 
(Marouli et al. 2017; Ogino et al. 2017). Due to the scarcity of Norwich and Norfolk 
Terriers receiving CT scans, only a superficial comparison could be made. Importantly, 
in the context of this manuscript, these Terriers had distinct craniofacial forms and 
occupied a unique morphospace compared to their brachycephalic counterparts, 
suggesting brachycephaly per se is not the cause of UAS in the Norwich Terrier. 
Limited intra-Terrier morphological conclusions could be drawn but suggest that the 
Norwich and Norfolk Terriers occupy overlapping morphospaces. Variants in 
ADAMTS3 have been linked with variation in human height whilst mouse knockouts 
of the gene have resulted in an anterior-posterior shortening of the skull and 
abnormal rib development (Marouli et al. 2017; Ogino et al. 2017). If such 
morphological variation also exists as a result of the derived variant in ADAMTS3 in 
the dog, it may provide a cryptic explanation for its enrichment in the Norwich Terrier 
over the Norfolk Terrier as breeders could select for a morphological trait. Ideally, to 
address this question whole body CT scans of a large Norwich and Norfolk Terrier 
cohort would be collected. Geometric morphometric analyses such as those 
previously described in this thesis (Chapter 3) could more accurately characterise 
craniofacial variation between Norwich and Norfolk Terriers as well as between dogs 
with different ADAMTS3 genotypes. Furthermore, whole body CT analysis would 
allow for the assessment of long bone and body axis length variation that have 
anecdotally been suggested to vary amongst affected and unaffected Norwich 
Terriers (personal communications with Dr Elisabeth Dietschi, University of Bern).  
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A second line of follow-up experiments would be to determine the age of onset 
of the UAS in the Norwich Terrier. Figure 6.6 began to show trends between age at 
the time of screening and the ADAMTS3:c.2786G>A genotype. Individuals 
homozygous for the derived variant appeared to have an increased severity score 
over the course of their lifetime whilst the heterozygous state appeared to have a 
later onset – possibly around 24 months. The data in hand was underpowered for 
such an experiment due to various reasons. Firstly, to truly determine the age of 
onset, multiple airway scores would have ideally been taken over the course of an 
individual’s lifetime, however due to the relatively invasive nature of the 
laryngoscopic screening method, many dogs received just one screen. As a result, if 
the screen was performed later in life, critical information regarding disease onset 
was completely missed. A second difficulty was the relatively small size of the study. 
Whilst 401 participants is a sizeable cohort for many canine disease studies, the 
division of participants by five age groups and then three genotypes results in too 
few individuals to meaningfully distil the age of disease onset. Using this current cross 
sectional study design, only a much larger population cohort, or multiple screens in 
a lifetime (longitudinal study) would resolve the age of onset – a likely unfeasible 
feat. Alternatively, a less invasive and easy to repeat scoring system could be 
acquired such as the use of whole-body barometric plethysmography. This system 
has been used to score upper airway resistance in brachycephalic breeds and 
presents no risk to the participants which would permit multiple screens in a lifetime 
(Liu et al. 2015; 2016). Such a scoring system could then be used to possibly identify 
the functional effects of the ADAMTS3 variant and track post-operative prognosis.  
Critical to the current hypothesis, it would be important to confirm that 
ADAMTS3 is expressed in the airway of dogs. This would be expected following the 
identification of ADAMTS3 in cartilage of the upper airway of humans (Fernandes et 
al. 2001). In the dog, post-mortems are often carried out at veterinary practices 
which may present the opportunity to collect appropriate upper airway tissues such 
as the pharynx, with owner permission. The expression of ADAMTS3 would not be 
predicted to vary across genotypes but real-time quantitative PCR would confirm this. 
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Sections of pharynx could be prepared for immunohistochemistry which would 
precisely localise ADAMTS3 and allow for the gross assessment of lymph vessel 
structure using common markers such as VEGFR3, LYVE1 and PROX1 which may be 
expected to vary in carriers of the ADAMTS3:c.2786G>A variant (McElroy et al. 2008; 
Vondenhoff et al. 2008; Kong et al. 2017).  
The modulation of collagen maturation in cartilage via procollagen N-
proteinase activity was one of the earliest and largely predictable functions of 
ADAMTS3 based on its sequence (Nagase et al. 1997; Fernandes et al. 2001; Colige et 
al. 2005; Le Goff et al. 2006; Olderøy et al. 2014). As discussed, more recent studies 
have highlighted its involvement in regulating lymphangiogenesis through VEGF-C 
modification (Jeltsch et al. 2014; Jha et al. 2017). A separate study identified a more 
comprehensive substrate repertoire for ADAMTS3 by comparing the secretome of 
two cell lines – one with minimal ADAMTS3 expression whilst the second was 
transfected to transiently overexpress ADAMTS3 (Bekhouche et al. 2016). Seventeen 
peptides were identified as substrate candidates of ADAMTS3 including peptides of 
the extracellular matrix (fibronectin and collagen α-chains) and receptors such as 
TGF-β rector 3 and human leukocyte antigen-A (HLA-A). Enzymatic cleaving of these 
substrates between the two ADAMTS3 cell lines were validated through altered 
banding profiles in Western blots. Similar Western blotting experiments using a cell 
line transfected with the ADAMTS3:c.2786G>A variant could elucidate possible 
functional ramifications the variant. Furthermore, an overexpressing 
ADAMTS3:c.2786G>A cell line could be used to purify samples of the derived 
ADAMTS3 for structural analysis. Liquid chromatography could tease apart subtle 
changes in the tertiary structure of the protein as a result of the missense variant and 




Chapter 7: Conclusion and Discussion 
At a time when the popularity of brachycephalic dog breeds is growing at an 
unprecedented level, an understanding of their associated health problems is 
paramount to address rising welfare concerns. To this end, this thesis endeavoured 
to determine the genetic risk factors of respiratory disease. 
Firstly, a novel computer tomography-based geometric morphometric 
approach was used to capture variation in canine craniofacial morphology. The 
intricate relationship of size on shape (allometry) was separated in an optimised 
manner which saw the use of the neurocranium centroid size and skeletal size-
determining genetic loci as regression variables to isolate non-allometric craniofacial 
shape changes. In doing so, notable intrabreed morphological variation was detected 
amongst purebred dogs, particularly in breeds such as the Yorkshire Terrier and 
Labrador Retriever. By necessity, this exploration of the neurocranium centroid size 
(a proxy for skeletal size), revealed eight loci previously known to be associated with 
canine size variation. At each of these loci, haplotype mapping defined new critical 
intervals permitting future studies to investigate their underlying causal variants. In 
addition to this, the FGF4 retrogene on CFA18 which was known to arrest 
development of the limbs was also predicted to dictate variation in the size of the 
neurocranium.  
Importantly, this thesis was able to distil the brachycephaly-associated QTL on 
CFA1 which had been elusive until now. A 175.6 kb critical interval was defined by 
individual-level haplotype mapping, which for the first time, could exploit the 
diversity amongst mixed-breed dogs. SMOC2 was the only gene residing in the critical 
interval. In a distinction from previous studies, this thesis aimed to better 
characterise the potential functional role of the associated gene in craniofacial 
development. Firstly, Smoc2 was demonstrated to be expressed in the first 
pharyngeal arch and frontonasal prominence of both the early chicken and mouse 
embryos which later give rise to the developing face. The geometric morphometric 
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assessment of Smoc2-null mice were then determined to be craniofacially 
dysmorphic with similar hallmarks to brachycephalic dogs.  
Specifically in the dog, a fragment of a retrotransposon (LINE-1) was identified 
in intron 8 of SMOC2 to segregate amongst the brachycephalic dogs of the study 
cohort. Transcriptomic analysis of the most brachycephalic breeds revealed the 
integration of this LINE-1 element into SMOC2 transcripts, thereby introducing a 
premature a stop codon and truncating potential protein products. Although no 
proteomic assessment was made, an 80% reduction in SMOC2 transcript count 
suggested that the truncated SMOC2 transcripts were targeted by nonsense-
mediated decay. Allele-specific downregulation of SMOC2 suggested that the LINE-1 
variant acted in cis and it could not be demonstrated to affect neighbouring genes 
that flank SMOC2. A truncated dominant negative protein product may also be 
produced but this was not investigated here. 
The presentation of respiratory disease in the Norwich Terrier provided an 
opportunity to parse the confounding influence of the brachycephalic head shape 
from upper airway disease presentation. A comprehensive characterisation of upper 
airway syndrome in Norwich Terriers and subsequent GWAS revealed a major QTL on 
CFA13. Haplotype mapping defined a critical interval to encompass, ADAMTS3. In 
reviewing sequencing data, an error was discovered in the reference assembly within 
the ADAMTS3 gene. Long read sequencing technologies corrected this assembly 
mistake and in doing so revealed 133 bp of missing exon from ADAMTS3. Once 
corrected, a missense coding variant was discovered to segregate with severely 
affected Norwich Terriers. The scarcity of available tissues restricted downstream 
functional analysis of the variant, however the derived variant was found to be 
enriched in the Norwich Terrier and brachycephalic dog breeds including English and 
French Bulldogs whilst being absent from 109 other breeds. 
7.1 Should We Define Canine Brachycephaly? 
The term “brachycephaly” was originally used to describe a form of 
craniosynostosis in humans following the premature fusion of the coronal sutures 
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(Persing et al. 1989). Since then, the term has been adopted by the canine veterinary 
field to define breed types. Traditionally, the expectation that all individuals of a given 
breed are morphological uniformed and invariable from one another has resulted in 
breeds being grouped as “brachycephalic”, “mesocephalic” and “dolichocephalic” 
based purely on assumption. In an attempt to more precisely define such boundaries, 
several studies sought to quantitatively isolate each subgroup. Evans (Evans 1993) 
suggested brachycephaly should be defined as having a cranial length to facial length 
ratio >1.60 whilst Brehm et al. (1985) suggested a skull length to skull width ratio 
<1.44 and Regodόn et al. (1993) proposed a craniofacial angle between the cranial 
base and the plane of the hard palate to define morphological types (Brehm et al. 
1985; Evans 1993; Regodón et al. 1993). Most recently, Koch et al. (2012) suggested 
a facial length to cerebrum length of <1.25 for brachycephalic dogs (Koch et al. 2012). 
The lack of consensus across these studies is reflective of the arbitrary values given 
and the introduction of inherent observer-based biases. For example, the boundary 
value of 1.25 for brachycephalic dogs by Koch et al. (1993) was set to ensure the 
inclusion of the Norwich Terrier as a brachycephalic breed due to its presentation of 
upper airway syndrome which was thought to be conformation-induced (Koch et al. 
2012). Chapter 6 revealed that the Norwich Terrier is in fact morphological distinct 
from BOAS-diagnosed dogs and the new hypothesis that a susceptibility to oedema 
rather than a conformation-induced predisposition to UAS is responsible has further 
disfavoured the use of Koch et al. (2012) definition of brachycephaly. 
Granted, in Chapter 3 the major source of variability in both the whole head 
and viscerocranium variability of the dog could be summarised by a brachycephalic-
to-dolichocephalic axis. However, along this axis there was no distinction of 
morphological subgroups, instead morphological variation formed a fluid continuum 
from one extreme to the other. Importantly, Chapter 3 also highlighted high levels of 
variation within breeds – more so than would be expected in breeds assumed to be 
morphologically uniformed. The classically defined “brachycephalic” Dogue de 
Bordeaux and “mesocephalic” breeds such as the Yorkshire Terrier and Labrador 
Retriever were amongst some of the most variable breeds. Sources of this 
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morphological variation is unclear – could there be morphological distinctions 
between the different functional classes within breeds? For example, is there 
morphological variability between subgroups of Labrador Retrievers working as ‘gun 
dogs’ compared to ‘show dogs’ or simply ‘family pets’? A study of UK Labrador 
Retrievers (largely non-show dogs) described distinct deviation in dog heights from 
the UK Kennel Club breed averages but it remains to be seen how the wider roles of 
the Labrador Retrievers may introduce selection pressures for differing craniofacial 
morphology (Pugh et al. 2015) 
The long-standing expectation of morphological uniformity (and genetic 
homogeneity) of breeds labelled as “brachycephalic” were in part to blame for 
previous unsuccessful attempts to resolve the brachycephaly-associated CFA1 QTL 
(Bannasch et al. 2010). In reality, phenotypic and genotypic variability within breeds 
assumed to be brachycephalic prevented the correct definition of a critical interval 
and isolation of causal variant(s) therein. This thesis eschewed the use of discrete 
brachycephalic groupings, opting instead to quantify the intra- and inter-breed 
morphological continuum to rank head shapes. In rejecting discrete subgroupings, 
and by using a highly specific phenotype (computer tomography), this analysis 
tolerated natural variation and was able to resolve the CFA1 QTL.  
These observations put into question whether a defined boundary for 
brachycephaly is truly warranted. Collectively, this thesis would be in favour of 
refraining from the use of misguided boundaries and instead acknowledging both the 
intra- and inter-breed fluid variability. Since “brachycephaly” represents the extreme 
of morphological variation, perhaps an appropriate morphological description of 
dogs at this extreme would be to refer to them as the “most brachycephalic” dogs 
rather than simply “brachycephalic”.  
7.2 The Reign of the Structural Variant 
Ever since the publication of the first canine draft assembly 15 years ago and 
its subsequent updates, structural variants such as LINEs and SINEs have been 
hypothesised to contribute to the extreme variability across the canine population 
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(Kirkness et al. 2003; Lindblad-Toh et al. 2005; Wang and Kirkness 2005). The high 
abundance of the elements which together make up to ~30% of the canine genome 
were believed to be rapidly enriched during domestication. Despite this, relatively 
few LINEs and SINEs have been identified as causing canine traits and diseases – until 
recently. Particularly within the last five years, more attention has been drawn to the 
family of retrotransposons which have been shown to cause a variety of traits from 
cleft palates to white spotting on coats (Brooks et al. 2004; Credille et al. 2009; Smith 
et al. 2010; Dreger and Schmutz 2011; van Steenbeek et al. 2013; Wolf et al. 2014; 
Downs and Mellersh 2014; Körberg et al. 2014; Wiedmer et al. 2015; Marchant et al. 
2017; Mauri et al. 2017; Everson et al. 2017). The previous expense of whole genome 
sequencing made it difficult to detect the often intronic localisation of these large-
spanning elements. Even today, the reliance on short-read data and the lack of a 
standardised pipeline for detecting structural variants comparable to the GATK best 
practice guidelines (DePristo et al. 2011), have resorted in geneticists visually 
inspecting genomes for hallmarks of retrotransposons (Downs and Mellersh 2014; 
Mauri et al. 2017; Everson et al. 2017). Ongoing developments in long-read 
sequencing platforms will likely aid in the discovery of large structural variants in the 
future. 
The characterisation of the brachycephaly associated LINE-1 element within 
intron 8 of SMOC2 in Chapter 5 adds to the mounting literature on the detrimental 
effects of retrotransposons. Through the introduction of alternative splice sites 
situated within the introduced LINE-1, varying portions of LINE-1 sequence is 
incorporated into SMOC2 transcripts after exon 8 on the canonical 13 exon gene. As 
a result, novel LINE-1 derived stop codons are predicted to prematurely terminate 
translation. It is unclear whether a protein product is formed however the absence 
of the exons ten through thirteen, which encode the protein’s extracellular calcium-
binding (EC) domain, is likely to render the truncated protein non-functional. The 
functional dependency of this domain has been proven in cell lines that lose 
migratory and differentiation regulatory properties once the EC domain of SMOC2 
was removed (Maier et al. 2008; Peeters et al. 2018). Furthermore, the ability of BM-
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40 members to bind substrates such as the collagens is calcium-dependent, 
highlighting the importance of the EC domain (Mayer et al. 1991; Sasaki et al. 1997; 
1998). Despite these predictions, it remains plausible that the truncated protein 
could act in a dominant-negative fashion, for example by generating protein 
aggregates and inducing toxicity (Veitia 2007). 
Regardless of whether a truncated protein product exists, the introduction of 
the LINE-1 fragment in a homozygous state causes an 80% loss of full-length SMOC2 
transcripts. Comparably, intronic LINE-1 insertions creating premature stop codons 
in the distal-less homeobox 6 (DLX6) and transglutaminase 1 (TGM1) genes reduce 
full transcript counts by ~75% and ~85% of their respective genes (Credille et al. 2009; 
Wolf et al. 2014). These LINE-1 insertions in DLX6 and TGM1 are linked with cases of 
cleft palates and ichthyosis in dogs, respectively. Across the SMOC2, DLX6 and TGM1 
examples, the LINE-1 fragments varied in length (6.2 kb, 2.1 kb, 2.0 kb) and were 
inserted after exons 8 of 13, 9 of 14 and 2 of 3, respectively. An additional intronic 
LINE-1 insertion of 2.0 kb after exon 5 of 8 in the factor IX (F9) gene was linked with 
mild haemophilia B in dogs however no expression analysis was performed (Brooks 
et al. 2004). It remains unclear to what extent the size of the LINE-1, which intron it 
resides in, the proximity to exons and its orientation may have on the host gene’s 
relative expression, which warrants further evaluation in future studies. 
Nevertheless, the effectiveness of LINE-1’s to cause morphological and disease traits 
is evident. As whole genome sequencing becomes cheaper, supplemented by 
advances in long-read technologies which can span these structural variants, the 
number of traits dictated by retrotransposons is likely to escalate further in the 
coming years.  
7.3 A New Perspective on Brachycephalic Obstructive Airway Syndrome 
The almost exclusive presentation of BOAS amongst the most brachycephalic 
short-faced dogs has long supported the broadly held belief that head conformation 
is responsible for the condition. The rationale being that the soft tissues of the 
shortened muzzle do not shrink proportionally with their bony framework and so 
185 
 
obstruct the airway causing the characteristic symptoms (Ladlow et al. 2018). The 
influence of weight and age on the condition have proven inconclusive and yet a 
heterogeneous disease presentation remains across and within breeds (2006; Torrez 
and Hunt 2006; Fasanella et al. 2010). In chapter 6, the discovery of the 
ADAMTS3:c.2786G>A variant in Norwich Terriers and its link to an oedematous upper 
airway phenotype has given new insights into the aetiology of respiratory disease. In 
addition to their compromising head shape, one in four French Bulldogs carry the 
ADAMTS3:c.2786G>A disease allele whilst in the English Bulldog this allele is 
approaching fixation. These observations challenge old perspectives of disease 
causation of BOAS and present a new hypothesis:  
Oedema of the airway caused by the disruption of ADAMTS3 
predisposes its host to upper airway obstruction with or without the 
brachycephalic skull conformation. 
The analysis of CT data suggests that the ADAMTS3:c.2786G>A allele does not 
affect head shape. In finding a novel, non-conformational modifier of respiratory 
disease in dogs, it has potentially wide-reaching ramifications in the veterinary and 
breeding communities. By necessity, this thesis developed an easy PCR-based 
method to genotyping the variant which can readily be replicated elsewhere. For the 
Norwich Terrier community, a screening programme for upper airway syndrome 
already exists – albeit using a physical examination of the airway. The willingness of 
the Swiss Terrier Club to use such a programme provides a framework upon which a 
genetic screen can be rolled out in place of/alongside the current physical 
examination. Hopefully the ease and reduced risk of a genetic screen would continue 
to reduce UAS severity amongst Norwich Terriers as already started by the airway 
screening programme.  
Currently, there are no existing large-scale programmes designed to tackle 
BOAS amongst the brachycephalic dogs. The importance of the physical trait 
conformation set down by the breed standards and avidly adhered to by breeders 
has limited the management of BOAS. For the French Bulldog at least, the discovery 
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of the ADAMTS3 variant at manageable frequencies (~0.25) provides the opportunity 
to selectively breed to reduce transmission of the risk variant to future generations 
of French Bulldog population with minimal, or potentially no changes to 
morphological traits. The fine-level impact of the ADMATS3:c.2786G>A allele on 
morphological variation is yet to be determined but it is expected to be limited due 
to high morphological similarities between the Norwich Terrier (carriers) and Norfolk 
Terrier (non-carriers).  
BOAS management in the English Bulldog may prove more difficult since the 
risk variant is nearly fixed in this population; of the twenty-four English Bulldogs 
tested, nineteen (79.2%) were homozygous carriers of the ADAMTS3:c2786G>A 
allele, three (12.5%) were heterozygous carriers whilst just 2 (8.3%) were free of the 
mutation. The enrichment of the deleterious ADAMTS3 variant is perhaps an 
uncomfortable testament to the high genetic homogeneity amongst English Bulldogs 
as the result of genetic bottlenecks and a small founder population (Pedersen et al. 
2016). It is estimated that there are just four paternal haplotypes in the breed with 
one haplotype occurring in 93% of dogs. Selective breeding to purge the risk allele 
from future English Bulldog generations risks exacerbating inbreeding further. To this 
end, the feasible resolution of the problematic ADAMTS3 variant, alongside 
managing a wide range of other detrimental congenital health defects whilst 
maintaining desirable traits from within the breed is questionable (Pedersen et al. 
2016). The combination of extreme brachycephaly and the ADAMTS3 variant explains 
the greater severity of pathology observed in Bulldogs with BOAS . 
7.4 Future Directions 
A persistent challenge for the field of canine genetics and genomics is the 
investigation of the biological relevance of positional candidate genes and their 
putatively causal variants. This thesis endeavoured to address such issues for the 
brachycephaly-associated LINE-1 insertion in SMOC2. Follow-up experiments 
included in silico modelling of protein function, localisation of embryonic SMOC2 
expression, comparison of transcriptomic profiles across SMOC2 genotypes in dogs, 
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comparison of sequence homology of predicted transcripts across species and the 
assessment of craniofacial structure in Smoc2-null mice. Collectively, these 
experiments strongly inferred the role of SMOC2 and its associated LINE-1 variant 
with canine brachycephaly. Unfortunately, causal proof could not be ascertained. 
Ultimately, proof would only be achieved through the introduction of the LINE-1 
element into a non-brachycephalic dog through the use of genome editing tools and 
subsequent craniofacial analysis. The myostatin (MSN1) gene was edited in the dog 
using a clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-
associated (Cas) 9 system to create a double-muscled Dachshund (Zou et al. 2015). In 
doing so, the viability of the system in the dog was proven however the ethical and 
moral responsibility of such experiments in the dog is questionable.  
A feasible alternative to aid the proof of causality would be to make 
comparable edits to the mouse genome. The CRISPR/Cas 9 system has revolutionised 
genome editing, particularly in the mouse where it was first described (alongside 
human cells) (Ran et al. 2013). The relative ease, quicker turnaround of edited 
offspring and higher efficiency of the system means multiple mouse lines could be 
generated in parallel to explore the role of the region on phenotypic output (Burgio 
2018). The predicted effect of the dog LINE-1 in SMOC2 is to truncate the protein 
after exon 8. Importantly, ancestral versions of SMOC2 are still produced (see 
Chapter 5) and so ablating exons 9 to 13 in the mouse would not be a reflective model 
of the dog. Instead, the LINE-1 insertion in dogs is ~6.3 Kb in size which could be 
inserted into the homologous region of the mouse intron 8 using a single guide RNA 
and a vector plasmid containing the LINE-1 to induce homology-directed repair. 
Alongside this, a number of additional mouse lines would help elucidate the function 
of the locus. Currently, it is unclear what, if at all, the intronic sequence in the 
immediate vicinity of the LINE-1 may have on its role in splicing SMOC2. To this end, 
appropriate further mouse modifications would be to swap the murine intron 8 for 
the dog intron 8 – a “caninisation” of the mouse gene. Such an experiment would 
need to be carried out for both the derived (containing the LINE-1) and ancestral (no 
LINE-1) versions of the dog intron 8 which could be achieved by a pair of guide RNAs 
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either side of the mouse target intron. The ancestral “caninised” mouse would act as 
a control to the derived “caninisation” of the gene whilst an additional wildtype 
mouse on the same background as the edited mice would act as a true control to any 
edits.  
Once the mouse models were generated, an array of experiments would be 
available. The primary interest would be in the end-stage phenotype i.e. do the mice 
harbouring a LINE-1 edit have dysmorphic skulls? A micro-CT scan of the mature skull 
(6 month) would permit a geometric morphometric analysis of craniofacial variation 
similar to that used here for dogs (Kristensen et al. 2009; Campbell and Sophocleous 
2014). The maintenance of mouse lines would also grant access to embryonic tissue 
throughout development. Smoc2 is predicted to regulate cell migration, the 
maturation of pre-osteoblast and the mineralisation of matrix (Rocnik et al. 2006; Liu 
et al. 2007; Maier et al. 2008; Peeters et al. 2018). Neural crest cells (NCC) represent 
a major migratory cell population which translocate from the dorsally positioned 
neural tube to the frontonasal prominence and pharyngeal arches (Nichols 1981; 
Erickson and Weston 1983; Calloni et al. 2009). All bone of the viscerocranium, the 
most prominently affected anatomical region to be altered in brachycephalic dogs, is 
entirely derived from NCCs (Chai et al. 2000; Jiang et al. 2002). Furthermore, the 
mobilisation of NCC are particularly sensitive to subtle variation in the surrounding 
extracellular matrix – something that may be induced by alterations in the quantity 
and possibly function of Smoc2 (Perris 1997; Henderson and Copp 1998; Perris and 
Perissinotto 2000). Therefore, an intriguing investigation would be to monitor NCC 
behaviour over the different mouse lines. Immunohistochemistry (IHC) staining of 
migrating NCCs using markers such as Pax3 or Foxd3 (Epstein et al. 1991; Dottori et 
al. 2001) could infer comparative migration at different embryonic time points. Also, 
the loss of the extracellular calcium-binding domain of Smoc2 has been shown in vitro 
to promote premature differentiation into osteoblasts and mineralisation of the 
surrounding matrix (Peeters et al. 2018). This could be confirmed by IHC staining of 
whole-mount sections with the osteoblast marker, osteonectin (Schulz et al. 1988) to 
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infer pre-osteoblast differentiation and cartilage (Alizarin Blue) and mineralisation 
(Alizarin Red) markers to detect endochondral ossification (Rigueur and Lyons 2014). 
SMOC2 is considered to be an important signal mediator by acting as an 
intermediary protein between various growth factors, the extracellular matrix and 
cell surface receptors (Rocnik et al. 2006; Liu et al. 2007; Maier et al. 2008). To this 
end, SMOC2 would be expected to influence the proteomic makeup of the tissues in 
which it is expressed. To investigate the proteomic networks around Smoc2, the 
pharyngeal arches, which are known to express Smoc2, could be excised from the 
previously generated mouse lines and prepared for proteomic analysis, possible with 
a labelled quantitative mass spectrometry approach such as iTRAQ (Wiese et al. 
2006). Furthermore, through the selected RT-qPCR in zebrafish, key members of the 
Bmp signalling network were shown to be downregulated in Smoc2 mutants 
(Mommaerts et al. 2014). A full transcriptomic analysis of Smoc2 variants has not 
been performed which again, could be executed in the pharyngeal arches of the 
generated mouse lines.   
The identification of the ADAMTS3:p.Arg929His allele as a disease modifying 
factor in conjunction with the confounding craniofacial shape influenced by the 
newly discovered SMOC2 LINE-1 insertion and previously known BMP3:p.Phe452Leu 
allele warrant the question; can these variants accurately predict BOAS severity? Or 
importantly in a veterinary setting, can these variants predict the likelihood of 
complications during surgery and a patient’s post-surgical success? To address this 
question, longitudinal studies that utilise whole-body barometric plethysmography 
could be used to assess upper airway function of brachycephalic breeds before and 
throughout disease onset over the course of their life and treatment. In parallel, non-
brachycephalic healthy breeds could be assessed as a comparative control which 
would not normally be subject to invasive airway assessments such as laryngoscopy. 
The objectivity of the barometric plethysmography coupled with its growing 
popularity amongst veterinarians means a UK-wide recruitment of patients could be 
achieved to increase the cohort size and overall power of the study. Genotypes for 
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the ADAMTS3, SMOC2 and BMP3 variants would be used as variables for upper 
airway function in a multivariate analysis. The results of this study would indicate the 
single, or combination of genotypes that have the greatest influence on BOAS 
severity, surgical complications and post-surgical prognosis. Therefore, veterinarians 
could screen for ADAMTS3, SMOC2 and BMP3 as predicative indicators of surgical 
success in their pre-surgical assessment of patients or highlight cases that are likely 
to warrant more intense post-operative care.  
Beyond the scope of the veterinary community, the discovery of variants in 
SMOC2 and ADAMTS3 may translate to the field of human medicine. SMOC2 is 
already known to at least partly have a role in craniofacial development in humans. 
Specifically, an isolated family with severe dental abnormalities including 
microdontia and oligodontia were attributed to missense mutations within SMOC2 
(Bloch-Zupan et al. 2011). It is unclear whether more substantial variants within the 
SMOC2 gene could have more global effects on craniofacial morphology. However, 
with 1 in 2,100 new born children having craniofacial abnormalities and just 20% of 
them receiving a genetic diagnosis (Lajeunie et al. 1995; Persing 2008; Johnson and 
Wilkie 2011), SMOC2 could offer a new gene to screen in cases where the causal 
genetic variant is unknown.  
Also, like dogs, humans suffer from obstructive respiratory diseases thought to 
be linked with variation in craniofacial shape. Namely, obstructive sleep apnoea 
(OSA) is a chronic respiratory condition caused by the repetitive partial or complete 
collapse of the upper airway during sleep (Lattimore et al. 2003). Sufferers commonly 
experience fragmented sleep, oxygen desaturation and are at risk of cardiovascular 
disease and other forms of mortality (Sin et al. 1999; Lattimore et al. 2003). It is 
predicted that up to 3.9% and 1.2% of the adult US male and female populations are 
affected by OSA, respectively (Bixler et al. 1998; Sin et al. 1999; Bixler et al. 2001). A 
single craniometric measurement, facial depth at the height of the palate can account 
for up to 15% of OSA severity (apnoea-hypopnea index), making it the second 
greatest explanatory variable after obesity (Dempsey et al. 2002). Separately, face 
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width, eye width and mandibular length can predict OSA with a sensitivity of 86% 
(Lee et al. 2009). These craniofacial morphological variations are consistent with 
brachycephalic head formation. An observation supported by Capistrano et al., 2015 
who identified a significant increase in apnoea-hypopnea index to be associated with 
the brachycephalic facial morphology compared to dolicho- and mesocephalic 
(Capistrano et al. 2015). The co-segregation of SMOC2 variants with respiratory 
distress in dogs could suggest variability in human SMOC2 could predispose humans 
to OSA. Furthermore, obstructive respiratory conditions in both dogs and humans are 
likely to have other non-conformation-related factors. Like the proposed 
oedematous airway hypothesis in upper airway syndrome of the Norwich Terrier, 
humans also experience severe respiratory obstruction caused by the predisposition 
to oedema of the upper airway. Laryngeal lymphedema and hereditary lymphedema 
are both debilitating conditions which amongst other symptoms, can cause severe 
breathing difficulties (López-Lera et al. 2011; Deng et al. 2012; Smith et al. 2014). To 
date, the aetiology of these conditions is restricted to the association of variants in 
the serpin family G member 1 (C1NH) gene with hereditary lymphedema (López-Lera 
et al. 2011). The identification of ADAMTS3 variants in canine cases of oedematous 
obstruction of the airway could warrant a screen for similar variants humans that 
suffer from these poorly understood conditions.  
As discussed here and previously, further experiments are warranted to dissect 
the biological effects of SMOC2/ADAMTS3 variants within their respective tissues and 
to interrogate the likely complex interplay in their predisposition of respiratory 
morbidities. Follow-up studies also have the capacity to uncover insights into human 
health however the fundamental implications of this thesis remain grounded in the 
field of veterinary medicine. The discovery of a predisposition to oedema in Upper 
Airway Syndrome and its likely contribution to specific breeds with Brachycephalic 
Obstructive Airway Syndrome have substantial ramifications for the management of 
the debilitating respiratory diseases across the Norwich Terrier and brachycephalic 
dog breeds alike. Particularly, the discovery of a potential role for a non-
conformation-related risk factor to Brachycephalic Obstructive Airway Syndrome 
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challenges current perceptions of this high prevalence condition. Hopefully, though 
the careful and considered use of this data, the welfare of breeds susceptible to 
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Supplemental Figure 1 - Phenotype Correlations. Pearson’s correlation scores between upper airway 
phenotypes with dendrogram indicating relationships between phenotypes. Phenotypes returning 






Supplemental Figure 2 - All GWAS Returning Significant Associations. Manhattan plots for (A) 
cartilage position, (B) laryngeal saccule, (C) oedema of the cricoid mucosa and (D) oedema of the 
oropharynx. The red dashed line denotes Bonferroni correction threshold (4.75 x 10-7) and maximum 

















Supplemental Figure 3 - Array Genotype PCA. Principal component 1 and 2 of the array genotypes 




Supplemental Figure 4 - Complete Haplotypes. Phased haplotypes (horizontal rows) for the region 
surrounding the index marker (chr13:61,255,943; arrowhead) on CFA13 for all 233 Norwich Terriers 
in the study cohort. Individuals are ranked by phenotype severity in order of their GWAS significance 






Supplemental Figure 5 - Error in CanFam3.1 Scaffold. DNA and RNA short-read sequencing data 
aligned to the (A) CanFam3.1 and (B) newly created consensus sequence for the region. Read 
coverage across the 5’ end of exon 20 and its immediate intron is lost. The error is corrected in the 
new consensus as indicated by complete coverage in the region. 
 253 
CFA Position Marker Allele 
Laryngeal Saccule Oedema of the Cricoid Mucosa Cartilage Position 
Oedema of the 
Oropharynx 
p-value beta p-value beta p-value beta p-value beta 
13 59,035,431 BICF2P1050096 A > G 3.43E-09 -2.5059 2.05E-07 -0.1896 2.01E-08 -0.8549     
13 59,083,075 TIGRP2P184171_rs8895564 A > C 1.10E-08 -2.4709 8.42E-08 -0.1985         
13 59,171,427 BICF2G630749007 C > G 1.10E-08 -2.4709 8.42E-08 -0.1985         
13 59,215,669 BICF2G630748960 C > T 1.10E-08 -2.4709 8.42E-08 -0.1985         
13 59,244,558 BICF2G630748919 A > G 1.10E-08 -2.4709 8.42E-08 -0.1985         
13 59,876,151 BICF2G630748126 T > C 4.10E-09 -2.4944 9.87E-09 -0.2083         
13 59,921,835 BICF2P559788 C > T         1.40E-07 -0.9191     
13 59,932,325 TIGRP2P184784_rs8637716 T > C         1.40E-07 -0.9191     
13 59,946,572 BICF2G630748106 C > G 4.10E-09 -2.4944 9.87E-09 -0.2083         
13 60,059,427 BICF2G630747989 T > C         1.40E-07 -0.9191     
13 60,104,647 BICF2S23551619 C > T 9.87E-08 -2.2869 1.62E-07 -0.1927         
13 60,119,822 BICF2P890262 C > T 9.87E-08 -2.2869 1.62E-07 -0.1927         
13 60,158,661 BICF2G630747923 A > G 9.18E-11 -2.7353 3.55E-08 -0.2009         
13 60,167,490 BICF2G630747914 A > G 9.18E-11 -2.7353 3.55E-08 -0.2009         
13 60,204,662 BICF2G630747899 C > G 6.42E-10 -2.8798 3.45E-07 -0.2050         
13 60,211,955 BICF2G630747887 A > G 1.12E-07 -2.5130             
13 60,220,792 BICF2G630747865 G > T 6.42E-10 -2.8798 3.45E-07 -0.2050         
13 60,231,218 BICF2G630747844 T > C 6.42E-10 -2.8798 3.45E-07 -0.2050         
13 60,243,398 BICF2G630747830 T > C 1.12E-07 -2.5130             
13 60,356,118 TIGRP2P184853_rs8673615 T > G 1.42E-07 -2.5290             
13 60,408,126 BICF2G630747706 C > G 1.76E-13 -3.0415 5.60E-09 -0.2087         
13 60,417,420 BICF2P940986 A > G 1.76E-13 -3.0415 5.60E-09 -0.2087         
13 60,431,667 BICF2S2376537 G > A 7.44E-12 -3.1082 2.69E-07 -0.2030         
254 
 
13 60,474,403 TIGRP2P184870_rs9068575 C > T 2.38E-10 -2.9146         4.18E-07 -0.3842 
13 60,484,759 BICF2G630747649 C > T 7.89E-09 -2.7127             
13 60,496,347 BICF2G630747628 C > T 7.68E-11 -2.7362             
13 60,651,846 BICF2G630747522 A > G 7.89E-09 -2.7127             
13 60,656,371 BICF2G630747517 A > G 7.89E-09 -2.7127             
13 60,679,228 BICF2G630747483 C > T 7.89E-09 -2.7127             
13 60,707,730 BICF2G630747446 T > C 2.41E-11 -2.7528 4.26E-07 -0.1806         
13 60,884,157 TIGRP2P184965_rs8996044 G > T 1.98E-09 -3.0824     9.79E-09 -1.0521     
13 60,928,962 BICF2G630747127 T > C 8.14E-10 -2.8460             
13 60,934,509 BICF2G630747111 T > C 8.14E-10 -2.8460             
13 60,935,555 BICF2S23032685 A > G 8.14E-10 -2.8460             
13 60,948,625 BICF2G630747091 T > C 2.59E-12 -2.8867 4.11E-07 -0.1825         
13 60,955,738 BICF2G630747083 A > G 2.59E-12 -2.8867 4.11E-07 -0.1825         
13 60,974,872 BICF2G630747065 G > A 8.14E-10 -2.8460             
13 60,981,733 BICF2S23549893 G > A 2.59E-12 -2.8867 4.11E-07 -0.1825         
13 60,990,552 BICF2G630747041 A > C 4.92E-10 -2.8464         1.98E-07 -0.3919 
13 61,017,164 BICF2G630747018 G > A 1.92E-13 -2.9879 7.70E-08 -0.1900         
13 61,039,571 BICF2G630746980 T > A 3.49E-08 -2.9012     3.37E-08 -1.0417     
13 61,054,798 TIGRP2P184991_rs9060216 T > C 4.21E-10 -2.8607             
13 61,076,409 BICF2G630746923 G > A 2.72E-10 -2.9433             
13 61,129,266 TIGRP2P185016_rs8744939 G > T 6.84E-14 -3.0560 2.77E-08 -0.1976         
13 61,139,969 BICF2P1046807 C > T 4.56E-13 -2.9556 1.59E-07 -0.1862         
13 61,234,642 TIGRP2P185072_rs9078356 T > C 7.80E-11 -2.8691     4.17E-08 -0.8752     
13 61,255,943 TIGRP2P185081_rs9043975 G > A 7.79E-16 -3.2283 2.87E-09 -0.2076 8.79E-09 -0.8536     
13 61,270,000 TIGRP2P185090_rs8834045 A > C 3.76E-13 -3.2052     6.80E-09 -0.9351     
13 61,324,727 BICF2G630746664 C > A 1.30E-11 3.7540         3.47E-09 0.5585 
255 
 
13 61,390,999 BICF2G630746542 C > T 1.92E-14 -3.1259 2.93E-08 -0.1973 4.62E-08 -0.8236     
13 61,418,089 BICF2G630746493 T > G 5.21E-11 -2.9697             
13 61,436,186 BICF2G630746463 T > G 4.52E-11 -3.0291             
13 61,496,628 BICF2P555379 T > C 2.94E-11 -2.9468             
13 61,549,154 BICF2S2355385 G > T 2.92E-07 -3.3241             
13 61,567,707 BICF2G630746277 T > C 2.92E-07 -3.3241             
13 61,732,795 BICF2G630746093 A > G 4.98E-11 -3.0130         4.34E-07 -0.3826 
13 61,830,084 BICF2G630745919 A > G 6.71E-11 -3.0095         1.64E-07 -0.3965 
 
Supplementary Table 1 - Significant SNVs. Four phenotypes have markers that surpass a Bonferroni correction threshold which correspond to the same QTL on 







61170181 A G 
61189929 A G 
61190053 A G 
61190184 T C 
61190246 C G 
61190348 AATG TATT 
61190752 CCTCT CCT,C 
61190789 GGTGAATAAAC CGTGAATAAAT,TGTGAATAAAT 
61191362 T A 
61191408 GAGA G 
61191554 T C 
61191750 A G 
61192115 C T 
61192271 A T 
61192476 G A 
61192504 G A 
61192540 G T 
61193292 T C 
61193340 G C 
61193366 G T 
61193672 C A 
61193693 G T 
61193761 C T 
61194302 C T 
61194342 C T 
61194542 G A 
61194604 G A 
61194613 CCTTTTTT C 
61195300 A G 
61195437 C A 
61195466 A G 
61195503 C T 
61195570 A T 
61195787 TTTTTTTTTTTTTA TATTTTTTTTTA 
61195847 T TTT 
61195902 TCAAAACCTA CCAAAACCTT 
61195965 G A 
61196420 A C 
61196508 AG GA,GG 
61197002 C T 
61197349 C T 
257 
 
61197483 A G 
61197836 T C 
61197933 A AT 
61197997 TAACTG CAACTA 
61198419 G A 
61205561 G GT,GTT 
61207979 G T 
61208736 G A 
61210349 G T 
61212738 T A 
61212777 GGT G,GGTGTGT,GGTGTGTGT 
61213741 C T 
61213959 G A 
61214054 AAT A 
61215142 G C 
61216135 CG C 
61216488 A T 
61218653 G A 
61219883 TTTTG T 
61220575 C G 
61220670 A G 
61221130 C G 
61221146 C T 
61221333 AAATAAATG A 
61221608 A G 
61221652 AGAAAATAATATTAG CGAAAATAATATTAA 
61222124 G C 
61222427 TGTATAACGTT TATAACGC 
61224152 A G 
61226001 G A 
61227517 C T 
61227956 A C 
61228172 C T 
61228229 T C 
61228323 G A 
61228409 T C 




61228935 G GTT,GTTT 
61229680 G A 
61230145 G T 
61230167 A G 
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61230191 T TA 
61230651 C A 
61231263 G C 
61241538 T C 
61243071 T TA 
61244812 C T 
61244832 T A,C 
61244946 G C 
61245474 T C 
61246597 G A 
61247277 T A 
61247324 G C 
61248328 T G 
61248415 C CT 
61250069 AT A 
61250267 A C 




61252577 C T 
61252689 TCTG T 
61252910 A AG 
61254081 CATGT AATGG 
61255943 A G 
61256419 T A 
61258164 AGTGGCCTAA GGTGGCCTAA,GGTGGCCTAC 
61258363 T C 
61258744 C T 
61258774 CTT C 
61258868 T G 
61258906 ATGA TCTT 
61259076 T G 
61259876 C A 
61262188 T C 
61262517 AG CA,CG 
61262834 G C,T 
61263699 A T 
61263848 A G 
61264085 TAAGTTAGAAGATAG CAAGTTAGAAGATAA 
61264492 C G 
61265325 G T 
61265383 AAG GAA 
61267404 C T 
259 
 
61271979 T C 
61272088 T G 
61272563 CACAA TACAA,TACAT 
61272600 T C 
61274339 C T 
61274752 AATGGGC GATGGGC,GATGGGT 
61274854 G GA 
61274950 C T 
61276616 ACT A 
61276989 TGACAAATAAAC AGACAAATAAAA,AGACAAATAAAC 
61278501 C T 
61281451 C G 
61281492 G A 




61281694 A G 
61282730 CATGGCAAGA TATGGCAAGG 
61282879 T TAAA 
61283039 T TTTTTATTTTATTTATTTTATTTTA 
61283136 T TTTTTTGTTG,TTTTTTTGTTGTTG 
61283508 GGAAAAA GAG 
61284432 C A 
61285186 T C 
61285305 T TAA,TA 
61286095 AATTTTT A 
61286424 A G 
61286641 G T 
61287796 G A 
61287813 A T 
61290789 T C 
61306616 ATT A,AT 
61331648 T A 
61373554 CGTTT CGTTTGTTT,C 
61376126 CGCAT C 
61376261 CACAAATATTGT GACAAATATTGC,GACAAGTATTGT 
61376333 C CAGAG 
61377534 CTGGTTGTG TTGGTTGTA 
61377776 T C 
61378126 G A 
61378382 C T 
61381005 TTCTC TCTCTC,T 
61381205 T A 
260 
 
61381670 T A 










61393645 T C 
61394050 G T 
61394062 G A 
61394068 GAAGA G 
61394075 C A 
61406265 CTT C 
61407704 TGTTCAGAA CGTTCAGAA,CGTTCAGAC 
61407920 A G 
61407998 G T 
61408820 G A 
61411415 C T 
61412572 G GA 
61415543 T C 
61415634 TTTTTTTTTTT GTTTTGTTTTG 
61415991 G A 
61416503 G GT 
61419324 TTTC T 
61420218 C CAATAAATAAATA,CAATAAATAAATAAATA 
61420225 CAAAC TAAAC,TAAAT 
61421201 TA TAA,T 
61422615 T C 
61428232 G A 
61428302 G A 
61428495 G A 
61429847 A AAGAGAGAGAG,AAGAGAGAGAGAGAGAG 
61431382 GCCTGCAGCCA ACCTGCAGCCG 
61433428 TGATTCAAT CGATTCAAC 
61434837 CA C 
61437360 C A 
61438274 C T 
61439951 G GA 
61440216 C CAT 
61440933 C A 
61441283 AG CT 
61441819 T C 
61442856 AT A 
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61443055 TAA TAAA,T 
61443079 A AT 
61443476 C T 
61444195 CTGACCCTTT TTGACCCTTG 
61445225 C G 
61445273 T A 
61445408 C T 
61445463 A G 
61446470 G A 
61448221 G A 
61448429 G A 
61448704 G A 
61449347 C T 
61449742 C T 
61449822 A G 
61449918 TGCCATGAGGACCG CGCCATGAGGACCA 
61460566 G C 
61461747 GGATAGATA G,GGATAGATAGATA 
61462213 TTTTTTTTTT ATTTTTTTTA 




61463119 G A 
61492288 TCTAGTACATTT ACTAGTACATTC,ACTAGTACATTT 
 
Supplementary Table 2 - List of Remaining Variants. Variants passing filtering criteria when aligned 










Breed n A/A G/A G/G N/N 
Disease Allele 
Frequency 




72 (18) 2 
(0.5) 
0.572 




2 (8.3) 0 (0) 0.854 




0 (0) 0.116 
Staffordshire Bull Terrier 8 0 (0) 2 (25) 6 (75) 0 (0) 0.125 
German Spitz (Mittel) 8 0 (0) 1 
(12.5) 
7 (87.5) 0 (0) 0.063 
Pomeranian 8 0 (0) 1 
(12.5) 
7 (87.5) 0 (0) 0.063 
Afghan Hound 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Airedale Terrier 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Akita 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Alaskan Malamute 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Alpine Dachsbracke 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
American Bulldog 2 0 (0) 0 (0) 2 (100) 0 (0) 0 
Appenzeller Cattle Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Australian Cattle Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Australian Kelpie 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Australian Shepherd 18 0 (0) 0 (0) 18 (100) 0 (0) 0 
Barbet 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Basset Hound 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Bavarian Mountain Hound 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Beagle 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Bearded Collie 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Bedlington Terrier 4 0 (0) 0 (0) 4 (100) 0 (0) 0 
Belgian Shepherd (Miniature Spitz) 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Bernese Mountain Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Bichon Frise 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Border Collie 17 0 (0) 0 (0) 17 (100) 0 (0) 0 
Borzoi 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Boston Terrier 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Boxer 8 0 (0) 0 (0) 7 (87.5) 1 
(12.5) 
0 
Bull Terrier 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Bullmastiff 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Cairn Terrier 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Cão da Serra de Aires 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Cavalier King Charles Spaniel 10 0 (0) 0 (0) 10 (100) 0 (0) 0 
Chesapeake Bay Retriever 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Chinese Crested Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
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Chinese Shar-Pei 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Chow Chow 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Collie 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Curly Coated Retriever 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Czechoslovakian Wolfdog 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Dachshund 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Dalmatian 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Doberman 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Dogue de Bordeaux 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Elo 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
English Cocker Spaniel 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
English Pointer 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
English Springer Spaniel 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Entlebucher Cattle Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Eurasier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Flat Coated Retriever 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
German Hound 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
German Hunting Terrier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
German Shepherd Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
German Short-haired Pointer 5 0 (0) 0 (0) 5 (100) 0 (0) 0 
German Spaniel 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
German Spitz (Giant Spitz) 6 0 (0) 0 (0) 6 (100) 0 (0) 0 
German Spitz (Keeshound) 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
German Spitz Klein 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
German Wirehaired Pointer 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Giant Schnauzer 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Golden Retriever 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Gordon Setter 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Great Dane 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Greater Swiss Mountain Dog 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Greyhound 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Hovawart 5 0 (0) 0 (0) 5 (100) 0 (0) 0 
Irish Red Setter 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Irish Setter 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Irish Terrier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Jack Russel Terrier 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Kromfohrländer 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Labrador Retriever 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Lagotto Romagnolo 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Lakeland Terrier 6 0 (0) 0 (0) 6 (100) 0 (0) 0 
Landseer 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Leonberger 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
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Maltese 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Mastiff 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Miniature Bull Terrier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Miniature Pincscher 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Miniature Schnauzer 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Mixed 2 0 (0) 0 (0) 2 (100) 0 (0) 0 
Mudi 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Newfoundland 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Norfolk Terrier 12 0 (0) 0 (0) 17 (100) 0 (0) 0 
Nova Scotia Duck Tolling Retriever 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Papillon 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Pekingese 2 0 (0) 0 (0) 2 (100) 0 (0) 0 
Perro de Agua Espanõl 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Peruanischer Hairless Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Picardy Sheepdog 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Polish Lowland Sheepdog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Poodle 14 0 (0) 0 (0) 14 (100) 0 (0) 0 
Pug 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Rhodesian Ridgeback 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Rottweiler 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
Saluki 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Schapendoes 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Scottish Terrier 17 0 (0) 0 (0) 17 (100) 0 (0) 0 
Shetland Sheepdog 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Shih Tzu 13 0 (0) 0 (0) 13 (100) 0 (0) 0 
Siberian Husky 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Sloughi 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Slovak Rough-Haired Pointer 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
St. Bernard 7 0 (0) 0 (0) 7 (100) 0 (0) 0 
Standard Schnauzer 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
Tibetan Terrier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Vizsla 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
West Highland White Terrier 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Whippet 9 0 (0) 0 (0) 9 (100) 0 (0) 0 
White Swiss Shepherd Dog 8 0 (0) 0 (0) 8 (100) 0 (0) 0 
Yorkshire Terrier 1 0 (0) 0 (0) 1 (100) 0 (0) 0 
 
Supplementary Table 3 - Multiple Breeds Genotyped for ADAMTS3 Variant. ADAMTS3:c.2786G>A 
genotypes of 1,353 dogs from up to 114 different breeds. The total number of dogs genotyped per 
breed (n) is given and the frequency of genotypes within breeds is given in brackets as a percentage. 
